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Abstract 
Iridium-catalyzed C-H borylation is an attractive method for synthesis of heteroaromatic 
boronate esters. Disappointingly however the Lewis-basicity of azinyl heterocycles limits 
their application in this methodology due to coordination to the iridium catalyst. 
Furthermore, the propensity for certain heteroaromatic boronate esters to undergo 
protodeborylation limits their application in downstream or one-pot chemistries.  
Coordination to the iridium catalyst can be disrupted by substituents ortho to the azinyl 
nitrogen, for example 2-substituted pyridines and protected indazoles undergo reaction 
efficiently. Following this hypothesis, the direct functionalisation of pyridines, pyrazines, 
pyrimidines, pyridazines, isoquinolines, indazoles and aza-indazoles has been 
demonstrated.  
When the ortho-substituent is sufficiently electron withdrawing it accelerates the 
formation of ortho-azinyl boronate esters which are typically disfavoured due to 
coulombic repulsion between an emerging negative charge at the site of C-H activation 
and the ortho co-planar azinyl lone pair. Moreover, electron withdrawing ortho 
substituents also sufficiently stabilise ortho-azinyl boronate esters to enable their 
isolation, for example methyl-2-fluoro-6-(Bpin)-isonicotinate and 1-mesyl-3-(Bpin)-
indazole were stable to column chromatography. Where isolation is not possible the 
boronate esters can be used in one-pot Suzuki-Miyaura cross-coupling transformations 
to enable the synthesis of pharmaceutically interesting biaryls in good yields. Exploiting 
the functional group tolerance of C-H borylation, the reaction of functionalised starting 
materials has enabled the multidirectional synthesis of compound libraries following 
downstream modifications. In alternative downstream sequences reduction of ortho-halo 
substituents provides products arising from functionalisation of an unhindered azinyl 
heterocycle. 
  
5 
 
Abbreviations 
aq – aqueous  
ASAP – atmospheric pressure solid analysis probe 
ATR – attenuated total reflectance 
bpy – 2,2’-Bipyridine 
Boc – tert-butoxycarbonyl 
ca.  – circa 
Cat – catecholato 
cat. – catalytic  
COD – 1,5-cyclooctadiene 
COE – cyclooctene 
COSY – correlation spectroscopy 
Cp - cyclopentadienyl 
Cp*- pentamethylcyclopentadienyl 
cymene – 4-isopropyltoluene 
DCM- Dichloromethane 
DFT – Density functional theory 
Diglyme – diethylene glycol dimethyl ether 
DMAP – 4-dimethylaminopyridine 
DMAc – N,N-Dimethylacetamide  
DME – 1,2-dimethoxyethane 
6 
 
dmpe – 1,2-bis(dimethylphosphino)ethane 
dmphen – 2,9-dimethyl-1,10-phenanthroline 
DoM – directed ortho metallation 
dppb – 1,4-bis(diphenylphosphino)butane 
dppe – 1,2-bis(diphenylphospino)ethane 
dppf –1,1’-bis(diphenylphosphino)ferrocene 
dtbpy – 4,4’-Di-tert-butyl-2,2’-bipyridine 
eg – Ethyleneglycolato  
EI – electron ionisation 
eq. – equivalents 
ESI – electrospray ionisation  
etc. et cetera 
FID – flame ionisation detector 
GC/MS – Gas chromatography/mass spectrometry 
h – hour(s) 
HMBC – heteronuclear multiple bonds correlation 
HSQC – heteronuclear single quantum coherence 
Hz - Hertz 
ind – indenyl 
IR – infra-red 
LC/MS – liquid chromatography/mass spectrometry 
m – meta 
7 
 
m/z – mass to charge ratio 
min – minutes 
Ms - mesyl 
MTBE – methyl-tert-butylether 
μW – microwave 
neo – neopentyl glycolato 
NMM- N-Methylmorpholine 
NMR – nuclear magnetic resonance 
NOESY – nuclear Overhauser effect spectroscopy 
o – ortho 
Oxone® - potassium peroxymonosulfate 
p – para 
pin – pinacolato 
pKa – Acid dissociation constant 
ppm – parts per million 
quant. – quantitative  
ref. – reference(s) 
rt – room temperature 
SEM – 2-(Trimethylsilyl)ethoxymethyl 
SM – starting material 
TC – thiophene-2-carboxylate 
TLC – thin layer chromatography 
8 
 
TSA – toluenesulfonic acid 
tmphen – 3, 4, 7, 8-tetramethyl-1, 10-phenanthroline 
UV – ultraviolet 
  
9 
 
Catalyst and Ligand Glossary 
 
  
Si POSi
O
O
O
Si-SMAP
P
iPr
iPr
iPr
PdH2N Cl
2ndGenPdXPhos
P
iPr
iPr iPr
XPhos
P
Me2N
DavePhos
P
OCH3
H3CO
SPhos
PdP
Cl
Cl
PMe2N NMe2
tBu
tButBu
tBu
Pd(Amphos)Cl2
10 
 
Table of Contents 
1 Introduction................................................................................................................ 16 
1.1 General Introduction to Thesis ........................................................................ 16 
1.2 Boronic Acids; Bonding, Physical Properties and Derivatives ....................... 16 
1.2.1 Boronic Acid Derivatives ............................................................................. 18 
1.3 Synthetic Routes to Boronic Acids and their Derivatives ............................... 19 
1.3.1 C-X Borylation Methods .............................................................................. 19 
1.3.1.1 Trapping of Organometallic Reagents ................................................ 19 
1.3.1.2 Transmetallation from Organosilanes ................................................. 23 
1.3.1.3 Catalytic C-X Borylation ...................................................................... 23 
1.3.1.4 Metal-Free C-X Borylation .................................................................. 26 
1.3.2 C-H Borylation ............................................................................................. 28 
1.3.2.1 Electrophilic C-H Borylation ................................................................ 28 
1.3.2.2 Catalytic C-H Borylation ...................................................................... 29 
1.3.3 Synthesis of Boronic Acid Derivatives ........................................................ 30 
1.4 Synthetic Applications ..................................................................................... 31 
1.4.1 Suzuki-Miyaura Cross-Coupling ................................................................. 32 
1.4.1.1 Substrate Scope – Electrophile .......................................................... 32 
1.4.1.2 Substrate Scope – Nucleophile .......................................................... 35 
1.4.1.2.1 Boronic Acids in Suzuki-Miyaura Cross-Coupling ........................ 35 
1.4.1.2.2 Boronate Esters in Suzuki-Miyaura Cross-Coupling .................... 36 
1.4.1.2.3 Boronamides in Suzuki-Miyaura Cross-Coupling ......................... 37 
11 
 
1.4.1.2.4 Trifluoroborate Salts in Suzuki-Miyaura Cross-Coupling ............. 37 
1.4.1.2.5 MIDA Boronates in Suzuki-Miyaura Cross-Coupling ................... 38 
1.4.1.3 ‘One-pot’ borylation/Suzuki-Miyaura Cross-Coupling Protocols ........ 40 
1.4.2 Oxidative Heck Coupling ............................................................................. 40 
1.4.2.1 Variation in Oxidant ............................................................................. 43 
1.4.2.2 Ligand-Assisted Protocols .................................................................. 43 
1.4.2.3 Substrate Scope – Boron Component ................................................ 44 
1.4.2.4 ‘One-pot’ Borylation/Oxidative Heck Coupling Protocols ................... 44 
2 Borylation of Azinyl Heterocycles ............................................................................. 45 
2.1 Catalytic aromatic C-H borylation ................................................................... 45 
2.1.1 History of Catalytic C-H borylation .............................................................. 45 
2.1.2 Mechanistic Discussion ............................................................................... 49 
2.1.2.1 In-situ active catalyst formation .......................................................... 51 
2.1.2.2 Oxidative Addition ............................................................................... 52 
2.1.2.3 Reductive Elimination ......................................................................... 53 
2.1.2.4 Catalyst Recycling ............................................................................... 53 
2.1.2.5 The HBpin Cycle ................................................................................. 54 
2.1.3 Substrate scope .......................................................................................... 55 
2.1.3.1 Borylation of Aromatic Substrates ...................................................... 55 
2.1.3.2 Borylation of Heteroaromatic Substrates ............................................ 58 
2.1.4 Borylation of Substituents Bearing an Azinyl Nitrogen ............................... 60 
2.1.4.1 Pyridyl-Boron Interactions ................................................................... 60 
12 
 
2.1.4.2 Pyridyl-Iridium Interactions.................................................................. 62 
2.1.4.3 Borylation of 2-Substituted Pyridines .................................................. 63 
2.1.4.4 Competition Experiments .................................................................... 64 
2.1.4.5 ortho-Azinyl Boronate Esters .............................................................. 64 
2.1.5 Protodeborylation ........................................................................................ 66 
2.2 Previous Work and Chapter Goals ................................................................. 67 
2.3 Results and Discussion ................................................................................... 73 
2.3.1 Borylation of 2-Substituted pyridines .......................................................... 73 
2.3.2 Borylation of 2,3-Disubstituted pyridines .................................................... 77 
2.3.2.1 Tandem Suzuki-Miyaura Cross-Coupling Reactions ......................... 82 
2.3.3 Borylation of 2,4-Disubstituted Pyridines .................................................... 84 
2.3.3.1 Tandem Suzuki-Miyaura Cross-Coupling Reactions ......................... 87 
2.3.4 Borylation of 2,5-Disubstituted Pyridines .................................................... 88 
2.3.4.1 Tandem Suzuki-Miyaura Cross-Coupling Reactions ......................... 91 
2.3.5 Multi-Directional Synthetic Strategies ......................................................... 92 
2.3.5.1 2-Chloro Reduction Sequence ............................................................ 93 
2.3.5.2 SNAr Substitution of Aryl-2-Halopyridines ........................................... 94 
2.3.6 Borylation of Other Azinyl Heterocycles ..................................................... 96 
2.3.6.1 Borylation of Pyrazines ....................................................................... 97 
2.3.6.1.1 Tandem Suzuki-Miyaura Cross-Coupling Reactions ................... 99 
2.3.6.1.2 ipso-Deuteration of (Bpin)-Pyrazine............................................ 100 
2.3.6.2 Borylation of Pyrimidines .................................................................. 101 
13 
 
2.3.6.2.1 Solvent Screen ............................................................................ 102 
2.3.6.2.2 Borylation of 2-Phenylpyrimidine ................................................ 104 
2.3.6.3 Borylation of Indazole ....................................................................... 106 
2.3.6.4 Borylation of Pyridazines .................................................................. 107 
2.3.6.5 Borylation of Isoquinolines ................................................................ 110 
2.3.6.6 Borylation of 1,8-Naphthyridine ........................................................ 113 
2.3.6.7 Borylation of Pyridine-N-oxides ........................................................ 114 
2.4 Conclusions and Future Work ...................................................................... 116 
3 Multidirectional Synthesis of Functionalised Indazoles .......................................... 118 
3.1 Background and Chapter Aims ..................................................................... 118 
3.2 Results and Discussion ................................................................................. 119 
3.2.1 Borylation of 3-Bromoindazole .................................................................. 119 
3.2.2 Borylation of Protected Indazoles ............................................................. 121 
3.2.2.1 Attempted Traceless Protecting Group Strategies ........................... 121 
3.2.2.2 Borylation of N-protected Indazoles ................................................. 124 
3.2.2.3 Tandem ‘one-pot’ Borylation/Suzuki-Miyaura cross-couplings ........ 132 
3.2.2.4 Multidirectional Synthesis of Functionalised Indazoles .................... 135 
3.2.2.4.1 Borylation of Bromoindazoles ..................................................... 135 
3.2.2.4.2 Borylation of 4-Bromoindazole .................................................... 139 
3.2.2.4.3 Suzuki-Miyaura Cross-Coupling of 3-Aryl-Bromoindazoles ....... 141 
3.2.2.4.4 Attempts at Directed Borylation of Indazole ............................... 143 
3.2.2.4.5 Attempted ipso-Deuteration of 3-(Bpin)-Indazole ....................... 145 
14 
 
3.2.2.4.6 Selective Protodeborylation of Polyborylated Indazoles ............ 148 
3.2.2.4.7 Synthesis of 1,3-bis-Arylindazoles .............................................. 152 
3.2.3 Borylation of Pyrazolo[1,5-a]pyridine ........................................................ 153 
3.2.4 Borylation of Pyrazolo[1,2-a]pyridine ........................................................ 156 
3.2.5 Borylation of Azaindazoles........................................................................ 159 
3.2.5.1 Substrate Synthesis .......................................................................... 159 
3.2.5.2 Attempted Borylation of 6-Azaindazole ............................................ 161 
3.2.5.3 Borylation of 4-Azaindazole .............................................................. 161 
3.2.5.4 Borylation of 7-Azaindazole .............................................................. 163 
3.3 Conclusions and Future Work ...................................................................... 166 
4 Development Towards a ‘One-pot’ C-H Borylation/Oxidative Heck Coupling Protocol
 170 
4.1 Aims and objectives ...................................................................................... 170 
4.2 Previous work in the group ........................................................................... 170 
4.3 Results and Discussion ................................................................................. 172 
4.3.1 Preliminary Results ................................................................................... 172 
4.3.2 Optimisation Studies ................................................................................. 174 
4.3.3 Aromatic Substrate Screening Exercise ................................................... 179 
4.4 Conclusions and future work ........................................................................ 182 
5 Experimental ........................................................................................................... 183 
5.1 General Considerations ................................................................................ 183 
5.2 General Methods ........................................................................................... 186 
15 
 
5.3 Experimental Details ..................................................................................... 192 
6 Bibliography ............................................................................................................ 258 
7 Appendix ................................................................................................................. 266 
  
16 
 
1 Introduction 
1.1 General Introduction to Thesis 
Due to their applicability in a variety of bond-forming reactions and functional group 
transformations, boronic acids and their derivatives are an extremely desirable class of 
synthetic intermediate. Reflecting this, efficient routes to these compounds are an 
important tool for organic chemists. This thesis describes an expedient method, using 
direct C-H activation, towards (hetero)aromatic boronate esters and their applicability in 
one-pot reactions. Chapter 2 will explore the application of C-H borylation to stubborn 
heterocycles that contain a Lewis-basic azinyl nitrogen. Chapter 3 will apply the findings 
and strategies developed in Chapter 2 to a focussed case study on the borylation of 
indazoles. Finally, Chapter 4 will discuss work undertaken towards the development of 
a one-pot single-solvent C-H borylation/oxidative Heck-coupling protocol. The remainder 
of this chapter will discuss the various routes to boronic acids and their derivatives, as 
well as their use in functional group transformations and bond forming reactions, with 
specific focus on their application in the Suzuki-Miyaura cross-coupling reaction and the 
oxidative Heck coupling. 
  
1.2 Boronic Acids; Bonding, Physical Properties and Derivatives 
Boronic acids are trivalent compounds with two bonds to hydroxyl groups and one bond 
to an organic (‘R’) group (1). The sp2-hybridized boron atom possesses a low energy, 
non-bonding vacant p orbital orthogonal to the plane of the molecule, which dominates 
its physical characteristics and reactivity patterns (Figure 1). Its susceptibility to electron 
donation from Lewis-basic donor groups enables the formation of tetrahedral ‘ate’ 
complexes, themselves possessing different patterns of reactivity and chemical 
properties.  
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Figure 1: General structure of boronic acids and esters 
 
Boronic acids are generally considered chemical and air stable compounds, however 
over prolonged periods atmospheric oxidation gives rise to boric acids.1 Moreover, under 
anhydrous conditions, boronic acids (2) have a propensity to form oligomeric anhydrides, 
such as trimeric boroxines (3), which can complicate characterisation and analysis 
(Scheme 1). In a practical sense this often necessitates the use of excess boronic acid 
in reactions. 
 
 
Scheme 1: Dehydrative oligomer formation 
 
In addition, the long-term stability and reactions of some aryl boronic acids are also 
plagued by potential protolytic pathways, which can cleave C-B bonds despite it being a 
relatively strong bond (323 kJ mol-1 versus 358 kJ mol-1 for C-C bonds).2 These 
deborylation pathways may occur by acid3, base4 or metal-mediated5 mechanisms. This 
phenomena is discussed more fully in Chapter 2. 
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With the development of the Suzuki-Miyaura cross-coupling process (Scheme 2),6 the 
need for novel, bench-stable reagents prompted an exploration of various boronic acid 
derivatives that circumvent, at least in part, many of these problems.7  
 
 
Scheme 2: Seminal application of boronic acids in the synthesis of biaryls 
 
1.2.1 Boronic Acid Derivatives 
The most commonly employed boronic acid derivatives used in modern cross-coupling 
chemistry are outlined below (Figure 2). 
 
 
Figure 2: Aryl boronic acid and its derivatives 
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Due to the varying electronic character of the p orbital, the displayed derivatives often 
exhibit unique stabilities and reactivity patterns. The relative stability is best exemplified 
in their varying Suzuki-Miyaura cross-coupling applications, which is discussed later in 
this chapter (c.f Section 1.4.1.2).  
 
1.3 Synthetic Routes to Boronic Acids and their Derivatives 
For over a century, the chemistry undertaken to utilise and synthesise arylboronic acids 
was limited, however, since the development of the groundbreaking cross-coupling 
reaction by Suzuki and Miyaura (c.f Scheme 2), a greater emphasis has been placed on 
developing robust, economical and efficient routes to these compounds. The following 
section will discuss their various methods of preparation, emphasising the respective 
advantages and disadvantages. This section focuses on routes to aryl boronic acids and 
their derivatives and consequently will not cover methods solely applicable to the 
synthesis of alkyl, vinyl and alkynyl boronic acids. 
 
1.3.1 C-X Borylation Methods 
The following section will explore and discuss the various functional group transformation 
routes to aryl boronic acids and esters. 
 
1.3.1.1 Trapping of Organometallic Reagents 
The seminal report on the synthesis of a boronic acid (16) involved the treatment of 
diethylzinc with triethylborate (14) with subsequent auto-oxidation of the borane (15) to 
yield the boronic acid (Scheme 3).8 
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Scheme 3: Seminal synthesis of a boronic acid 
 
This approach has since been developed to provide the classical synthesis of boronic 
acids, by way of a metallation step, typically to form either a Grignard or organolithium 
reagent, with subsequent quenching by a boron electrophile. The class of boron 
electrophile applied may vary, with borates (18) (Figure 3a), boronates (21) (Figure 3b), 
boranes, such as pinacol borane (HBpin, 24), (Figure 3c) and boron halides (27) (Figure 
3d) all applicable.9-11 A standard aqueous workup hydrolyses the labile boronate ester 
substituent, furnishing the desired boronic acid product (19, 28). However, in most cases 
(reflecting their ease of purification and greater solubility in organic solvent) organic 
chemists will often isolate the borate or boronate ester (22, 25, 30) (Figure 3b, c). Several 
examples are also reported in which (trans)esterification is included within the sequence 
(Figure 3e).12,13 
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Figure 3: Organoboronic acid/ester synthesis by electrophilic trapping of aryl metal 
intermediates 
 
Whilst transmetallation occurs most commonly from aryl lithium or magnesium 
intermediates, within the literature there also exists similar scope for trapping of 
organocadmium14, zinc14 and mercury species.9 However, these examples are less 
common and suffer from the use of toxic metals.  
In addition to direct metallation of carbon-halogen bonds, it has been demonstrated that 
ortho directing functional groups, such as ethers11, carbamates (31)15, esters16 and 
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amides17 can direct metallation to neighbouring C-H bonds, in a process known as 
directed ortho metallation (DoM) (Scheme 4). 
 
 
Scheme 4: Directed ortho-metallation approach to aromatic borylation, utilising a carbamate 
directing group 
 
DoM has found large scale industrial application, for example in the synthesis of the 
antihypertensive drug Losartan (36), in which the initial metallation step is directed by a 
tetrazole moiety (33) (Scheme 5).18 
 
 
Scheme 5: Application of DoM towards the total synthesis of Losartan® 
 
Despite their having found application on large industrial scale and in target syntheses, 
direct C-X borylation, via reactive aryl metal intermediates, and DoM methodologies are 
restrictive in their use. The invoking of strongly nucleophilic and/or basic reagents is not 
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only a practical hindrance, due to the requirement for low temperatures and stringent 
anhydrous conditions, it also limits substrate scope as a number of common functional 
groups such as amides, esters and nitriles, are recalcitrant with this methodology (c.f 
Figure 3). This means that when applying these reactions in target syntheses, it is usually 
prudent to incorporate protection steps for potentially sensitive functional groups. With 
the recent drive towards greener chemistries, organic chemists have attempted to limit 
the use of protecting groups where possible as each functional group adds two additional 
steps in linear syntheses. As a consequence, reactions that preclude the use of hard 
anions or nucleophiles are often invoked.  
 
1.3.1.2 Transmetallation from Organosilanes  
The use of an ipso-borodesilylation protocol, which proceeds by transmetallation from a 
soft organosilane (38), has also been reported.11 The stability of the newly formed B-C 
and Si(Sn)-X bonds, relative to the weaker B-X and Si(Sn)-C bonds in the starting 
materials, provides a thermodynamic driving force for the reaction (Scheme 6). 
 
 
Scheme 6: ipso-borodesilylation of an in-situ generated arylsilane 
 
1.3.1.3 Catalytic C-X Borylation  
Reflecting an overall drive towards greener and sustainable processes, synthetic 
chemists will often use catalytic reactions to reduce steps and enable late-stage 
OMOM
37 38 39
OMOM
TMS
i) nBuLi
ii) TMSCl
OMOM
B(OH)2
i) BBr3
ii) aq. HCl
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modification of functionalised starting materials. One such direct, expedient approach to 
aryl boronate esters, which circumvented the need for strongly basic aryl metal 
intermediates, was proposed by Miyaura and co-workers.19,20 In the presence of catalytic 
palladium, aryl halides (40) (or pseudo-halides, 43) are cross-coupled with diboronate 
esters, such as bis(pinacolato)diboron (B2pin2, 41) (Figure 4a). The Masuda group 
reported an extension of this methodology, utilising metal hydride borylating agents, such 
as HBpin (24) or catechol borane, providing the added advantage of wider reaction scope 
(due to the more ready availability of dialkoxyborane reagents versus the corresponding 
diboronate esters) and greater atom economy (Figure 4b).21 More recently, the use of 
bis-boronic acid (46) has enabled direct synthesis of boronic acids (47),22,23 obviating the 
need for prior synthesis of the corresponding ester with subsequent additional 
hydrolysis,24 oxidative25 or reductive26 steps (Figure 4c). Direct routes to boronic acids 
are of great value due to their greater atom economy and reactivity in cross-coupling 
chemistry compared with the corresponding boronate esters.  
Copper-catalysed cross-coupling variations have been investigated by Zhu and Ma, who 
reported the synthesis of aryl boronates (49) catalysed by copper(I)iodide, in the 
presence of HBpin (24) and sodium hydride, from the substituent aryl iodides (48) (Figure 
4d).27 Substrate scope was expanded to include aryl bromides by Marder and co-
workers.28 Complementary iron-catalysed radical transformations of aryldiazonium salts 
(50) were described by Pucheault et.al (Figure 4e).29 The resulting aryl aminoboranes 
act as an intermediary species to boronate esters (52) and acids as well as trifluoroborate 
salts. The use of iron and copper catalysts are an attractive alternative to their palladium 
counterparts due to their relative abundance, affordability, lower toxicity and 
environmental innocuousness.  
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Figure 4: Catalytic C-X borylation strategies 
 
Cross-coupling methods between organic electrophiles and boron-nucleophiles provide 
a convenient and direct method for the synthesis of boronic acids and their derivatives. 
Such methods obviate the need for rigorously anhydrous reaction conditions and are, 
therefore, amenable to a wider substrate scope (due to increased functional group 
compatibility) arising from low reactivity and stability of the boron reagents as well as the 
absence of strongly basic reagents (c.f Figure 3). This enables access to a range of 
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structurally diverse functionalised (hetero)aryl boronic acids and esters. Use of 
potentially costly metal catalysts is, however, a hindrance. 
 
1.3.1.4 Metal-Free C-X Borylation  
Due to a declining global supply of heavy transition metals and the costly nature of 
certain transition-metal catalysts, a greater emphasis is being placed on developing new 
methodologies that circumvent their use. Recent advances in borylation chemistry reflect 
this drive, for example Wang and co-workers have developed a modified Sandmeyer 
process for conversion of aryl amines (53) into aryl boronates (54) (Figure 5a).30 Aryl 
amines are an attractive synthon for boronic acid synthesis due to their low cost and 
abundance (resulting from their ease of synthesis by prior nitration of arenes). This 
transformation utilises tert-butyl nitrite as a diazotisation agent to enable in-situ formation 
of the corresponding diazonium salts (55). The presence of catalytic benzoyl peroxide 
(BPO), as a radical initiator, enables the production of a variety of aryl boronates in short 
reaction times. The synthetic utility of this process was expounded further in one-pot 
borylation-Suzuki Miyaura cross-coupling reactions. A modification of this work, reported 
by Blanchet and co-workers, enabled access to the more reactive boronic acid products 
(57) (Figure 5b).31 
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Figure 5: Metal-free borylation of arylamines 
 
Diazotisation routes to boronic acids and esters benefit from experimental simplicity, 
short reaction times and wide functional group tolerance, however the in-situ formation 
of potentially hazardous diazonium salts is problematic. Furthermore, synthetic routes to 
these starting reagents are limited by product distribution from the prior aromatic nitration 
reaction.  
On a more general note, the synthetic utility of C-X borylation itself is limited by the 
requirement for pre-existing halide or amine functionality. As a result, starting materials 
often have to be purchased with the required functional group (which may in some cases 
increase costs), or functionality will need to be incorporated into the molecule, thereby 
reducing the overall efficiency of any reaction sequence. Consequently, reflecting the 
drive towards greener and more sustainable processes, there has been a growing focus 
on C-H activation routes to boron compounds. 
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1.3.2 C-H Borylation 
The following section will consider direct borylation of aromatic C-H bonds. These 
methods are of particular interest as they circumvent the requirement for pre-existing 
functionality and are more atom economical. 
 
1.3.2.1 Electrophilic C-H Borylation 
Ingleson and co-workers have reported a direct electrophilic borylation protocol. 32,33 This 
methodology relies on the in-situ formation of highly electrophilic, transient borenium 
cations (59), reacting effectively as [R2B]+, from commercially available boryl halide 
starting materials (Scheme 7).34 
 
 
Scheme 7 Direct electrophilic borylation of an indole substrate 
 
Electrophilic borylations generate catechol or pinacol esters (60) in short reaction times, 
however the requirement for stringent reaction conditions and the limited substrate 
substrate scope are factors which limit the widespread application of this methodology.32 
Moreover, only the borylation of electron-rich aromatics, N-heterocycles (58) and 
thiophenes have been reported to date.35 
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1.3.2.2 Catalytic C-H Borylation  
Catalytic C-H borylation, catalysed by in-situ generated iridium tris-boryl complexes, has 
a varied and diverse substrate scope. Due to the steric bias affecting C-H borylation 
reactions, regioselectivity is often dictated by steric effects and is, therefore, 
complementary to electrophilic borylation (Figure 6a).  
More recently, the respective groups of Chirik and Darcel have developed C-H borylation 
catalysed by pincer-ligated cobalt (64) and iron bis(diphosphine) complexes (67) 
respectively (Figure 6b, c).36,37 Iron and cobalt-catalysed variants represent an attractive 
future alternative due to the high cost and declining global supply of iridium but are still 
in their infancy and currently suffer from inconsistent yields and narrow substrate scope. 
 
 
Figure 6: Catalytic C-H borylation 
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The development of C-H borylation as a catalytic process, its reaction mechanism, 
substrate scope and regioselectivity are discussed in the next chapter and the work 
undertaken using this methodology will provide the backbone to this study. 
 
1.3.3 Synthesis of Boronic Acid Derivatives 
Whilst there are various direct C-H and C-X borylation protocols towards boronate 
esters, direct synthesis of the other boronic acid derivatives (by functional group 
interconversion or C-H activation methods) outlined in Figure 2, is not known. 
Consequently their synthesis involves reaction of the corresponding boronic acids or 
esters. For example, aryl trifluoroborate salts (12) are prepared from reaction of aryl 
boronic acids (4) or esters with potassium bifluoride (KHF2), or a combination of 
potassium fluoride (KF) and tartaric acid (Figure 7a).38-40 Alternatively, condensation of 
the boronic acid (69, 72) with diethanolamine ligands, such as N-methyliminodiacetic 
acid (70), or with 1,8-diaminonaphthalene (73), under Dean-Stark conditions, provide the 
N-coordinated (MIDA) ester (71) and B(dan) amide (74) respectively (Figure 7b, c).41 
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Figure 7: Synthesis of a) trifluoroborate salts; b) MIDA boronates; c) B(dan) amides 
 
1.4 Synthetic Applications 
Arylboronic acids and their derivatives are an extremely versatile class of organic 
intermediate that can act as precursors in a variety of carbon-carbon (C-C) and carbon-
heteroatom bond forming processes, as well as functional group transformations 
including; a. Suzuki-Miyaura cross-couplings; b. oxidative Heck couplings; c. conjugate 
additions;42,43 d. Chan-Lam aminations;44-46 e. Chan-Lam etherifications;46,47 f. ipso-
halogenations;48-54 g. oxidations;48,55-58 h. homologations;59 i. trifluoromethylations;60-66 j.  
azidations;67-69 k. nitrations;70,71 l. cyanations (Figure 8).72-75 Given the focus of this thesis 
and the work undertaken in this study, the following section will only explore the Suzuki-
Miyaura cross-coupling, with focus on the scope of organic electrophiles and boron 
nucleophiles permitted, and the oxidative Heck coupling. A thorough review of the other 
transformations can be found in the aformentioned references. 
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Figure 8 Synthetic applications of boronic acids and their derivatives 
 
1.4.1 Suzuki-Miyaura Cross-Coupling 
C-C bond forming reactions are extremely important tools to synthetic chemists as they 
allow the ‘building up’ of complex molecules from simple substrates and a movement 
towards more convergent syntheses, whereby complex precursors are prepared 
separately and subsequently ‘tied together’ at a late stage in the synthesis. Transition 
metal-catalysed cross-coupling reactions are among the most widely used for C-C bond 
formation, constituting 25% of all reactions carried out in the pharmaceutical sector (of 
which, the Suzuki-Miyaura cross coupling reaction makes up the largest proportion).23 
 
1.4.1.1 Substrate Scope – Electrophile 
The Suzuki-Miyaura cross-coupling reaction describes the direct coupling of 
organoboron nucleophiles (76) with halide or pseudohalide electrophiles (75) under 
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palladium or, in some cases, nickel catalysis (Figure 9a). Vast amounts of research has 
been undertaken, such that a variety of conditions now exist by which an array of aryl 
and heteroaryl halides, triflates (78)76 and tosylates (81) 77 can be routinely reacted in 
good yields even on large industrial scale (Figure 9b, c).78 
 
 
Figure 9: Examples of Suzuki-Miyaura cross-coupling 
 
Although less common, cross-coupling reactions have also been reported with 
diazonium compounds (84),79 aryl carbamates (86),80 aryl carbonates (88),81 thioesters 
(90)82 and thioethers (93) (Figure 10).83 
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Figure 10: Alternative Suzuki-Miyaura cross-coupling electrophiles 
 
Owing to the functional group tolerance, mild reaction conditions and ease of practical 
set-up, the Suzuki-Miyaura cross-coupling reaction is used routinely in the 
pharmaceutical, agricultural and polymer sectors as well as in the synthesis of molecular 
wires, liquid crystals and natural products.84-87 
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1.4.1.2 Substrate Scope – Nucleophile  
Another key advantage of the Suzuki-Miyaura cross-coupling is the scope of the 
organoboron component, with organoboranes, boronic acids, boronate esters, 
trifluoroborate salts, boronamides and MIDA boronates all tolerated. By exploiting their 
unique stabilities and reactivities, the choice of boron reagent can be tailored to the 
process or reaction requirements.  
 
1.4.1.2.1 Boronic Acids in Suzuki-Miyaura Cross-Coupling 
Given their superior reactivity, ease of synthesis and commercial availability, boronic 
acids are often the reagent of choice for synthetic chemists. Reflecting this, boronic acids 
(97) are often used in target syntheses, for example in the synthesis of Boscalid® (99) 
(Scheme 8), a multi-purpose fungicide, manufactured on a multi-tonne scale annually, 
and in the the synthesis of Losartan® (36) (c.f Scheme 5).88  
 
 
Scheme 8: Application of organoboronic acid cross-coupling towards the total synthesis of 
Boscalid 
 
However, due to their propensity to undergo side reactions such as homocoupling, 
oxidation and protodeborylation under aqueous conditions,89 as well as their tendency to 
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form oligomeric boroxines in anhydrous conditions (c.f Scheme 1), excess reagent is 
often required and yields can often be limited. Reflecting this, it is often prudent to use 
organoboronic acid derivatives. 
 
1.4.1.2.2 Boronate Esters in Suzuki-Miyaura Cross-Coupling 
Boronate esters represent an attractive alternative due to their relative cost, availability, 
ease of preparation, bench and chromatographic stability. The inductively donating 
capabilities of the carbon group result in increased conjugation of oxygen into the boron-
centre thereby reducing its Lewis acidity and reactivity. Owing to their enhanced stability 
the cross-coupling of the typically unstable 2-pyridyl moiety (100) has been carried out 
in excellent yields (Scheme 9).90 Reactions involving substrates such as these are 
pertinent to the studies described in Chapters 2 and 3. Reactions of ortho-azinyl boronic 
acids and esters are typically extremely difficult due to their tendency to undergo 
protodeborylation.   
 
 
Scheme 9: Application of boronate esters in the cross-coupling of the unstable 2-pyridyl moiety 
 
Modern C-H activation strategies have provided efficient routes to boronic esters and as 
such they are an attractive reagent for tandem or one-pot reactions. These processes 
are central to this thesis and will be explored in Chapters 2 and 3. 
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1.4.1.2.3 Boronamides in Suzuki-Miyaura Cross-Coupling 
Boronamides, such as B(dan) amides (103), possess complementary reactivity profiles 
to both boronic esters and acids (103), as well as MIDA boronates. The Lewis acidity of 
the boron atom is tempered by lone pair donation from the amine groups resulting in 
their stability to column chromatography and aqueous work-ups. Their distinct reactivity 
is exemplified by the requirement for aqueous acid to affect the hydrolysis to the 
substituent boronic acid required for cross-coupling. As such, the aqueous basic 
conditions typically employed for Suzuki reactions leave the B(dan) functionality intact 
(Figure 11a), enabling orthogonal, iterative cross-coupling strategies as demonstrated 
by Suginome and co-workers (Figure 11b).41 
 
 
Figure 11: Boron-masking capabilities of the B(dan) functionality 
 
1.4.1.2.4 Trifluoroborate Salts in Suzuki-Miyaura Cross-Coupling 
Trifluoroborate salts (109) are an ideal boron-masking agent due to their ease of handling 
and stability to both air and atmospheric moisture. Due to the tetravalency of the boron 
atom, the usual Lewis acidic properties are attenuated and as a result trifluoroborate 
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salts can effectively function as a boron protecting group, enabling distal functional group 
manipulations or iterative cross-coupling strategies.91-93 Their stability in anhydrous 
media enables site-selective reaction at distal boron functionality, such as boronic acids 
or boranes, whilst the trifluoroborate group remains intact.94 Upon addition of an 
activating quantity of protic solvent, reaction of the trifluoroborate moiety (110) is 
initiated, proceeding by prior hydrolysis to the free boronic acid (Scheme 10). Reactions 
involving trifluoroborate salts often proceed in superior yields than with the equivalent 
boronic acid, due to the suppression of the aformentioned side reactions (c.f Section 
1.4.1.2.1).95 
 
 
Scheme 10: Iterative cross-coupling application of an aryltrifluoroborate 
 
1.4.1.2.5 MIDA Boronates in Suzuki-Miyaura Cross-Coupling 
N-coordinated boronates, such as MIDA boronates (113), possess similar properties and 
reactivity patterns to the aforementioned trifluoroborate salts. The Lewis acidity of boron 
is masked by a dative bond between boron and a Lewis basic nitrogen atom. As a result 
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MIDA boronates are stable to column chromatography as well as a variety of reaction 
conditions, such as oxidation and reduction, and are applicable in similar iterative cross-
coupling sequences.96,97 In this instance aqueous base is required to trigger the MIDA 
boronate hydrolysis to the substituent boronic acid, which can then undergo cross-
coupling. Exploiting their boron-masking capabilities, Burke has reported their 
application in the automated flow-synthesis of natural product derivatives and small 
molecule scaffolds (118) (Figure 12a).87 MIDA boronates have also found application in 
the cross-coupling of traditionally unstable 2-pyridyl compounds (119), in which a slow-
release mechanism keeps the concentration of boronic acid low, minimising competing 
protodeborylation pathways (Figure 12b).98 
 
 
Figure 12: Suzuki-Miyaura cross-coupling applications of MIDA boronates 
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1.4.1.3 ‘One-pot’ borylation/Suzuki-Miyaura Cross-Coupling 
Protocols 
In order to improve efficiency and remove tedious separation and purifications of 
intermediates, chemists will often where possible try and combine multiple steps into one 
reaction vessel. A vast array of examples exist by which the process of C-X or C-H 
borylation can be combined with Suzuki-Miyaura cross-coupling into tandem one-pot 
processes (Figure 13).23,99-102 Such sequences will be further explored over the course 
of this thesis.  
 
Figure 13: Examples of tandem 'one-pot' borylation/Suzuki-Miyaura cross-coupling reactions 
 
1.4.2 Oxidative Heck Coupling 
In their separate seminal reports, Mizoroki, Heck and their respective co-workers 
described the direct coupling of arylation/vinylation of olefins (131) with aromatic (or 
vinylic) electrophiles (130), catalysed by palladium salts, now commonly referred to as 
the Mizoroki-Heck coupling (Scheme 11).103,104 
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Scheme 11: Seminal Mizoroki-Heck coupling 
 
A subsequent report by Heck and co-workers found that the olefin arylation could occur 
with nucleophilic organometalloid species, such as boronic acids (4).105 
Comparison of the reaction mechanism showed the key distinction to be in the formation 
of the arylpalladium intermediate; whilst the classic Mizoroki-Heck coupling required the 
oxidative addition of an aryl/vinyl halide to a Pd(0) active catalyst, the oxidative Mizoroki-
Heck variant proceeded via base-mediated transmetallation from the organometalloid 
species (4) to the active Pd(II) species (134). Consequently after elimination of the 
product (135) a reoxidation is required to regenerate Pd(II) from Pd(0) (Scheme 12). 
 
 
Scheme 12: Pd(II) catalysed oxidative Heck coupling 
 
The distinct mechanistic pathway has been proven by competition experiments, whereby 
the oxidative coupling is carried out in the presence of an organic halide (electrophile) 
(136).106,107 Analysis of the product ratio demonstrated that the reaction favoured 
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oxidative Heck product (139) formation over Heck (138) and Suzuki-Miyaura cross-
coupling products (140) (Scheme 13). 
 
 
Scheme 13: Suzuki-Miyaura/oxidative Heck competition experiment 
 
Exploiting this distinct mechanistic pathway, Jung and co-workers reported a 
chemoselective 3-component tandem oxidative Heck/Suzuki-Miyaura cross-coupling 
reaction (Scheme 14).108 
 
 
Scheme 14: Multi-component oxidative Heck/Suzuki-Miyaura cross-coupling reaction 
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1.4.2.1 Variation in Oxidant 
Common chemical oxidants employed in oxidative Heck couplings include copper and 
iron salts or organic oxidants, such as benzoquinone.109-111 Alternatively, molecular 
oxygen or air have also been employed, offering both practical and environmental 
advantages.106,112 Moreover, recent reports have demonstrated that in the absence of a 
formal oxidant the olefin reagent, present in stoichiometric excess, may also facilitate the 
reaction by acting as a hydride acceptor after elimination of the cross-coupled product.113  
 
1.4.2.2 Ligand-Assisted Protocols 
Further advances have been reported through ligand-assisted protocols (c.f Scheme 13 
and Scheme 14).114 As well as providing improved yields and facilitating the redox 
processes, chelating dinitrogen ligands have also enabled control of regioselectivity. For 
example, the arylation of electron-rich olefins, such as vinyl ethers or enamides (146), 
occurs predominantly at the electron-deficient alpha-position (147) (Scheme 15).115 
Conversely, the corresponding reaction carried out in the absence of 2,9-dimethyl-1,10-
phenanthroline (dmphen) gives the opposite regioisomer (148).  
 
 
Scheme 15: Regioselective oxidative Heck coupling example 
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1.4.2.3 Substrate Scope – Boron Component 
The scope for variation within the boron-component is somewhat limited, with substrate 
scope limited to aryl boronic acids and esters (pinacol (149) and neopentyl glycol esters 
(151) (Figure 14).106,107 Both electron-rich and electron-poor boronic acids and esters are 
well tolerated, as well as heteroaryl systems. 
 
 
Figure 14: Applications of boronate esters in oxidative Heck couplings 
 
1.4.2.4 ‘One-pot’ Borylation/Oxidative Heck Coupling Protocols 
Recent advances in routes to structurally diverse aromatic boronic esters and acids 
means that there is vast potential for improved reaction and substrate scope. 
Furthermore, whereas there is a diverse array of literature available detailing one-pot 
borylation/Suzuki-Miyaura cross-couplings, the analogous one-pot borylation/oxidative 
Heck couplings have not been reported. Attempts towards their development are 
described in Chapter 4. 
  
45 
 
2 Borylation of Azinyl Heterocycles 
2.1 Catalytic aromatic C-H borylation 
C-H activation has been a longstanding goal in synthetic chemistry and offers an 
expedient route by which traditionally unreactive C-H bonds can be cleaved and 
functionalised to yield more desirable and synthetically useful functionalities, avoiding 
the more classical approach of transforming pre-existing functional groups to achieve the 
desired functionality (c.f Section 1.3.1). This chemistry offers valuable new disconnection 
strategies for the construction of complex scaffolds as C-H bonds are ubiquitous in all 
organic molecules. As discussed in the previous chapter, the incorporation of boronic 
acid-derived functionality allows for a variety of downstream flexibility (c.f Figure 8). 
Building on this theme, this chapter will begin by reviewing the development of aromatic 
C-H borylation into a mild catalytic reaction, the postulated reaction mechanism and 
substrate scope of the reaction. From consideration of the reaction mechanism, 
strategies were gleamed for the borylation of stubborn azinyl heterocycles, which will 
form the focus of the remainder of the chapter. 
 
2.1.1 History of Catalytic C-H borylation 
The first observed C-H borylation product was noted in the supporting information of a 
paper published in 1993 by Marder and co-workers, in which the target was a trisboryl-
iridium complex (154).116 The reaction yielded trace amounts (<1% by GC/MS analysis) 
of two isomers of tolyboronate ester (155,156), which arose as a result of borylation of 
the toluene solvent (Scheme 16). This observation was not eluded to further in the main 
text and further developments on this work were not pursued at this time. 
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Scheme 16: First reported C-H borylation products 
 
The first stoichiometric borylations, proceeding by photochemically-induced decay of 
pre-prepared metal-boryl complexes ([Mn(CO)5BCat] (157), [Re(CO)5BCat] (158) and 
[Cp*Fe(CO)2BCat]) (159) in aromatic solvents, were reported by Hartwig et. al in 1995 
(Figure 15).117  
 
 
Figure 15: C-H borylation via photochemically-induced decay of metal-boryl complexes 
 
The earliest reported examples of aromatic C-H borylation as a catalytic process used 
[Cp*Ir(PMe3)(H)(Bpin)] (161),118 and [RhCl(PiPr3)2(N2)] (163) (Figure 16).119 However, 
these processes generally required high temperatures (in excess of 140 °C), high 
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catalysts loadings, long reaction times and suffered from chemoselectivity issues (166). 
Subsequent work was therefore focused towards solving these issues. 
 
 
Figure 16: First reported catalytic C-H borylation protocols 
 
In 2002, Smith and co-workers reported that in-situ generated phosphine-ligated iridium 
complexes could catalyse borylation reactions under milder conditions whilst avoiding 
some of the previously reported selectivity problems (Figure 17a).99 This methodology 
also circumvented the need for expensive or pre-formed boryl complexes, which can be 
expensive and difficult to synthesise, and improved the practical simplicity by enabling 
the mixing of simple starting materials in the arene (167, 171) of choice. The synthetic 
utility of this process was demonstrated in the first reported one-pot borylation/Suzuki-
Miyaura cross-coupling protocol (Figure 17b). 
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Figure 17: C-H borylation catalysed by phosphine-ligated Iridium complexes 
 
In a report published concurrently with Smith’s work, Hartwig, and co-workers reported 
borylations using in-situ generated bipyridine-ligated iridium complexes, which catalysed 
the reaction in higher turnover numbers than had previously been observed for 
preceeding catalytic borylation protocols (Figure 18a).120 This system was also the first 
reported aromatic C-H borylation to proceed at room temperature (Figure 18b). 
 
 
Figure 18: C-H borylation catalysed by bipyiridine-ligated iridium 
 
Later work carried out by the same group in 2002 investigated various factors including 
ligand substituents, iridium precursors, substituent effects and plausible reaction 
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solvents.121 It was found that the most effective iridium complexes were comprised from 
alkoxy-iridium precursors (178) with bipyridine ligands (176, 179) containing electron-
donating substituents (tBu, NMe2 and OMe) at the para-position. Whilst most prior 
reported C-H borylation reactions were carried out in neat arene, the findings of Hartwig 
and Ishiyama enabled the use of low polarity, non-coordinating solvents such as hexanes 
(Figure 18b).  
One main attraction to iridium-catalysed C-H borylation is the experimental simplicity, 
with pre-mixing of pre-catalyst, ligand and bis-boryl reagent generating the active catalyst 
in-situ. The combination of [Ir(COD)OMe]2 (178) and dtbpy (179) is still the most widely 
used catalytic system by synthetic chemists, though recent findings of Smith, Hartwig 
and their respective groups, suggest improved reactivity may be attained through the 
use of phenanthroline-based ligands, such as 3,4,7,8-tetramethyl-1,10-phenanthroline 
(tmphen, 182) (Scheme 17).122,123 
 
 
Scheme 17: Comparative performance of Me4Phen ligand vs dtbpy 
 
2.1.2 Mechanistic Discussion 
C-H borylation catalysed by either phosphine or bipyridine-ligated iridium complexes is 
believed to follow a similar mechanistic pathway. Since the latter is more commonly used 
and represents the catalytic system used in this study, this discussion will focus on this 
particular system.99 
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In light of prior knowledge gleamed from iridium redox chemistry, two mechanistic 
possibilities were considered; i) an Ir(I)/Ir(III) catalytic cycle or ii) an Ir(III)/Ir(V) catalytic 
cycle. A computational investigation conducted by Sakaki and co-workers suggested the 
active catalyst to be Ir(III).124 The basis for this was the calculated activation energy of 
oxidative addition of B2pin2 to an Ir(I)boryl complex, which was  considerably lower than 
the calculated activation energy of the oxidative addition of arene. In addition the 
activation energy barrier to reductive elimination of B2pin2 from an Ir(III)trisboryl complex 
exceeded the experimentally determined energy barrier of C-H bond cleavage during 
oxidative addition. On these grounds the potential intermediacy of an Ir(I) complex was 
discounted. These findings have been experimentally supported by Hartwig et.al, who 
have observed an Ir(III)trisboryl complex in catalytic reaction mixtures.120 Moreover, 
reactions involving a pre-formed Ir(III)trisboryl complex showed it to possess excellent 
catalytic activity.125 The overall catalytic cycle as determined by computational 
calculations and experimental observations is given below (Figure 19);  
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Figure 19: Catalytic cycle 
 
The key steps in the catalytic cycle are summarised in the following sections. 
 
2.1.2.1 In-situ active catalyst formation 
It was hypothesised that in-situ formation of the active catalyst could proceed via initial 
dissociation of alkene ligand (cyclooctadiene or cyclooctene) (from [Ir(COD)OMe]2 (178) 
or [Ir(COD)Cl]2) (189) with subsequent coordination of bipyridine (bipy) ligand (Figure 
20). The electron-donating ability of the bipyridine ligand can subsequently supplement 
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the oxidative addition of bis-boryl reagents. DFT calculations found that reductive 
elimination of Cl-Beg from IrCl(Beg)2(bipy) to be highly unfavourable as the reaction was 
found to be very endothermic. It was calculated that prior oxidative addition of a second 
molecule of diboron reagent with subsequent Cl-Beg reductive elimination was more 
energetically favourable, thus reinforcing the intermediacy of Ir(III)trisboryl complexes. 
Hartwig and co-workers have also noted the observance of an induction period 
corresponding to required reduction of COD to COE.120 This induction period is 
eliminated with added catalytic quantities of HBPin or with pre-catalysts bearing COE 
ligands. It was shown that overall the reaction is inverse first order with respect to added 
COE (185), which supported the theory of reversible dissociation of COE prior to 
oxidative addition. 
 
2.1.2.2 Oxidative Addition 
Oxidative addition of arene (160) to the active Ir(III)trisboryl complex (186) generates the 
sterically crowded 7-coordinate Ir(V) intermediate (187) (Figure 20). DFT calculations 
supported the formation of the hindered Ir(V) intermediate and attribute its stability to 
stabilisation by the electron-rich bipyridyl ligand. A primary isotope effect observed in 
reactions involving the isolated active complex with arenes and deuterated arenes 
suggests that the C-H activation step is rate-limiting and is in agreement with 
computational calculations of the activation energy barriers of the individual catalytic 
cycle steps.  
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2.1.2.3 Reductive Elimination 
Reductive elimination of the arylboronate ester (8) from this sterically crowded Ir(V) 
species proceeds quickly due to the small activation energy barrier to yield an 
Ir(III)monohydride species (188) (Figure 20).  
 
2.1.2.4 Catalyst Recycling 
Reformation of the active catalyst is achieved through oxidative addition of a further 
equivalent of B2pin2 (41), with subsequent reductive elimination of HBpin (24) (Figure 
20). 
 
 
Figure 20: B2pin2-mediated catalytic cycle 
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2.1.2.5 The HBpin Cycle 
Upon consumption of B2pin2, HBpin liberated from the initial cycle may supplement the 
reaction. Oxidative addition of HBpin (24) generates the Ir(V)bishydride species (191), 
with regeneration of the active catalyst accomplished through reductive elimination of H2 
(192) (Figure 21). Anecdotal observations made in this study suggest however that the 
overall picture for this cycle is not as clear. 
  
 
Figure 21: The HBpin-mediated cycle 
 
Sakaki and co-workers calculated that the cycle invoking HBpin proceeds more slowly 
due to the greater energy barrier to oxidative addition relative to B2pin2 and because the 
evolution of H2 by reductive elimination is very endothermic.124 
Combining the two independent cycles gives the overall binary system as shown below 
(Figure 22); 
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Figure 22: Binary catalytic cycle 
 
2.1.3 Substrate scope 
The following section will explore the substrate scope of aromatic C-H borylation, and 
the relationship between mechanism and regioselectivity.  
 
2.1.3.1 Borylation of Aromatic Substrates 
Due to the steric bulk surrounding the active iridium trisboryl complex (186), the C-H 
borylation reaction is highly sensitive to steric effects (c.f Figure 19). Reflecting this, 
borylation ortho to substituents is highly disfavoured and as such regioselectivity is, in 
many cases, predictable.120 For example, borylation of 1,3-disubstituted arenes (193) 
yields the 1,3,5-trisfunctionalised product (194) and the borylation of unsymmetrical 1,4-
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disubstituted arenes (195) yields products favouring borylation ortho to the least sterically 
encumbering substituent (Figure 23).126 
 
 
Figure 23: Steric-directed aromatic C-H borylation 
 
In their investigation into the reaction mechanism, Hartwig and co-workers found 
intermolecular electronic effects, for example electron-deficient arenes, such as 1,3-
bis(trifluoromethyl)benzene (198) react more efficiently than, and in preference to, 
electron-rich arenes, such as m-xylene (199) (Scheme 18).125 
 
 
Scheme 18: Intermolecular electronic effects 
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Our group has demonstrated that intramolecular electronic influences can be observed 
at lower temperatures. For example, the borylation of unsymmetrical 1,2-disubstituted 
arenes (202) favours borylation para to π-electron withdrawing groups (Scheme 19). In 
many, but not all cases, qualitative selectivity predictions can be made on the basis of 
relative C-H acidity values.127,128 This provides regioselectivity complementary to 
classical arene functionalisation methods, such as electrophilic aromatic substitution or 
DoM (c.f Scheme 4). 
 
 
Scheme 19: C-H acidity as a predictor of regioselectivity 
 
Lower temperatures also lead to enhanced selectivities observed in the borylation of 
monsubstituted arenes, with borylation of anisole (205), for example, showing enhanced 
ratios in favour of meta borylation at room temperature (Scheme 20).129 
 
 
Scheme 20: Electronic effects in the borylation of a monosubstituted arene 
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2.1.3.2 Borylation of Heteroaromatic Substrates 
Electronic effects are more prevalent in the borylation of heteroarenes, with electron-rich 
heteroaromatics (209-211) and their benzofused congeners (66, 215, 216) undergoing 
borylation with excellent regiocontrol ortho to the heteroatom, consistent with the C-H 
acidity hypothesis (Figure 24a, b). Steric effects do still dominate, as is evidenced in the 
borylation of N-TIPS-indole (219), which undergoes borylation at C-3 rather than the 
preferred C-2, due to the presence of the sterically encumbering silyl protecting group, 
however the absence of borylation of the phenyl ring is noteworthy (Figure 24c).130 Smith 
and co-workers also demonstrated that indole could also undergo borylation at the 7-
position through an N-H directing mechanism, in the presence of a C-2 blocking group 
(221) (Figure 24d). 
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Figure 24: Borylation of electron-rich heteroaromatics 
 
By comparison, the borylation of azinyl heterocycles is less favourable and proceeds 
with regioselectivity distinct from that observed in reactions involving electron-rich 
heterocycles. In their seminal study on the borylation of pyridine, Ishiyama and Miyaura 
found the borylation of pyridine (223) to proceed sluggishly, even under forcing 
conditions, to give a statistical mixture of 3 and 4-boryl products (224 and 225 
respectively) (Scheme 21).131 This poor reactivity is somewhat surprising given the 
superior reactivity of electron-deficient arenes vs electron-rich congeners (c.f Scheme 
18). 
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Scheme 21: Borylation of pyridine 
 
Reflecting this sluggish reactivity, the scope for borylation of Lewis-basic heterocycles is 
limited. The following sections will explore the underlying reasons for these observations. 
 
2.1.4 Borylation of Substituents Bearing an Azinyl Nitrogen 
Two mechanistic possibilities have been considered to account for the poor reactivity of 
Lewis-basic substrates; coordination of the azinyl nitrogen lone pair to the Lewis-acidic 
boron reagent or coordination to the iridium catalyst. 
 
2.1.4.1 Pyridyl-Boron Interactions 
The Lewis-acidity of boron and its effect on its chemistry is well established (c.f Section 
1.2). Furthermore, Marder and co-workers have reported the formation of Lewis acid-
base pyridyl-boron adducts arising due to energetically favourable and fast interactions 
between bis-catecholatodiboron (B2cat2, 226) and 4-picoline (227) (Figure 25).132 Lewis 
acid-base interactions such as these, demonstrable by an upfield shift in the 11B NMR 
spectroscopic signal, may inhibit the oxidative addition of the bis-boryl species required 
for active catalyst generation and recovery (c.f Section 2.1.2).  
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Figure 25: Lewis acid-base pyridyl-boron adduct formation 
 
Our group has investigated such interactions with B2pin2, as this is the standard bisboryl 
reagent used in most borylation reactions. Through 11B NMR studies, Mkhalid has 
showed that a solution of 4-picoline (227) and B2pin2 (41) does not lead to formation of 
a tetravalent boron adduct (229), even when independently varying the concentrations 
of picoline and B2pin2 (Scheme 22).133 It was suggested that because the relative 
electron density at the boron atoms in a molecule of B2pin2 is greater than in the catechol 
derivative (226), adduct formation is disrupted. This suggested that azinyl coordination 
to the iridium centre was solely responsible for the sluggish borylation of pyridyl 
substrates.  
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Scheme 22: Attempted reaction between 4-picoline and B2pin2 
 
2.1.4.2 Pyridyl-Iridium Interactions 
Given that C-H oxidative addition is the rate-determining step of the catalytic cycle, the 
active Ir(III) trisborylcomplex (186) will be at greatest concentration at any given point in 
the reaction (c.f Section 2.1.2.2). The oxidative addition step is contingent upon formation 
of a vacant coordination site in order to proceed and thus borylation of Lewis-basic 
substrates bearing coordinating azinyl nitrogen atoms is problematic. It was postulated 
that Lewis acid-base interactions between coordinating substrates and the Lewis-acidic 
iridium centre furnishes a coordinatively saturated complex (230) which therefore cannot 
undergo C-H oxidative addition (Figure 26). 
 
 
Figure 26: Catalyst poisoning through pyridine coordination 
 
Our group sought to test this hypothesis by reacting of a series of 2-substituted pyridines. 
 
N
Ir
Bpin
N
N Bpin
Bpin
230
63 
 
2.1.4.3 Borylation of 2-Substituted Pyridines 
Mkhalid demonstrated that the presence of one or two ortho-substituents enabled the 
substrate to undergo borylation efficiently. For example, the borylation of 2-
phenylpyridine (231) proceeded efficiently, providing good conversion to a 45:55 mixture 
of 4 and 5-boryl products (232 and 233 respectively), with complete chemoselectivity for 
the phenyl ring (Figure 27a). Similarly the borylation of 2-picoline (234) provides a 49:51 
mixture of isomers (235, 236) (Figure 27b).133 
 
 
Figure 27: Borylation of 2-substituted pyridines 
 
In light of these results, it was suggested that the presence of ortho substituents 
disrupted the coordination of the azinyl nitrogen. One possible reason for this is that 
additional steric bulk within the inner coordination sphere is not well tolerated and as a 
result C-H oxidative addition dominates. 
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2.1.4.4 Competition Experiments 
Confirming this hypothesis, competition experiments entailing the borylation of 2,6-
lutidine (237) doped with varying quantities of an inhibitor (4-tert-butyl-pyridine, 238) 
demonstrated the inhibitory nature of azinyl coordination. Near complete shutdown of 
reactivity was observed even at low levels of inhibitor (Table 1, entry 5). Conversely, 
control reactions carried out in the absence of 238, proceeded efficiently, with complete 
conversion to 4-boryl product (239) observed (entry 1). 
 
 
Table 1: Borylation of 2,6-lutidine doped with varying quantities of 4-tert-butyl-pyridine 
 
2.1.4.5 ortho-Azinyl Boronate Esters 
The absence of 6-boryl products in the borylation of 2-substituted pyridines was 
noteworthy and was initially attributed to steric hindrance imparted by the ortho azinyl 
lone pair, which was postulated to function similarly to a substituent, with the substrate 
thereby borylating analogously to a 1,2-disubstituted benzene (c.f Scheme 19). 
However, borylation of 2,4-lutidine (240) provided a 75:25 mixture of 5 and 6-boryl 
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products (241 and 242 respectively), with borylation occurring preferentially ortho to the 
more sterically encumbering methyl substituent, therefore suggesting an energy barrier 
to formation of ortho-azinyl boronate esters (Scheme 23). 
 
 
Scheme 23: Borylation of 2,4-lutidine 
 
In addition, ortho-azinyl boronate esters have been found to be highly 
unstable,98,122,134,135 for example the borylation of 4-tert-butyl pyridine (238), whilst 
unfavourable due to catalyst binding, provided limited formation of ortho-azinyl product 
243, which readily underwent C-B bond cleavage upon exposure to D2O (Scheme 24). 
The instability of ortho-azinyl boronate esters is another key factor limiting their 
widespread utility and is discussed in the following section. 
 
 
Scheme 24: Attempted borylation of 4-tert-butyl-pyridine, with in-situ ipso-deuteration 
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2.1.5 Protodeborylation 
Protodeborylation describes the process by which a boryl group is cleaved and lost from 
a molecule and replaced with a hydrogen atom. This decomposition pathway represents 
a long standing limitation on the handling and reactions of 2-heteroaryl boronic acids and 
esters. 
Although widely reported, the mechanism is not well understood. Nonetheless, work 
carried out to date has enabled pathways to be postulated. Seminal work carried out by 
Kuivila and co-workers demonstrated that protodeborylation may proceed via acid, base 
or metal-mediated catalysis.3-5 Stevens later proposed that acid-mediated 
protodeborylation of 2-pyridine boronic acids or esters (245) proceeds via initial 
protonation of the azinyl nitrogen (246), with nucleophilic displacement of the boronic 
acid or ester forming a ylide intermediate (247) which could then rearrange to restore 
aromaticity (223) (Scheme 25).135 
 
 
Scheme 25: Mechanism of acid-mediated protodeborylation 
 
Stevens also postulated that due to the Lewis-basicity of the azinyl nitrogen, similar pre-
coordination to Lewis-acidic metal salts (249) could initiate a similar mechanistic pathway 
(Scheme 26). Due to the requirement for metal salts in downstream cross-coupling 
pathways this pathway is particularly problematic and limits the application 2-pyridyl 
boronic acids and esters in synthesis. 
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Scheme 26: Mechanism of metal-mediated protodeborylation 
 
Similarly, due to the requirement for base in Suzuki-Miyaura cross-couplings, the base-
catalysed pathway is also pertinent. Boronate (250) generation arising from nucleophilic 
attack of base or in-situ generated hydroxide ion and subsequent B-C cleavage by 
protonolysis is accepted as the general base-catalysed mechanism, however the role of 
the azinyl nitrogen or ortho-heteroatom is unclear (Scheme 27).89 
 
 
Scheme 27: Mechanism of base-mediated mechanism 
 
Reflecting the instability of ortho-azinyl boronic acids and esters, several groups have 
reported the use of boronic acid derivatives, such as MIDA boronates or triol borates, as 
surrogates, with slow release cross-coupling mechanisms minimising the in-situ 
concentrations of the unstable boronic acid or ester species (c.f Figure 12).98,134,136,137 
 
2.2 Previous Work and Chapter Goals 
As described in section 2.1.4, whilst borylation of pyridine is difficult, the presence of a 
2-substituent enables pyridyl substrates to react efficiently. This was attributed to 
inhibition of coordination to the catalyst. Similarly, other work in the group has 
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demonstrated the surprising reactivity of quinoline substrates (251), which built on 
previous work by Miyaura and Ishiyama (Scheme 28).131 This was attributed to the 
inhibitory effect of the peri C-H bond which prevents coordination of the azinyl 
nitrogen.127,129 
 
 
Scheme 28: Borylation of quinoline 
 
Consistent with previous observations (c.f Figure 27), was the lack of formation of 2-boryl 
products, for example borylation of 4-chloro-7-(trifluoromethyl)quinoline (254) gave full 
conversion to the 3-boryl product (256), with the 2-boryl product (255) not observed even 
at trace levels by GC/MS analysis (Figure 28a). Similarly borylation of 4-methyl-7-
(trifluoromethyl)quinoline (257) was recalcitrant to borylation due to steric inhibition of C-
3 (Figure 28b). 
 
 
Figure 28: Borylation of 4,7-disubstituted quinolines 
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Moreover, work carried out by Mkhalid studying the borylation of bipyridines found that 
there was a similar reluctance to borylation ortho to the azinyl nitrogen. For example 
borylation of 4,4’-dimethoxy-2,2’-bipyridine (260) gives 5,5’-bisboryl product (261) as the 
solitary product despite the presence of substituents ortho to the site of functionalisation 
(Figure 29a). However, the presence of a sufficiently bulky 4-substituent enables 
borylation ortho to the azinyl nitrogen, as is evident by the borylation of dtbpy (179) which 
provided sole access to the 6,6’-diboryl product (262) (Figure 29b). 138 
 
 
Figure 29: Borylation of 2,2’-bipyridines 
  
This surprising result contrasted the result described previously, in which 4-tert-
butylpyridine (238) borylated sluggishly (c.f Scheme 24). This was attributed to both 
disruption of coordination to the iridium and the inductive withdrawing effect of the 2-
pyridyl substituent, which reduces the relative basicity of the azinyl lone pair and 
stabilises a key transition-state structure in which oxidative addition forms a partial 
negative charge on the ortho-carbon (Figure 30). 
[Ir(COD)OMe]2 5 mol%
 dtbpy 10 mol%
B2pin2 2 eq., Hexanes, 80 °C
a)
b)
N
OMe
N
OMe
N
OMe
N
OMe
Bpin
pinB
85% (1H NMR)
i)[Ir(COD)OMe]2 5 mol%
 dtbpy 10 mol%, B2pin2 2 eq. 
Hexanes, 80 °C, 
ii) Pd(dppf)Cl2 10 mol%
PhI 3 eq., K3PO4 4 eq.
DMF, 80 °C
N
N
N
N
67%
179 262
260 261
70 
 
 
Figure 30: Disfavoured repulsive interactions arising from ortho oxidative addition of pyridine 
 
The resistance to borylation ortho to Lewis-basic nitrogens was, therefore, rationalised 
on the basis of disfavoured coulombic repulsions between an emerging negative charge 
at the site of C-H activation and the lone pair on the azinyl nitrogen (264), which provides 
an energy barrier to oxidative addition at these sites. Early work by Tajuddin has 
demonstrated that by increasing the inductive withdrawing capabilities of the 2-
substituent, formation of ortho-azinyl products occurs more readily, for example 
borylation of methyl-2-chloroisonicotinate (265) undergoes conversion to ortho-azinyl 
product 266 efficiently, at room temperature. Whilst to date the instability of the resulting 
boronate esters has precluded their purification by column chromatography, their 
solution lifetime was sufficient to enable in-situ trapping by Suzuki-Miyaura cross-
coupling reactions, which circumvented their isolation and provided access to potentially 
pharmaceutically interesting privileged biaryl structures (268) (Scheme 29). Work in this 
chapter will seek to build on this observation.  
 
 
Scheme 29: Tandem ‘one-pot’ borylation/Suzuki-Miyaura cross-coupling reaction of methyl-2-
chloroisonicotinate 
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Given that electronic repulsion between the azinyl lone pair and the developing negative 
charge on the α-carbon atom is likely to be related to the relative availability of the N-
lone pair, the reactivity of a series of 2-substituted pyridines (274-277) will be considered 
to test this hypothesis (Figure 31).139 
 
 
Figure 31: pKa of various 2-substituted pyridinium salts 
 
There is also evidence to suggest that protodeborylation may also be sensitive to azinyl 
basicity. Analysis of the acid-mediated mechanism shows that it proceeds via an initial 
protonation of the azinyl-nitrogen (c.f Scheme 25). Brown has demonstrated the effects 
of ortho substituents on pyridine basicity, for example 2,6-dichloropyridine is completely 
resistant to protonation.139 Moreover, work by Raoult and co-workers has shown that 
halopyridyl boronate derivatives (281, 282) exhibit greater stability by comparison with 
pyridines bearing electron-donating substituents. This was illustrated in the attempted 
synthesis of 2-methoxy-6-(Bpin)-pyridine (284), whereby the instability precluded its 
isolation (Figure 32).140 
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Figure 32: Literature synthesis of 2-substituted ortho-pyridyl boronate esters 
 
The remainder of this chapter will explore the issue of boronate stability and find 
strategies to enable efficient synthesis and isolation of ortho-azinyl boronate esters.  The 
rate of borylation and stability of the boronate esters will be explored in relation to their 
relative azinyl basicity. Where instability on silica precludes chromatographic purification, 
regioselectivity will be confirmed by trapping the boronate adduct in-situ via a Suzuki-
Miyaura cross-coupling reaction. Furthermore, the functional group tolerance of C-H 
borylation will be exploited to enable multi-directional synthesis of privileged structures, 
combining a one-pot C-H borylation/Suzuki-Miyaura cross-coupling with downstream 
reactions with a view to small compound library synthesis. 
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2.3 Results and Discussion  
2.3.1 Borylation of 2-Substituted pyridines 
Initial work focussed on borylation of the aforementioned series of 2-substituted pyridines 
(c.f Figure 31). Exploiting the homogeneity of the C-H borylation reaction and the in-situ 
formation of active catalyst, catalyst stock solutions containing the iridium pre-catalyst, 
dtbpy and B2pin2 were prepared (see Experimental Section). This allowed long term 
storage of bulk mixtures, improved the simplicity of the experimental set-up and enabled 
consistent reproducibility. 
Preliminary experiments explored the borylation of 2-methoxypyridine (274). An aliquot 
of catalyst stock solution was added to a sealed vial containing the substrate. Given the 
propensity for products containing an ortho-azinyl boronate ester functionality to undergo 
fast protodeboronation, reaction ratios were monitored by in-situ 1H NMR spectroscopy. 
A 0.5 mL aliquot of the reaction solution was transferred to a Young’s tap sealed NMR 
tube. NMR spectra were referenced against a coaxial acetone-d6 solvent stick, exploiting 
the high deuterium loading of the solvent to enable efficient referencing. In order to gauge 
the relative rates of reaction of the individual substrates, reactions were monitored up to 
24 h, at which point the reaction mixture was concentrated in vacuo. GC/MS and 1H NMR 
spectroscopic analyses were carried out on the crude reaction mixture and ratios 
compared to this acquired by in-situ measurements for validation. As bis-borylated 
products represented a significant outcome of the reaction, the reaction was also carried 
out with sub-stoichiometric (0.5 eq.) B2pin2. 
Identification of product regioselectivity was achieved by observation of an approximate 
0.3 - 0.5 ppm shift to higher frequency of signals (relative to their chemical shift in the 1H 
spectrum of the starting material) corresponding to protons ortho to the inductively 
withdrawing C-B bond coupled with a change in multiplicity (Figure 33). 
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Figure 33: Borylation of 2-methoxypyridine (274) (1H NMR spectrum of crude product 
mixture) 
 
Product 285 is identifiable by a shift in the 3 and 5-H signals, with a further downfield 
shift of 5-H observed upon conversion to bis-boryl product 286. Similarly, product 287 
was identified by a shift in both 4 and 6-H signals with a similar downfield shift of the 4-
H signal again occurring upon conversion to bis-boryl product 288.  
Following this same procedure of experimentation and assignment, the series of 2-
substituted pyridines was completed, and the results are summarised in the table below 
(Table 2); 
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Table 2: Borylation of 2-substituted pyridines (274-277) 
 
Bis-borylation represented a significant outcome with substantial quantities of the 4,6-
bisborylated products observed. The degree of 6-borylation correlated well with azinyl 
nitrogen basicity, with greater degrees of 4,6-bis(Bpin) formation observed for 2-chloro 
(entry 2) and 2-trifluoromethyl pyridine (entry 3) than for the more basic 2-
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methoxypyridine (entry 1), whereby the ratio of 4-Bpin to 4,6-bis(Bpin) products 
demonstrated a reluctance to ortho-azinyl boronate ester formation. Unfortunately, due 
to the low steric demands of the fluorine atom, ortho-borylation became competitive, thus 
complicating the reaction (entry 4). This was demonstrable from the observed 2-fluoro-
3-(Bpin) product (301) in both reactions of 2-fluoropyridine.  
Experiments conducted with sub-stoichiometric B2pin2 clearly demonstrated that 6-
substitution arose as a result of prior reaction at the 4-position (which rendered C-5 
sterically hindered). Similarly 3,5-bisboryl products required initial borylation at the 5-
position as C-3 is sterically inhibited by the 2-substituent. In all cases, product ratios 
favoured products arising from initial borylation at C-4 over C-5 which is consistent with 
the C-H acidity hypothesis (Figure 34).128 These ratios differed from the 1:1 mixtures 
observed previously by Mkhalid in the borylation of 2-phenylpyridine and 2-picoline (c.f 
Figure 27). The lack of borylation at the most deshielded C-6 (in the absence of steric 
effects) reinforced the proposed energy barrier, which prevents C-H activation at this site 
even when the relative Lewis basicity is low. 
 
 
Figure 34: C-H acidity values of 2-substituted pyridines 
 
Relatively speaking, the rates of reaction and extent of the reaction mirrored the 
previously described pKa series (c.f Figure 31) with faster rates and better conversions 
observed in the presence of more inductively withdrawing 2-substituents. This was 
unsurprising given the propensity for electron-deficient substrates to undergo faster 
reactions.125.  
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Encouraged by these preliminary results a series of bis-functionalised pyridines were 
then subjected to these borylation conditions in order to further gauge the relative stability 
of ortho-azinyl boronate esters and in order to provide single products for isolation or 
one-pot elaboration.  
 
2.3.2 Borylation of 2,3-Disubstituted pyridines 
In order to gauge the extent of the influence of the 2-substituent on reaction rates and 
boronate stability, a series of nicotinate esters were chosen as test substrates. Whereas 
the 2-chloro and 2-(trifluoromethyl) derivatives are commercially affordable, the high cost 
of the 2-methoxy and 2-fluoroderivatives meant synthesis from their substituent 
carboxylic acids was required (Figure 35).  
Methylation of 2-methoxynicotinic acid (302) with methanol using a substoichiometric of 
concentrated sulfuric acid generated the methyl ester in excellent yield without the need 
for further purification after neutralisation with saturated NaHCO3 solution and extraction. 
The product (304) was characterised by observation of a strong carbonyl stretch in the 
IR spectrum at 1731 cm−1 and a singlet at 3.90 ppm, in the 1H NMR spectrum  
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Figure 35: Synthesis of 2-substituted nicotinate esters 
 
Given the potential lability of the C-F bond in 2-fluoropyridyl substrates, a milder method 
of esterification was sought for the esterification of 2-fluoronicotinic acid (303). Reaction 
with oxalyl chloride ((COCl)2) in the presence of catalytic DMF enabled formation of the 
acyl chloride as confirmed by IR analysis, which displayed a carbonyl stretch at 1758 
cm−1, in conjunction with the absence of the broad OH stretch. Methylation of the acid 
chloride provided methyl ester (305), as confirmed by an observed resonance at 3.94 
ppm in the 1H NMR spectrum.  
With the nicotinate series in hand, the substrates were then tested in the C-H borylation 
process. Preliminary experiments explored the borylation of 2-methoxynicotinate (304) 
using the previously described method (c.f Section 2.3.1). Consistent with previous 
observations, the preferred regioselectivity was confirmed by disappearance of the 5-H 
resonance and corresponding downfield shifts in 4 and 6-H resonances. Similarly minor 
product (307) assignment was obtained by observed loss in the 6-H resonance and a 
shift to higher frequency in the neighbouring 5-H resonance (Figure 36). 
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Figure 36: Borylation of methyl-2-methoxynicotinate (304) (1H NMR spectrum of crude product 
mixture) 
Following this method of characterisation, the data was collected and tabulated for the 
remaining compounds within the series (Table 3). 
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Table 3: Borylation of 2,3-disubstituted pyridines 
 
Consistent with the previously noted observations, borylation proceeded with excellent 
selectivity at the 5-position. This selectivity mirrors the greater C-H acidity of 5-H with 
respect to 6-H, however selectivity is likely influenced by the energetic barrier to 6-
borylation and steric inhibition of the 4-position (Figure 37). In line with the relative azinyl-
basicity, the greatest degree of 6-borylation is observed in the borylation of the 2-
fluoroderivative (entry 2), however the lack of 6-borylation observed in the borylation of 
the trifluoromethyl derivative (entry 4) is surprising (c.f Figure 31). 
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Figure 37: C-H acidity values of 2,3-disubstituted pyridines 
 
Disappointingly, the borylation of methyl-2-chloronicotinate (310) did not proceed to 
completion even when left over an extended period of time (entry 3). This was somewhat 
surprising given the relative electron-deficiency of the ring relative to the 2-methoxy 
derivative (304), which reacted efficiently (entry 1). The catalysed reduction of 2-halo 
pyridines is known within the literature and potential for reduction with in-situ generated 
HBpin or H2 was considered. Reflecting this, reactions of both substrates were carried 
out with a stoichiometric equivalent of HBpin using a method analogous to that which 
was previously described (c.f Section 2.3.1) (Table 4). 
 
 
Table 4: Borylation of 2,3-disubstituted pyridines with HBpin 
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The regioselectivity ratios obtained were surprising, with increased formation of the 6-
boryl products (307, 312) observed. At the time of publishing, this remained an 
unexplained result and has not since been embellished upon. Whilst relative conversions 
followed a similar pattern to reactions conducted with B2pin2, analysis of both crude GC 
and LC/MS traces found no evidence of chlorine reduction (m/z = 137) even at trace 
levels. In addition, the reaction of 2,3-dichloropyridine (316) with B2pin2 was also carried 
out and proceeded efficiently and with full conversion to product, demonstrating that C-
Cl bond reduction was not a limiting factor (Table 3, entry 5). 
Due to the low observed levels of minor products, direct chromatographic purification of 
the crude mixtures enabled isolation of boronate esters 311 and 317. The pure boronate 
esters were characterised by NMR spectroscopy, for example compound 317 was 
identified by a characteristically broad 11B NMR resonance at 30.0 ppm in conjunction 
with a small (1.5 Hz) 4JH-H coupling, observed between 4 and 6-H resonances (thereby 
confirming the previously assigned regioselectivity).  
 
2.3.2.1 Tandem Suzuki-Miyaura Cross-Coupling Reactions 
Disappointingly, attempted column chromatographic purification of 306, 308 and 314 
failed to yield a pure product sample. Post TLC development with phosphomolybdic acid 
(PMA) solution demonstrated the tendency of the boryl products to streak. This often 
meant pinacol was observed in large quantities in the post-chromatographic 1H NMR 
spectrum. Where chromatographic purification of the boronate ester was not possible, 
the borylation reaction was monitored to optimum conversion then concentrated in 
vacuo. To the crude boronate ester was added Pd(dppf)Cl2, Cs2CO3, iodoanisole and 
DMF. Given that C-H borylation is an ideal strategy for late-stage functionalisation, the 
starting pyridine was used as the limiting reagent and a standard reaction stoichiometry 
was employed. Subsequent microwave irradiation enabled trapping of the boronate 
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esters as Suzuki-Miyaura cross-coupling products. The cross-coupling conditions used 
were not optimised for any one substrate as final products were only required for 
analytical purposes and to confirm the regioselectivity of the borylation reaction. (Figure 
38). The reported cross-coupling yields are based on the starting heteroarene. 
 
 
Figure 38: Tandem ‘one-pot’ borylation/Suzuki-Miyaura cross-couplings of 2,3-distubstituted 
pyridines 
 
GC/MS analyses after 3 h heating showed full consumption of the intermediate boronate 
ester in all cases. Cross-coupled products 319, 320 and 321 were identified by diagnostic 
molecular ion peaks of m/z = 274, 261 and 311 respectively.  
Due to the lack of observed formation of ortho-azinyl boronate esters in isolable 
quantities to this point, it was then of interest to investigate 2,4-disubstituted pyridines, 
in which all other C-H bonds were sterically encumbered. 
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2.3.3 Borylation of 2,4-Disubstituted Pyridines 
Due to high commercial costs, the methyl esters of 2-methoxy (322), 2-(trifluoromethyl) 
(323) and 2-fluoroisonicotinic acids (324) were synthesised using the prior discussed 
methods (c.f Figure 35). Methylation was confirmed by observation of 1H NMR singlet 
resonances at 3.96, 4.00 and 3.97 ppm for 2-methoxy (325), 2-(trifluoromethyl) (326) 
and 2-fluoroisonicotinate (327) esters respectively. 
Preliminary C-H borylation reactions were carried out with 2-chloro-4-
(trifluoromethyl)pyridine (328) using the method discussed previously (c.f Section 2.3.1). 
Due to steric hindrance imparted by the 4-trifluoromethyl moiety, borylation at C-5 was 
disfavoured and consequently no 5-(Bpin) product (329) was observed. Consistent with 
selective borylation at C-6, the in-situ borylation product (330) possessed a 1H NMR 
trace lacking the 6-H resonance in conjunction with a neighbouring 5-H resonance 
shifted to higher frequency (Figure 39). 
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Figure 39: Borylation of 2-chloro-4-(trifluoromethyl)pyridine (328) (1H NMR spectrum of crude 
reaction mixture) 
 
Encouraged by this preliminary result, a series of 2,4-disubstituted pyridines were 
borylated and the results are summarised in the table below (Table 5); 
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Table 5: Borylation of 2,4-disubstituted pyridines 
 
Despite the prevalence of steric effects in borylation, 5-boryl products were still observed 
in instances whereby the 4-substituent was sterically smaller. For example borylation of 
2,4-dichloropyridine (331) gave a 1:1 mixture of 5 and 6-boryl products (332 and 333 
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respectively) (entry 2). Similarly, the previously described borylation of 2,4-lutidine (240) 
gave a 3:1 ratio of 6:5-boryl products (c.f Scheme 23).  
Analysis of the borylation products of the isonicotinate series, whereby the 4-
methoxycarbonyl moiety is sufficiently sterically encumbering to force borylation to C-6, 
demonstrates that enhanced conversions and reaction rates were obtained in substrates 
containing less-basic azinyl nitrogens. For example, borylation of methyl-2-
fluoroisonicotinate (327) proceeds to completion (entry 5) whereas borylation of the 
analogous 2-methoxy derivative (325) proceeds only sluggishly to 57% conversion (entry 
3). This is representative of a sufficiently decreased energy barrier to 6-borylation 
provided by inductively withdrawing ortho substituents. 
Attempts to purify the boronate esters were largely unsuccessful, with complete 
reversion to the starting material observed after column chromatography in most cases. 
However, in line with previous observations made by Raoult and co-workers (c.f Figure 
32), the 2-fluoro derivative was amenable to chromatographic purification enabling 
isolation of the 6-(Bpin) product (339), as confirmed by post-purification GC/MS analysis 
(m/z = 281, [M]+), in modest yield.  This confirmed that not only do inductively withdrawing 
2-substituents reduce the barrier to formation of ortho-boryl compounds, they stabilise 
the products and sufficiently slow the rate of protodeborylation. 
 
2.3.3.1 Tandem Suzuki-Miyaura Cross-Coupling Reactions 
Owing to the instability of the majority of the 6-boryl products, the crude boronate esters 
were subjected to the previously described Suzuki-Miyaura cross-coupling conditions (c.f 
Section 2.3.2.1) with iodoanisole to give the biaryl products (341-344) in good yields 
across the two steps (Figure 40).  
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Figure 40: Tandem ‘one-pot’ borylation/Suzuki-Miyaura cross-couplings of 2,4-distubstituted 
pyridines 
 
The cross-coupled products bore a characteristic singlet at ca. 3.9 ppm in the 1H NMR 
spectrum corresponding to the incorporated anisole OCH3 functionality. The observed 
reduction in overall yield of the one-pot reactions relative to those described in Section 
2.3.2.1 was attributed to the reduction in stability of the intermediate boronate esters (c.f 
Table 3). 
 
2.3.4 Borylation of 2,5-Disubstituted Pyridines 
Application of the previously described esterification method to 6-fluoronicotinic acid 
(345) enabled the synthesis of methyl-6-fluoronicotinate (346) (c.f Figure 35). 
Methylation was confirmed through observation of a 1H NMR singlet at 3.95 ppm. 
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Preliminary borylation experiments explored the reactivity of 2,5-dichloropyridine (347) 
using the previously described procedure (c.f Section 2.3.1). Regioselectivity was 
assigned based on a downfield shift of the neighbouring 3 or 4-H resonances upon 
incorporation of the boryl group (Figure 41). 
 
 
 
Figure 41: Borylation of 2,5-dichloropyridine (347) (1H NMR spectrum of crude product mixture) 
 
Following this method of characterisation, the data was collected and tabulated for a 
series of 2,5-disubstituted pyridines (Table 6). 
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Table 6: Borylation of 2,5-disubstituted pyridines 
 
The reaction of 2,5-disubstituted pyridines generally proceeded sluggishly due to the 
requirement for unfavourable borylation ortho to functional groups. For example, 2,5-
lutidine (350) borylated with a 10% conversion and failed to provide improved 
consumption even when reacted over longer time periods of up to 96 h (entry 2). 
Conversely, owing to the small steric size of the fluorine atom and the electron-
withdrawing capability of the fluoro substituents, the borylation of difluoro derivative 356 
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proceeded efficiently with bis-borylated products observed by 1H NMR spectroscopy 
(entry 4).  
Consistent with calculated C-H acidity values, symmetrically disubstituted substrates 
gave product ratios favouring borylation at the more deshielded C-4 (Figure 42). Whilst 
the observed regioselectivity of reactions involving unsymmetrical substrates also 
favoured the more acidic C-H bonds, it is more likely that this is reflective of the steric 
bias of the reaction. 
 
 
Figure 42 C-H acidity values of 2,5-disubstituted pyridines 
 
Isolation of single product 359, characterised by a shift in 19F NMR signal to −52.2 ppm 
and a broad 11B singlet at 29.7 ppm, was possible after column chromatography. This 
boronate ester could also be elaborated by in-situ Suzuki-Miyaura cross-coupling with 4-
iodoanisole providing the bis-aryl product (364) in good yield (Figure 43).  
 
2.3.4.1 Tandem Suzuki-Miyaura Cross-Coupling Reactions 
Attempted column chromatographic purification of single product 353 was unsuccessful 
due to co-elution with B2pin2. Application of the standard Suzuki-Miyaura cross-coupling 
conditions enabled synthesis of the biaryl (363) as demonstrated by in-situ LC/MS, with 
N
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N
NCl
42.1 (100)
42.2 (0)
32.9 (100)
34.5 (0)
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31.1 (84)
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Cl
CO2Me
CO2Me
F
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the diagnostic chlorine isotopic pattern evident in the observed molecular ion peaks (m/z 
= 279 (37Cl, [M+H]+), 277 (35Cl, [M+H]+)) (Figure 43) (c.f Figure 38).  
 
 
Figure 43: Tandem ‘one-pot’ borylation/Suzuki-Miyaura cross-couplings of 2,5-distubstituted 
pyridines 
 
2.3.5 Multi-Directional Synthetic Strategies 
Thus far, it has been demonstrated that by judicious choice of substitution pattern, 
pyridines are a viable substrate for C-H borylation, with boronate esters isolable in good 
yields after column chromatography or tandem ‘one-pot’ Suzuki-Miyaura cross-
couplings. Moreover, in the presence of sufficiently electronegative ortho substituents, it 
provides sufficient stability to the resulting boronate ester that the yields and reaction 
rates are enhanced. It was also envisaged that a range of downstream chemistries, 
which exploit the reactivity of 2-halopyridines, would become viable to enable multi-
directional synthesis of small compound libraries.  
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2.3.5.1 2-Chloro Reduction Sequence 
Initial focus centred upon the desire for substitution with a hydrogen atom, as this 
provides a formal protecting group approach to the 2-pyridyl boronate problem. A survey 
of the literature suggested direct SNAr substitution of a 2-halo substituent with hydride is 
not known, however, scope exists for chloroarenes to undergo reduction under transfer 
hydrogenation conditions.141-144  
Using the previously described method of tandem borylation/Suzuki-Miyaura cross 
coupling (c.f Section 2.3.2.1), reaction of methyl-2-chloroisonicotinate (266) with 4-
iodoanisole provided the desired cross-coupled intermediate (365) as observed by in-
situ GC/MS (m/z = 279 (37Cl, [M]+), 277 (35Cl, [M]+)). The ratio of desired product to 
starting material was observed as 55:45 as a result of incomplete (73%) conversion to 
boronate ester (267) and losses incurred during the cross-coupling step. TLC analysis 
after the cross-coupling step showed a complex mixture and as a consequence a work-
up was carried out prior to reduction. Under a stream of nitrogen, Pd/C was added to an 
ethanolic solution of the crude mixture and ammonium formate. Celite filtration enabled 
separation of the catalyst and GC/MS analysis showed full consumption within 2 h at 
room temperature (m/z = 243 [M]+), with the notable absence of the chlorine isotopic 
pattern confirming conversion to the reduced product (366) (Figure 44). 
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Figure 44: ‘Protecting group’ approach to 2-pyridyl borylation 
 
2.3.5.2 SNAr Substitution of Aryl-2-Halopyridines 
In addition, both 2-chloro and fluoro products were also subjected to SNAr conditions to 
enable a second mode of variation in multi-directional synthesis. Due to the potential for 
nucleophilic cleavage of the 2-halo bond, reactions were carried out neat (with respect 
to the nucleophile) or in polar aprotic solvents. Simple reaction of the 2-fluoro starting 
material with the desired nucleophile in refluxing dioxane gave products lacking the 19F 
signal by NMR spectroscopy. Confirmation of product formation was provided by LC/MS 
analysis with the characteristic molecular ion peaks m/z = 273 ([M]+), 329 ([M+H]+) and 
328 ([M+H]+) observed for compounds 319, 369 and 371 respectively. SNAr of the chloro 
derivatives was carried out using a literature protocol.145 The results are presented in the 
below (Table 7).  
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Table 7: SNAr substitution of 2-halo-arylpyridines 
 
Reflecting the greater electronegativity of the fluorine atom, reactions involving the 
displacement of fluoride proceeded in superior yields (entries 1-3). This is exemplified in 
the respective yields of entries 2 and 4. Displacement was demonstrated with both 
oxygen and nitrogen nucleophiles in excellent yields. The use of 1,2-diamines (377) as 
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nucleophile provides a facile route to substituted pyridodiazepine (378) scaffolds of 
potential biological interest (entry 6).  
With scope for variation in both the Suzuki-Miyaura cross-coupling partner as well as the 
nucleophilic component, there is promising potential for small molecule library building. 
Research in this area is ongoing within the group with both variation in Suzuki-Miyaura 
cross-coupling partner and a variety of downstream chemistries, including 
decarboxylative couplings which seek to functionalise at the ester carbons, currently 
under investigation. 
 
2.3.6 Borylation of Other Azinyl Heterocycles 
Having established that the inhibition of azinyl nitrogen coordination was key to 
overcoming the poor reactivity of pyridine, it was then of interest to apply this strategy to 
other Lewis-basic heterocycles. Reflecting this, the basicity of a series of other such 
heterocycles was considered (Figure 45). 
 
 
Figure 45: pKa of other azinyl heterocycles 
 
The remainder of this chapter will explore the borylation of these substrates, with a 
focussed case study on indazoles forming the basis of the following chapter. 
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2.3.6.1 Borylation of Pyrazines 
Work in this area began with a study of the borylation of pyrazine, due to its markedly 
lower basicity. Preliminary work explored the attempted borylation of 2,3-
dimethylpyrazine (383) with an aliquot of borylation stock solution at room temperature 
as previously described (c.f Section 2.3.1). Pleasingly, and consistent with the earlier 
hypothesis, the substrate underwent efficient borylation at room temperature, as evident 
by a downfield shift in the solitary aromatic resonance in the 1H NMR spectrum. 
Encouraged by this, a series of pyrazine substrates were subjected to analogous 
conditions, the results of which are summarised in the table below (Table 8). In the 
absence of reactivity at room temperature, the reaction was repeated at 80 °C.  
 
 
Table 8: Borylation of substituted pyrazines 
 
N
N
Entry
1
2
3
Substrate Conditionsa,b Product(s)
A
N
N
No products observed
N
N Bpin
N
NCl
A
N
N Bpin
N
NCl
N
NCl
N
N
B
Bpin
Bpin
4
387
(56%)c(28%)d
386
384
(90%)c(44%)d
383
388 389 390
(91%)c
(1:3)
(23%)d
a. [Ir(COD)OMe]2 2.5mol%, d
tbpy 5 mol%, B2pin2 1 eq. b. Conditions A)
rt, 24 h; B) 80 °C, 16 h; c. 1H NMR conversion; d. Yield after Suzuki-
Miyaura cross-coupling (see experimental section for details)
385
B
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Despite its lower basicity, borylation of pyrazine heterocycles also required judicious 
choice of substitution pattern in order to enable boronate ester formation. Steric inhibition 
of azinyl nitrogen coordination remained a prerequisite for borylation of these substrates, 
for example 2,6-dimethylpyrazine (385) was recalcitrant to borylation, even under forcing 
reaction conditions, (entry 2) whereas 2,3-dimethylpyrazine (383) borylated readily (90% 
conversion by 1H NMR) at room temperature (entry 1). Despite the steric hindrance 
imposed by neighbouring methyl groups, 2,5-dimethylpyrazine (386) also underwent 
successful reaction (entry 3), however, higher temperatures were required relative to the 
borylation of 383.  
Reflecting the preference for boryation ortho to the less basic azinyl nitrogen, borylation 
of 2-chloro-3-methylpyrazine (388) occurred preferentially at C-6. The inductively 
donating effect of the methyl group renders the ortho azinyl nitrogen more electron rich 
and as such borylation at C-5 is more disfavoured. This regioselectivity mirrors calculated 
C-H acidities (Figure 46). Regioselectivity was again assigned based on downshield 
shifts, relative to starting material 388, of neighbouring 1H resonances upon incorporation 
of neighbouring Bpin ester groups. High field NMR analysis enabled characterisation of 
the starting material on the basis of a small but detectable 5JH-H coupling (0.76 Hz) 
between 5-H and CH3 resonances. 
 
 
Figure 46: C-H acidity values of 2-chloro-3-methylpyrazine 
 
 
 
99 
 
2.3.6.1.1 Tandem Suzuki-Miyaura Cross-Coupling Reactions 
Purification of the resulting boronate esters remained problematic, with products 384 and 
387 undergoing full reversal to starting material by protodeborylation during flash column 
chromatography. Reflecting this, tandem ‘one-pot’ cross-coupling reactions using the 
previously described procedure were carried out (Figure 47) (c.f Section 2.3.2.1). 
Compound identification was enabled by both 1H NMR spectroscopy and mass 
spectrometry analysis, for example compound 391 displayed characteristic 1H NMR 
singlet resonances at 8.65 and 3.86 ppm, corresponding to 6-H and OCH3 resonances 
respectively, as well as the diagnostic molecular ion signal by ASAP accurate mass 
analysis (m/z = 215.1187 [M+H]+) 
 
 
Figure 47: Tandem ‘one-pot’ borylation/Suzuki-Miyaura cross-couplings of pyrazine substrates 
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2.3.6.1.2 ipso-Deuteration of (Bpin)-Pyrazine 
As has been previously noted the isolation of ortho-azinyl boronate esters and their 
Suzuki-Miyaura products is challenging due to their propensity to undergo rapid 
protodeborylation, catalysed by acids, bases and various metal ions.3-5 In light of the 
previously discussed acid-mediated mechanism and observations made by Mkhalid,133 
it was suggested that use of mild deuterated acid surrogates could facilitate efficient ipso-
deuteration of heterocycles (c.f Scheme 25 and Scheme 24).  
To build on this earlier observation, 2,3-dimethylpyrazine was treated with an aliquot of 
stock solution to provide efficient conversion to 2,3-dimethyl-5(Bpin)-pyrazine (384) as 
described above. Disappointingly, direct addition of D2O to the reaction mixture gave 
only limited conversion to the ipso-deuterated product (395) (Table 9, entry 1). 
Interestingly, and somewhat surprisingly, when the order of addition of C-H borylation 
reagents was changed so that an MTBE solution of B2pin2 and 383 was added to a 
solution of [Ir(COD)OMe]2 and dtbpy, D2O quenching gave full conversion of the 
intermediate boronate ester to the desired ipso-deuterated product (entry 2). The current 
reasons for this observed order of addition effect are unknown and this remains an 
anecdotal observation.  
 
 
Table 9: ipso-deuteration of in-situ generated 2,3-dimethyl-5-(Bpin)pyrazine (384) 
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The degree of 2H incorporation was calculated based on the degree of depletion of the 
6-H resonance of 2,3-dimethyl-5(Bpin)-pyrazine (384) as judged by comparisons 
between crude 1H NMR taken before and after deuteration (Figure 48). In this instance 
a disappearance of the 6-H resonance equated to complete deuteration. 2H NMR 
spectroscopy, using the previously reported W5 solvent suppression technique,146 run in 
protiated solvent enabled observation of the 2H resonance at 8.30 ppm. 
  
 
Figure 48: 1H NMR spectrum; a. after deuteration; b. before deuteration; c. reference of 2,3-
dimethylpyrazine starting material. 
 
2.3.6.2 Borylation of Pyrimidines 
Despite the markedly reduced basicity of pyrazinyl heterocycles with respect to pyridiyl 
substrates, disruption of azinyl coordination remained a pre-requisite for the borylation 
of pyrazine substrates. In light of observations made up to this point, initial focus of 
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f1 (ppm)
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2
3
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b)
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pyrimidine borylation centred upon 2-substituted pyrimidines, as it was hypothesised that 
this would disrupt potential coordination of both azinyl nitrogens. Reflecting this, 2-
chloropyrimidine (396) was chosen as a test substrate. In addition to disrupting azinyl 
coordination, the chlorine substituent would enable flexibility in downstream chemistries.  
On the basis of poor solubility at both room temperature and 80 °C with microwave 
irradiation, the attempted borylation of the starting material with a THF stock solution was 
unsuccessful. Frustratingly, poor solubility also accounted for the unsuccessful 
attempted borylation of 2,4-dichloropyrimidine (397) under analogous conditions 
(Scheme 30).  
 
 
Scheme 30: Attempted borylation of 2-chloropyrimidines 
 
Reflecting this, a solvent screen was embarked upon in an attempt to broaden the 
potential substrate scope. 
 
2.3.6.2.1 Solvent Screen 
Due to its predictable regioselectivity and reliable reactivity, m-xylene (198) was chosen 
as the test substrate. Initially a control reaction was run in MTBE as this is the standard 
solvent used for most borylations within the group and in literature protocols (Table 10, 
entry 1). To a vial containing the iridium catalyst, dtbpy and B2pin2 was added 2 mL of 
MTBE. At the point of full solubilisation of all solid, m-xylene (1 mmol) was added and 
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the reaction mixture subjected to microwave irradiation for 1 h. Given that many of the 
screened solvents were less volatile than the substrate itself, the NMR conversions was 
calculated in-situ without prior solvent removal, using the previously described method 
(c.f Section 2.3.1). Based on a downfield shift in the neighbouring 4/6-H resonance, the 
1H NMR conversion was calculated as 93%. Following this general protocol, a range of 
solvents were tested. The results of the solvent screen are summarised in the table 
below (Table 10); 
 
 
Table 10: Borylation solvent screen 
 
Predictably, due to their relatively low coordinating capabilities, ethereal solvents were 
well tolerated, with both 1,2-DME and diglyme (entries 4 and 5 respectively) performing 
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comparably to the more commonly used THF (entry 3), however, employment of triglyme 
resulted in complete loss of reactivity (entry 6). The poor performance of hexanes was 
surprising given its lack of coordinating ability. The relative activity of NMP (entry 8) was 
surprising due to its structural similarities to DMAc (entry 7), in which reactions 
proceeded sluggishly.  
With the results of the solvent screen in hand, it was then of interest to test both the 
solubility and reactivity of both 2-chloro (396) and 2,4-dichloropyrimidine (397) in a more 
polar solvent. Subsequent solubility tests carried out with both diglyme and 1,2-DME 
showed that both substrates were readily soluble in both solvents and as such 
borylations were attempted in these solvents using the procedure described above (c.f 
Scheme 30). Disappointingly however, both substrates were recalcitrant to borylation 
even at high temperatures and with microwave irradiation with only starting material 
observed by in-situ 1H NMR spectroscopy. This pointed to a more fundamental problem 
specific to these substrates. 
 
2.3.6.2.2 Borylation of 2-Phenylpyrimidine 
As a consequence, and reflecting the difficulties also encountered with some 2-chloro 
substrates (c.f Table 3 and Table 4), pre-functionalisation of the C-Cl bond was 
attempted. 2-Phenylpyrimidine (398) was synthesised by a literature reported Suzuki-
Miyaura cross-coupling reaction of 2-chloropyrimidine (396) with phenylboronic (4) 
(Scheme 31).147 Upon cooling a white precipitate was observed amongst a yellow 
supernatant solution. After work-up and chromatographic purification, 398 was isolated 
as a white amorphous solid and bore the characteristic molecular ion peak (m/z = 156, 
[M]+) by GC/MS analysis, with a notable absence of the chlorine isotopic pattern. 
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Scheme 31: Synthesis of 2-phenylpyrimidine 
 
With 2-phenylpyrimidine in hand, the substrate was then tested in the C-H borylation 
process. In order to prevent competing borylation on the phenyl ring, a substoichiometric 
(0.6 equivalents) quantity of diboryl reagent was used at room temperature. Pleasingly, 
the borylation proceeded efficiently with good regioselectivity and chemoselectivity for 
the more electron-deficient pyrimidine ring, thereby mirroring the selectivity of previously 
discussed reactions involving 2-phenylpyridine (c.f Figure 27). Borylation was selective 
for the 5-position (399) as evident by the shift in the 4/6-H resonance to higher frequency 
in the 1H NMR spectrum. In-situ trapping by Suzuki-Miyaura cross-coupling with 3-
iodopyridine (400) using the method detailed previously (c.f Section 2.3.2.1), was 
monitored by LC/MS, with full consumption of the intermediate boronate ester observed 
within 1 h. The desired molecular ion peak (m/z = 234 [M+H]+) was observed, thereby 
confirming the presence of product 401 (Scheme 32). 
 
 
 
Scheme 32: Tandem ‘one-pot’ borylation/Suzuki-Miyaura cross-coupling of 2-phenylpyrimidine 
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The requirement for a 2-phenyl substituent limits the potential substrate scope of 
pyrimidines, however, the chemoselective preference for borylation of the 
heteroaromatic ring is promising and allows for late-stage functionalisation of these 
scaffolds. 
  
2.3.6.3 Borylation of Indazole 
The application of indazole in the C-H borylation process was attractive due to its 
isosterism with indole. It was hypothesised, however, that due to the presence of an 
additional azinyl nitrogen, that its reactivity pattern would be distinct to that of indole (c.f 
Figure 24b). 
To explore this hypothesis, the parent indazole (402) was reacted with an aliquot of stock 
solution in a microwave reactor at 120 °C. Consistent with the above hypothesis, 
borylation products were not observed, as evident by 1H NMR spectroscopic analysis of 
the crude reaction mixture (Figure 49a). GC/MS and LC/MS analyses also failed to detect 
products even at trace levels. However, consistent with disruption of azinyl coordination 
to the iridium catalyst, an ortho N-methyl protecting group is sufficient to enable efficient 
reaction. This is consistent with results obtained previously in the borylation of 2-picoline 
(Figure 49b) (c.f Figure 27b). Strategies for indazole borylation are discussed more fully 
in Chapter 3. 
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Figure 49: Borylation of indazoles 
 
2.3.6.4 Borylation of Pyridazines 
Pyridazine was a substrate of potential interest due to the neighbouring azinyl nitrogens 
and their potential effect on reactivity. Preliminary investigation involved the reaction of 
the parent heterocycle with an aliquot of stock solution. Unsurprisingly, given the 
presence of two unencumbered azinyl nitrogens, the borylation of the parent pyridazine 
heterocycle (406) proceeded sluggishly even with high temperature microwave 
irradiation. Conversion was tentatively assigned as 57% based on C-4 borylation (409) 
and a subsequent downfield shift of neighbouring 3 and 5-H resonances, however, 
significant quantities of decomposition products were observed by 1H NMR and as such 
an accurate measure was not possible. GC/MS analysis failed to confirm the conversion 
ratio and to identify the decomposition products. Reflecting this, subsequent reactions 
were carried out on 3-substituted substrates and the results are summarised in the table 
below (Table 11);  
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Table 11: Borylation of pyridazines 
 
The corresponding borylation of 3-methylpyridazine (407) proceeded smoothly with a 
serendipitous crystallisation of the 5-boryl product (410) enabling easy identification of 
regioselectivity with 4 and 6-H singlet resonances observed at 7.64 and 9.22 ppm 
respectively in the 1H NMR spectrum (Table 11, entry 2) (Figure 50). Copious washings 
with cold MTBE and attempted recrystallisations failed to remove co-crystallised boron-
impurities observed at 22.5 ppm in the 11B NMR spectrum and as such an analytically 
pure sample was not obtained. The filtration liquors were concentrated in vacuo and 
analysed by 1H NMR to confirm the absence of any minor borylation products and 
starting pyridazine, thereby confirming the full clean conversion to product. 
Disappointingly, 3-chloropyridazine (408) was recalcitrant to borylation due to its poor 
solubility in both THF and the more polar diglyme and NMP (entry 3).  
 
 
 
[Ir(COD)OMe]2 2.5 mol%
dtbpy 5 mol%  
B2pin2 1 eq., MTBEN
N
R
N
N
R
Entry R Temp
(°C)
Time (h)  Conversion
(1H NMR)
1a H 80 1 57%
Yield
N/A
2 Me rt 24 100% 63%b
3a,c Cl 80 1 0% N/A
a. Run in microwave reactor; b. Contains minor impurities;
c. Reaction attempted in THF, NMP and diglyme
pinB
R = H (406)
R = Me (407)
R = Cl (408)
R = H (409)
R = Me (410)
R = Cl (411)
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Figure 50: 1H NMR spectrum of 3-methyl-5-(Bpin)-pyridazine 
 
Reflecting the difficulties in purification, 3-methyl-5-(Bpin)pyridazine (410) was trapped 
by a tandem ‘one-pot’ Suzuki-Miyaura cross-coupling with 2-bromonaphthalene (412) 
using the method previously described (Scheme 33) (c.f Section 2.3.2.1).  
 
 
Scheme 33: Tandem ‘one-pot’ borylation/Suzuki-Miyaura cross-coupling of 3-methylpyridazine 
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Product 413 was characterised by a shift in the 4 and 6-H resonances to 7.63 and 9.43 
ppm respectively, as well as the diagnostic molecular ion found by ASAP accurate mass 
(m/z = 220.1000, [M]+). 
 
2.3.6.5 Borylation of Isoquinolines 
The borylation of quinoline scaffolds is well established both in literature and within the 
research group (c.f Section 2.2). The borylation of isoquinoline and its derivatives has 
remained a somewhat neglected area but with the wide range of reported biological 
activities exhibited by isoquinoline derivatives, direct functionalisation of the isoquinoline 
core is an attractive tool for synthetic chemists.148 Reflecting this, a series of simple 
isoquinoline substrates were screened. Preliminary experiments studied the direct 
functionalisation of the parent heterocycle by reaction with an aliquot of catalyst stock 
solution (414). GC/MS analysis of the crude concentrated product displayed no 
borylation products and full conversion of the starting material to an unknown product 
bearing the molecular ion peak m/z = 102. The mass loss corresponds to loss of HCN 
(m/z = 27), likely initiated by coordination of the azinyl nitrogen to the iridium catalyst. 
Reflecting this observation, and in light of knowledge gained previously in the study, a 
series of 1 and 3-substituted isoquinolines were subjected to C-H borylation (Table 12).  
 
111 
 
 
Table 12: Borylation of isoquinolines 
 
Disappointingly, 1-chloroisoquinoline (415) was recalcitrant to the borylation conditions 
showing no conversion to borylation products by in-situ 1H NMR spectroscopy (entry 2). 
1-methylisoquinoline (416) borylated readily at room temperature displaying a 94% 
GC/MS conversion to borylated products. The complex mixture observed by 1H NMR 
spectroscopy precluded the calculation of a regioisomeric ratio. GC/MS ratios showed a 
96:4 ratio of monoborylated (m/z = 269, [H]+) to bis-borylated (m/z = 395, [M]+) products 
(entry 3). Analysis of in-situ 1H spectra taken early in the reaction enabled tentative 
assignment of 6 and 7-boronate esters (417, 418) as the major products on the grounds 
of downfield shifts of 5 and 8-H resonances with accompanying change in multiplicity. 
The 4-boryl product was discounted on the grounds of no observed change in the peri 
5-H resonance (Figure 51).  
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Figure 51: Borylation of 1-methylisoquinoline (In-situ 1H NMR spectrum)  
 
Borylation of the 3-methyl derivative (419) gave a 75% conversion to a 53:47 mixture of 
two monoborylated products (420, 421) by GC/MS. After concentration and reaction with 
3-fluoro-iodobenzene (422) catalysed by the 2ndGenPdXPhos pre-catalyst using the 
previously discussed method (c.f Section 2.3.2.1), products 423 and 424 were isolated 
as an inseparable mixture in a roughly 1:1 ratio (Scheme 34).  
 
 
Scheme 34: Tandem ‘one-pot’ borylation/Suzuki-Miyaura cross-coupling of 3-
methylisoquinoline 
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The final products after Suzuki-Miyaura cross-coupling were confirmed by two merged, 
indistinguishable 19F signals at −112.6 ppm as well as two closely eluting LC/MS peaks 
exhibiting the desired molecular ion peak (m/z = 238, [M+H]+). The regioselectivity and 
compound mixture obtained was unsurprising given the steric and electronic similarities 
of 6 and 7-H.  
 
2.3.6.6 Borylation of 1,8-Naphthyridine 
Due to their potential use in medicinal chemistry as quinoline isosteres, there has been 
increased interest towards synthesis of naphthyridine derivatives. Substituted 
naphthyridine cores have often been prepared via de novo synthesis.149,150 Development 
of strategies which permit late stage functionalisation is more synthetically desirable and 
as such work was focussed on direct borylation of the 1,8-naphthyridine core (425). In 
order to prevent excessive formation of bis-borylated products, reactions were 
conducted at room temperature with sub-stoichiometric B2pin2 (Scheme 35). 
 
 
Scheme 35: Tandem ‘one-pot’ borylation/Suzuki-Miyaura cross-coupling of 1,8-naphthyridine 
 
Consistent with desymmetrisation of the molecule, the 3-boryl product (426) was 
observed by shifts to higher frequency of 2-H and 4-H resonances. Conversion was 
tentatively assigned as 65%. Attempted purification of the boronate ester was 
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problematic due to the streaky nature of the product on both silica and alumina matrices. 
As such the 3-boryl product and regioselectivity was confirmed after tandem Suzuki-
Miyaura cross-coupling reaction of the crude boronate ester with 3-iodoanisole (340). 
Product 427 was confirmed by observation of a 2.6 Hz 4JH-H coupling between 2 and 6-
H resonances and a singlet at 3.92 ppm, corresponding to the newly incorporated OCH3 
functionality. 
 
2.3.6.7 Borylation of Pyridine-N-oxides 
Direct borylation of pyridine N-oxides was also of interest due to their distinct electronic 
character, with respect to azinyl heterocycles, and their pre-existing capped azinyl 
nitrogen. Reflecting this, boryation of pyridine-N-oxide (428) was attempted with a THF 
stock solution for solubility reasons. Consistent with previous findings, the attempted 
direct borylation of pyridine-N-oxide was unsuccessful, with only starting material 
observed by 1H NMR after concentration of the reaction mixture. Significant quantities of 
oxidised B2pin2 were observed by GC/MS (m/z = 270), likely a by-product of the oxidative 
nature of the substrate (Scheme 36). 
 
 
Scheme 36: Attempted borylation of pyridine-N-oxide 
 
In light of this finding, the N-oxide was alkylated in order to suppress the formation of 
oxidised B2pin2 and prevent coordination to the iridium catalyst. Consideration was given 
to ensure the product counter ion facilitated solubility of the product in low polarity 
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borylation reaction media and was itself non-coordinating. Reflecting this, a solution of 
Meerwein’s salt (430) was slowly added to a DCM solution of 428. Concentration in 
vacuo gave the crude product as a pink solid. Recrystallisation from hot EtOAc with 
copious washings with cold Et2O gave the product (431) as a white solid, characterised 
by a quartet and triplet (J = 7.0 Hz) at 4.70 and 1.39 ppm respectively, corresponding to 
the newly incorporated alkyl resonances, in the 1H NMR spectrum (Figure 52a).  
 
 
Figure 52: a. Alkylation of pyridine-N-oxide; b. Attempted borylation of alkylated pyridine-N-
oxide 
 
Disappointingly, despite good solubility in THF and the conversion of the oxide 
functionality into an ethereal oxygen, the attempted borylation of 431 with a THF stock 
solution gave no observable C-H borylation products after overnight heating, as evident 
by 1H NMR and LC/MS analysis of the crude reaction mixture (Figure 52b). 
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2.4 Conclusions and Future Work 
Through judicious choice of substrates, iridium-catalysed C-H borylation can be 
conducted with Lewis-basic heterocycles. Borylation is contingent upon the presence of 
an ortho-substituent to disrupt azinyl coordination to the iridium catalyst.  
The borylation of 2-substituted pyridines gives product mixtures, with the preferred 
regioselectivity correlating well with the relative acidity of C-H bonds. The reaction of 
difunctionalised pyridines enables synthesis of single products, which are isolable by 
column chromatography (stability permitting) or applicable in tandem ‘one-pot’ Suzuki-
Miyaura cross-coupling reactions in good yields.  
The borylation of C-H bonds ortho to azinyl nitrogen atoms is disfavoured on the grounds 
of unfavourable repulsive interactions between the lone pair and a partial negative 
charge during oxidative addition. However, the presence of a suitably sterically 
encumbering group at C-4 is sufficient to overcome this energy barrier. In addition, 
electron-withdrawing groups at C-2 accelerate the reaction by sequestering the Lewis 
basicity of the lone pair. Moreover, this also stabilises them to chromatographic 
purification by sufficiently slowing the rate of protodeborylation. These findings 
somewhat contradict a concurrent report published by Hartwig et al., in which it was 
suggested that the lack of ortho azinyl borylation was attributable to rapid in-situ 
protodeborylation rather than an intrinsic barrier to C-H activation.122 
Where the instability of the boronate esters precludes their purification by 
chromatographic methods, they have been trapped by Suzuki-Miyaura cross-coupling 
reactions. Whilst Burke and co-workers have reported strategies for the cross-coupling 
of 2-pyridyl boronic species (c.f Scheme 9), these strategies often require the use of a 
large excess of boron compound or proceed from the MIDA boronate (synthesised in 
multiple steps via the boronic acid) (c.f Figure 12). 
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Whilst their basicity is markedly lower than pyridine, the borylation of pyazines, 
pyrimidines, pyridazines and isoquinolines also required an ortho-substituent to improve 
efficiency. The activity of 3-methylpyridazine was somewhat surprising, because despite 
the steric bulk present at C-3 to disrupt the coordinating effects of N-2, the N-1 azinyl 
lone pair remained unencumbered and was expected to partially suppress the reaction. 
It was postulated that the repulsion caused by the co-planar azinyl lone pair of N-2 
restricted the coordination of the N-1 lone pair to the iridium catalyst thereby enabling 
borylation to occur. Also surprising, was that 1,8-naphthyridine also borylated without the 
requirement for pre-functionalisation. This was rationalised on the basis that the co-
planar peri lone pairs effectively cancel out one another and prevent the docking onto 
the iridium on the basis of repulsion.  
Current work in the group is seeking to expand upon the multi-directional synthetic 
strategies expounded upon in this chapter. Exploiting the functional group tolerance of 
C-H borylation, the synthesis of functionalised biaryls has been demonstrated. The pre-
existing functionality was then reacted in downstream chemistry to allow small library 
synthesis.  
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3 Multidirectional Synthesis of Functionalised 
Indazoles 
3.1 Background and Chapter Aims 
The C-H borylation of indole substrates is well established in the literature (c.f Figure 24). 
Due to its isosterism with indoles, indazoles are an important class of heterocycle in 
medicinal chemistry and agrochemical programs.151 Amongst other applications, 
indazole derivatives have been found to possess antifertility,152 anticancer,153 
antispermatogenic154,155 and HIV protease inhibitory activity.156 Therefore, protocols by 
which substituted and functionalised indazole derivatives can be synthesised in good 
yields and with good atom efficiency would have widespread synthetic utility in the 
pharmaceutical sector and in drug discovery programs. 
Direct C-H borylation is particularly attractive for a drug or agrochemical discovery 
program as it allows for efficient library synthesis from known and readily available 
starting materials, or for later stage functionalisation of common precursors. Therefore, 
in order to investigate the potential utility of the indazole moiety in these programs, work 
was first carried out to probe the reactivity of the unmodified parent heterocycle. As 
previously discussed, the parent heterocycle was recalcitrant to borylation even at high 
temperatures and with microwave irradiation (c.f Figure 49). This chapter addresses the 
steps taken to address the limited reactivity of indazole, in light of the strategies gleamed 
from the previous chapter, in order to enable its application in multidirectional synthetic 
strategies towards privileged multiaryl units. 
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3.2 Results and Discussion  
3.2.1 Borylation of 3-Bromoindazole 
Given the propensity for unmodified indole to undergo fast and selective borylation, it 
was hypothesised that the additional azinyl nitrogen present in indazole (relative to 
indole) was inhibiting borylation through coordination to the Ir-centre at the vacant 
coordination site. This effect is similar to that previously observed in the borylation of 
pyridyl substrates (c.f Section 2.1.4.2). In order to circumvent this issue, coordination of 
the azinyl nitrogen to the iridium catalyst would need to be disrupted. In light of previous 
observations (c.f Section 2.1.4.3), two solutions were suggested; incorporation of a 
formal substituent C-3 ortho to the coordinating azinyl nitrogen, or incorporation of an N-
protecting group. Given the commercial availability of 3-haloindazoles and the drive 
towards green chemistry that avoids the use of protecting groups (where possible) in 
drug discovery programs, the former strategy was investigated. It was also postulated 
that nitrogen protection could induce regioselectivity issues and prevent potential N-
directed borylation as previously observed in the borylation of 2-substituted indole 
substrates (c.f Figure 24d). Moreover, the presence of 3-halosubstitution could allow for 
downstream modification, enabling multidirectional synthesis and the efficient synthesis 
of small compound libraries. On this basis, the commercially available 3-bromoindazole 
(433) was selected as a substrate to explore (Scheme 37). 
 
 
Scheme 37: Borylation of 3-bromoindazole 
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The reaction of 433 with an equivalent of B2pin2 in the presence of 3 mol% iridium was 
sluggish even with heating at 120 °C over extended periods. However, the fact that 
borylation products (434, 435) were observed confirmed inhibition of coordination was 
key to enabling indazoles to undergo borylation. 1H NMR spectroscopic analysis enabled 
characterisation of a roughly 1:1 mixture of products arising from borylation at C-5 and 
C-6, which could be distinguished using the previously outlined method (c.f Figure 36), 
through observation of downfield shifts in neighbouring 1H resonances (Figure 53).  
 
 
 
Figure 53: Borylation of 3-bromoindazole (433) (1H NMR spectrum of the crude product 
mixture) 
 
Whilst an ortho substituent was sufficient to enable pyridyl substrates to undergo efficient 
borylation at room temperature, it was insufficient to suppress sufficiently azinyl 
coordination in this instance. It was hypothesised that the suppressive effect of the ortho-
substituent on azinyl nitrogen coordination was less significant on 5-membered motifs, 
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due to their expanded H-C-C bond angles, relative to 6-membered systems. It was also 
envisaged that, like the parent heterocycle, 3-bromoindazole could exist in 2-tautomeric 
forms in solution (Figure 54). Given the low catalyst loadings employed in this reaction, 
only a small concentration of the minor tautomer (433b), bearing the unhindered azinyl 
nitrogen, would be required to inhibit reactivity.  
 
 
Figure 54: Tauomerisation of 3-bromoindazole 
 
With the low selectivity and sluggish reactivity observed, focus was therefore turned to 
borylation of protected indazoles.  
 
3.2.2 Borylation of Protected Indazoles 
3.2.2.1 Attempted Traceless Protecting Group Strategies 
Initially the possibility of traceless protecting groups was explored, as this offers the 
added advantage of not requiring formal protection and deprotection steps in a synthetic 
pathway. A survey of the literature found two potential protocols of interest. 
Smith and co-workers had demonstrated that Bpin could function as a Boc group 
surrogate in the borylation of nitrogen heterocycles (Figure 55, Route B)157 Pre-exposure 
to HBpin was shown to form a N-boryl adduct (439) which functioned as a formal 
protecting group subsequently enabling regioselective borylation of the heterocycle and 
thereby circumventing the need for protection and deprotection steps. 
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Figure 55: Bpin as a traceless protecting group for indole borylation 
 
Attempts were then made to apply this protocol to the borylation of indazole (Scheme 
38). Prior to the addition of an aliquot of catalyst stock solution, indazole (402) was 
reacted with excess HBpin in the presence of triethylamine (Et3N). No change in 11B 
NMR shift was observed after stage 1, which suggested formation of the N-boryl adduct 
(441) was unsuccessful, however given the potential instability of the adduct, the stock 
solution was added to the crude reaction mixture and the reaction continued as planned.  
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Scheme 38: Attempted borylation of indazole with traceless Bpin protecting group 
 
Analysis of the crude reaction mixture by 1H NMR spectroscopy and GC/MS found only 
unreacted starting indazole. Reflecting this unfortunate result, an alternative protocol 
was considered. 
Given that the Lewis-basicity of the azinyl nitrogen had to this point been a practical 
hindrance to the direct borylation of indazole, it was hypothesized that the substrate 
could be activated by coordination of a supplementary metal species present in the 
reaction media. Gorelsky had previously showed that the Palladium-catalysed direct C-
H arylation of azoles could be accomplished in the presence of a non-reactive copper 
source, whose primary role was coordination to the azinyl nitrogen (Figure 56).158 
 
 
Figure 56: Regioselectivity tuning with Cu(I) salts 
 
It was also observed that copper binding enhanced C-H acidities of proximal protons, 
thereby adjusting the preferred regioselectivity. C-H acidity has been found to have an 
important role in predicting preferred regioselectivity of C-H borylation and thus this 
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method was pursued and applied to indazole. It was postulated that the azinyl nitrogen 
would bind to copper in preference to the iridium catalyst, thereby allowing C-H oxidative 
addition by transmetallation onto the iridium catalyst. Following this hypothesis, one 
equivalent of CuX was added to the substrate prior to the addition of catalyst stock 
solution (Scheme 39). 
  
 
Scheme 39: Attempted borylation of indazole, with Cu(I) salts as traceless protecting 
groups 
 
Disappointingly, the reaction was unsuccessful both with suspended Cu(I)I and with 
soluble Cu(I)TC (copper (I) thiophene-2-carboxylate). Concentration of the reaction 
mixture after celite filtration (to remove copper species) gave a crude mixture bearing 
only unreacted starting material. Protodeborylation prior to analysis was possible, but 
unlikely given the mild work-up conditions. 
 
3.2.2.2 Borylation of N-protected Indazoles 
The unsuccessful investigation into traceless protecting strategies suggested formal 
protecting groups would be required to facilitate C-H borylation. Various literature 
precedents have been reported for the protection of indazole substrates with a variety of 
protecting groups.159-161 Given that its synthesis avoids the use of strong bases, attention 
first focused on the use of N-Boc-1H-indazole (450) (Scheme 40). 
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Scheme 40: Boc-protection of indazole 
 
Simple reaction with di-tert-butyl-dicarbonate (Boc2O) in MeCN afforded 450, which 
lacked the characteristic N-H stretch of the parent indazole. Confirmation of Boc-
protection was provided by a strong CO stretch at 1732 cm−1 in the IR spectrum and a 
singlet at 1.66 ppm in the 1H NMR spectrum, corresponding to the methyl (CCH3) 
resonance of the tert-butyl moiety. The regioselectivity was confirmed by comparison to 
literature data. With the protected indazole in hand, work focused on testing the substrate 
in the borylation process.  
Using pre-prepared catalyst stock solutions, full clean conversion to the 3-borylated 
product (451) was observed within two hours by in-situ 1H NMR spectroscopy (Scheme 
41). In-situ NMR analysis was facilitated using the previously described method (c.f 
Section 2.3.1). 
 
 
Scheme 41: Borylation of Boc-1H-indazole 
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Confirmation of 3-borylation was obtained from the 1H NMR spectrum, in which loss of 
the 3-H singlet was observed to leave a single four-spin system as observed by 
correlation spectroscopy (COSY). Moreover, consistent with 3-borylation was an 
observed upfield (ca. 0.4 ppm) shift of the peri 4-H proton (Figure 57). 
 
 
 
Figure 57: a. in-situ 1H NMR spectrum of borylation of Boc-indazole; b. Reference spectra of 
450 (enhanced aromatic region). 
 
Regioselectivity in this instance is chemoselective for the heteroaromatic ring with 
preferential reactivity at the most acidic C-H bond.160 This is in keeping with many 
previously recorded observations within the group.129 Frustratingly, attempts to purify the 
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mono-borylated product were unsuccessful, with flash column chromatography leading 
to significant protodeborylation back to starting material.  
Having established that ortho-azinyl boronate ester stability was sensitive to the 
electronic effects of ortho functionality (c.f Table 5), it was envisaged that indazoles 
bearing more electron-withdrawing protecting groups would enable chromatographic 
purification. Removal of electron density from the azinyl nitrogen would reduce the 
prominence of hydrolytic degradation pathways. It was also of interest to study the 
relative rates of formation of ortho-azinyl boronate esters as a function of protecting 
group electronics. Consequently, a series of protected indazoles were prepared (Table 
13). Given the propensity for kinetic control in indazole protection to provide 2-protected 
indazoles, it was also suggested that access to these alternative substrates may enable 
a redirection in regioselectivity by steric effects. 
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Table 13: Preparation of a series of protected indazoles 
 
Slow addition of a solution of indazole (402) in THF to a NaH suspension in THF at 0 °C 
gave a homogeneous grey solution. Addition of MeI (452) enabled the synthesis of both 
N-methyl isomers (404 and 453) (entry 1). Repetition of this procedure with electrophiles 
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454 and 457 enabled synthesis of 455, 456 and 458. Regioselective synthesis of 2-{[2-
(trimethylsilyl)ethoxy]methyl}-2H-indazole (2-SEM-2H-indazole, 459) and synthesis of 
the N-mesyl species (461), were carried out in accordance with literature procedures 
(entries 4 and 5).160,162 Addition of a catalytic quantity of solid pTSA.H2O to indazole and 
dihydropyran in DCM, accompanied by a loss in turbidity and a gradual colour change 
from grey to faint pink, enabled synthesis of THP (tetrahydropyran-2-yl) derivatives (464 
and 465) (entry 6).  
Characterisation was achieved through mass spectrometry in conjunction with 1H NMR 
spectroscopy, for example N-methyl-1H-indazole (404) and N-methyl-2H-indazole (453) 
were identified by their characteristic LC/MS molecular ion peaks 133 ([M]+) and 134 
([M+H]+) respectively, as well as their respective CH3 resonances in the 1H NMR 
spectrum at 4.08 and 4.21 ppm.  
Differentiation between the regioisomers was accomplished by observation of long range 
coupling in the HMBC spectrum between the NCH3 carbon and 3-H proton and also 
between the corresponding NCH3 protons and C-3 carbon. This far range correlation was 
present in the 2-protected isomers but absent in the 1-protected isomers (Figure 58). 
This pattern was observed in all cases where the protecting groups bore 
(pseudo)benzylic proton resonances (entries 1, 2, 3, 4 and 6). 
 
 
Figure 58: Regioselectivity assignment by HMBC correlations 
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To test their applicability to C-H borylation, the protected indazoles were treated with an 
aliquot of stock solution and the results are tabulated below (Table 14). Reactions were 
monitored by in-situ 1H NMR up to 24 h to enable analysis of relative reaction rates and 
product regioselectivity was assigned using the previously described method (c.f Figure 
57). 
 
 
Table 14: Borylation of a series of 1 and 2-protected indazoles 
 
Significantly, and consistent with the previously observed results obtained for 2-
substituted pyridine borylation (c.f Table 2), more strongly electron-withdrawing 
protecting groups led to faster reactions and higher conversions. This was evident by the 
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superior reactivity of both the mesyl-derivative (461) (entry 4) and the previously 
described Boc-derivative (450) (c.f Scheme 41). Surprisingly, borylation of 2-protected 
indazoles occurred more rapidly and in higher conversions than the corresponding 1-
protected isomers, with no change in regioselectivity observed (entries 6-9). This 
occurred in spite of the presence of bulky THP or benzyl protecting groups ortho to the 
preferred site of functionalisation. The higher reactivity of these isomers was most 
notably observed with complete borylation of the bulky 3,5-dimethylbenzyl derivative 
(456) being observed in minutes (entry 7), in contrast to the many hours required for the 
analogous 1-N protected isomer (455) (entry 2). This pattern was attributed to Coulombic 
repulsive interactions between the emerging negative charge at C-2 and the 2-N azinyl 
lone pair (475) (Figure 59a). These interactions are notably absent in the borylation of 2-
N protected isomers, in which oxidative addition occurs distal to the azinyl lone pair (476, 
477) (Figure 59b).This may also explain the enhanced reaction rates observed for 
borylation of indazoles bearing electron withdrawing protecting groups. The increased 
electron-withdrawal by the Boc and mesyl protecting groups diminishes the destabilising 
repulsive effect of the azinyl lone pair, thus accelerating the rate of borylation ortho to 
the azinyl nitrogen. 
 
 
Figure 59: a. Disfavoured repulsive interactions from ortho oxidative addition of indazole; b. 
Favoured oxidative addition distal from the azinyl lone pair 
 
A second observation arose from these studies. Unlike borylation products 405 and 451 
which underwent significant protodeborylation on both silica and alumina column 
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matrices, product 468 (entry 4) was stable towards column chromatography. Isolation of 
468 was confirmed by observation of a characteristically broad singlet at 28.9 ppm in the 
11B NMR spectrum as well as the diagnostic molecular ion peak m/z = 321.1195 ([M]+) 
by ASAP accurate mass measurement. The electron-withdrawing capabilities of the 
mesyl group render the azinyl lone pair less basic and thus sufficiently slows the rate of 
protodeborylation to enable chromatographic purification.135 This is consistent with the 
observed stability of methyl-2-fluoro-6-(Bpin)-nicotinate (339) described previously (c.f 
Table 5). 
 
3.2.2.3 Tandem ‘one-pot’ Borylation/Suzuki-Miyaura cross-couplings 
Although the isolation of this typically unstable boronate ester was pleasing, the 
instability of the other boronate esters was so far a limiting factor in the application of C-
H borylation methodology to indazole substrates. Furthermore, whilst the stability of 
many of these boronate esters was insufficient for them to be purified by column 
chromatography, it was envisaged that their solution lifetime might be sufficient enough 
to trap them in-situ by Suzuki-Miyaura cross-coupling (Figure 60). Consequently a series 
of 1 and 2-protected indazoles were borylated and then reacted with a selection of aryl 
halides, the results of which are shown below. 
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Figure 60: Tandem ‘one-pot’ borylation/Suzuki-Miyaura cross-coupling of protected indazoles 
 
Given that borylation of certain N-1 protected indazoles had previously failed to reach 
full conversion and in some cases lead to minor product formation (c.f Table 14), sub-
stoichiometric B2pin2 and higher borylation reaction temperatures were employed to 
ensure single product formation. Borylation reactions were monitored by GC/MS until 
optimum conversion was reached, at which point the reaction was concentrated in vacuo 
and the Suzuki-Miyaura reagents and degassed DMF were added to the reaction 
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mixture. CuCl was added in order to increase the rate of transmetallation onto the Pd-
catalyst in step iii and thus reduce the prominence of protodeborylation.90 The absence 
of CuCl lead to greatly reduced yields for reactions involving 1-protected indazoles, for 
example the equivalent reaction involving 1-methyl-1H-indazole (404) with iodobenzene 
(130) carried out in the absence of CuCl gave only an 11% yield. Confirmation of cross-
coupled product formation was confirmed by mass spectrometry, for example 481 
possessed the diagnostic molecular ion peak by ASAP accurate mass measurement; 
m/z = 208.0995, [M]+.  
N-2 protected indazoles proceeded cleanly to 3-boryl intermediates. The Suzuki-Miyaura 
cross-coupling step was set up in an analogous fashion in the absence of CuCl as this 
was observed to have no beneficial effect on the isolated yields, for example, the 
equivalent reaction involving 2-methyl-2H-indazole (453) with iodobenzene (130) carried 
out in the presence of CuCl gave only a slightly diminished yield (41%). This was 
attributed to the fact that the 2-protected-3-(Bpin)-indazole intermediates are not ortho-
azinyl boronates and are therefore less prone to protodeborylation pathways. The N-2 
protected Suzuki-Miyaura products were characterised in an analogous fashion. 
The isolated yields obtained clearly demonstrated that competitive protodeborylation 
was yield-limiting. Borylation conditions were sufficiently forcing to enable 100% 
conversion to boronate ester in many cases as evident by GC/MS after stage 1. This, 
therefore, showed that yield losses were incurred during the Suzuki-Miyaura cross-
coupling step. This observation was attributed to potential metal or base-mediated 
protodeborylation pathways, both of which are potentially prevalent in cross-coupling 
reactions.4,5 
Overall, the method is general for a range of electron-rich and electron-poor aryl and 
heteroaryl iodides and bromides. Frustratingly, the cross-coupling of aryl chlorides 
proved not to be viable under these standard cross-coupling conditions even when 
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reactive 2-heteroaryl chlorides, such as 2-chloropyridine (275), were used as coupling 
partners. Moreover, the attempted reaction with the even more reactive 2-
chloropyrimidine (396) was also unsuccessful. 
 
3.2.2.4 Multidirectional Synthesis of Functionalised Indazoles 
Having successfully demonstrated the regioselective borylation, and subsequent 
arylation, of protected indazoles, it was then of interest to apply this strategy in 
multidirectional syntheses of privileged multiaryl scaffolds. The functional group 
tolerance of C-H borylation enables borylation of functionalised starting materials, which 
would be otherwise recalcitrant to classical synthetic routes to boronate esters (c.f 
Section 1.3.1.1). A retrosynthetic analysis of a multiaryl indazole suggested protected-
bromoindazoles as suitable starting materials due to their availability, synthetic utility and 
the stability of the bromo functionality to C-H borylation (Scheme 42). 
 
 
Scheme 42: Retrosynthetic analysis of bis-arylindazoles 
 
3.2.2.4.1 Borylation of Bromoindazoles 
With this objective in mind, initial work focussed on assembly of the required precursors. 
Due to their low cost, 5, 6 and 7-bromo-1H-indazoles could be purchased from 
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commercial suppliers whereas the 4-substituted isomer would require pre-formation of 
the indazole framework. This was accomplished by reaction of the substituent bromo-
fluorobenzaldehydes with hydrazine (Scheme 43). 
 
 
Scheme 43: Synthesis of 4-bromoindazole 
 
Simple reflux of the required bromo-fluorobenzaldehyde (496) in a 1:1 mixture of 
dioxane:hydrazine hydrate gave the desired product (497), lacking the 19F and aldehyde 
CHO resonances. Confirmation of indazole formation was provided by a broad N-H 
resonance at 10.67 ppm, in conjunction with a 3-H singlet at 8.13 ppm.  
In order to enable borylation, prior protection was required. 2-SEM protected indazoles 
were chosen due to their selective synthesis and superior reactivity in the borylation 
reaction relative to the 1-protected congeners (c.f Table 14). As such, the protection of 
bromo-indazoles was undertaken using the previously outlined method (Scheme 44) (c.f 
Table 13). 
 
 
Scheme 44: Regioselective 2-SEM protection of bromoindazoles 
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Initial attempts to apply the previously described tandem ‘one-pot’ borylation/Suzuki-
Miyaura cross-coupling protocol were undertaken with the 6-bromo derivative (503) (c.f 
Figure 60). Predictably, in-situ 1H NMR spectroscopy showed full clean conversion to 
monoborylated product, the regioselectivity of which was confirmed using the previously 
stated method of characterisation (c.f Section 3.2.2.2). Attempts at cross-coupling with 
methyl-4-iodobenzoate (267) catalysed by Pd(dppf)Cl2, led to small but detectable 
amounts of homocoupled indazole products by LC/MS (m/z = 574 (81Br, [M]+), 572 (79Br, 
[M]+)). In order to suppress competing pathways, milder cross-coupling conditions were 
sought. It was hypothesised that the milder Pd(PPh3)4 catalyst would effect a more clean 
reaction and avoid unwanted by-products. Gratifyingly, this catalyst swap meant no such 
homocoupling products were observed. With the modified one-pot method in hand, the 
bromoindazoles were reacted with 267 or 2-bromopyridine (479) and the results are 
shown below (Figure 61). 
 
138 
 
 
Figure 61: Tandem ‘one-pot’ borylation/Suzuki-Miyaura cross-couplings of bromo-indazoles 
 
Confirmation of cross-coupled product formation was provided by 1H NMR spectroscopy 
supported by mass spectrometry, for example compound 508 displayed a diagnostic 
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singlet at 3.98 ppm of the 1H NMR spectrum, characteristic of the incorporated CO2CH3 
functionality. Mass spectrometry analysis provided the diagnostic molecular ion peaks 
with the characteristic 1:1 bromine isotopic ratio; m/z = 462(81Br, [M]+) and 460 (79Br, 
[M]+).  
The yields observed were consistent with previous tandem ‘one-pot’ reactions of 
indazoles (c.f Figure 60).  
 
3.2.2.4.2 Borylation of 4-Bromoindazole 
An interesting observation arose from the borylation of bromoindazoles. Reaction of the 
4-bromo derivative 501 was not regioselective for C-3, as evident by the regioisomeric 
mixture of 3 and 6-arylated products (505, 511) observed after cross-coupling. This was 
attributed to the increased steric hindrance imparted by a 4-bromo substituent relative to 
a 4-hydrogen. As a consequence oxidative addition at C-3 is disfavoured (Figure 62). 
Consequently, this rendered C-H activation disfavoured at C-3 and partially redirected 
reaction to the more sterically accessible C-6. It was hypothesised that borylation was 
favoured at C-6 over the equally sterically accessible C-7 due to the fact that an 
developing negative charge at C-7 in the oxidative addition step would be located peri to 
the lone pair of the 1-N azinyl nitrogen. In light of this observation, attempts were made 
to develop a protocol for regioselective borylation at C-6. 
 
 
Figure 62: Disfavoured C-3 oxidative addition of 4-bromoindazole 
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Previously within the group, Tajuddin had observed enhanced regioselectivities upon 
running reactions at room temperatures (c.f Scheme 20). Reflecting this, a room 
temperature borylation experiment was run to attempt selective borylation at C-6 of 501 
(Figure 63). Initial experiments utilising 3 mol% iridium proceeded slowly therefore 
subsequent reactions were run with a higher catalyst loading in order to accelerate the 
reaction rate. 
 
 
Figure 63: Regioselective borylation/cross-coupling/reduction sequence of 4-bromoindazole 
 
Using a stoichiometric quantity of B2pin2 and 10 mol% iridium, selective borylation at C-
6 was observed as evidenced by a single product peak, displaying the characteristic 
molecular ion peak in the crude GC/MS trace after borylation; m/z = 454 (81Br, [M]+), 452 
(79Br, [M]+). Regioselectivity was confirmed by disappearance of the 6-H signal in 
conjunction with a corresponding shift to higher frequency of the neighbouring 5 and 7-
H resonances in the 1H NMR spectrum. Using the tandem method described previously 
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(c.f Figure 61), 511 was isolated and characterised by a strong IR stretch at 1723 cm−1, 
coupled with the observation of the characteristic CO2CH3 resonance at 167 ppm of the 
13C NMR spectrum. Given the stability of the intermediate boronate ester relative to the 
previously observed 3-boronate intermediates, fewer material losses were incurred in 
the cross-coupling step and as such an improved cross-coupling yield was obtained. 
As observed previously in Chapter 2, halide substituents may undergo reduction under 
transfer hydrogenation conditions (c.f Figure 44). It was suggested that this method could 
be applied as an alternative second stage of a multi-directional sequence, whereby the 
4-bromo substituent acts as a blocking/directing group for borylation and cross-coupling, 
with subsequent reduction enabling a net protecting group strategy for adjusting 
regioselectivity. Applying the conditions utilised previously, reductive debromination 
gave product 514, which lacked the characteristic 1:1 bromine isotopic ratio by crude 
GC/MS (m/z = 382, [M]+).  
 
3.2.2.4.3 Suzuki-Miyaura Cross-Coupling of 3-Aryl-
Bromoindazoles 
Having successfully demonstrated that protected bromoindazoles could undergo tandem 
borylation/Suzuki-Miyaura cross-coupling sequences without competitive homocoupling, 
the next step focused on cross-coupling of the bromine functionality with a series of 
boronic acids in order to complete the multidirectional sequence (Figure 64). 
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Figure 64: Suzuki-Miyaura cross-coupling of aryl-bromoindazoles 
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Reacting the bromoindazoles with an excess of boronic acid in the presence of Cs2CO3 
and 5 mol% catalyst gave efficient conversion to tris-aromatic products. Reactions were 
monitored by TLC (9:1 Hexanes:Ethyl Acetate) and showed full, clean starting material 
consumption within two hours of reaction time. 1H NMR spectroscopy supported by LC 
or GC/MS analysis enabled product characterisation, for example, observation of the 
tolyl CH3 resonance at 2.45 ppm and ester CO2CH3 resonance 3.95 ppm, in conjunction 
with the absence of the 1:1 bromine isotopic ratio, confirmed the synthesis of products 
518 and 521 respectively.  
 
3.2.2.4.4 Attempts at Directed Borylation of Indazole 
To this point, it has been observed that borylation of protected indazoles proceeds rapidly 
and selectively at the 3-position. Subsequent borylation of the phenyl ring proceeds 
unselectively in the absence of steric effects. In order to circumvent the requirement for 
pre-existing functionality, the directed C-H borylation protocols described by Hartwig, 
Ishiyama and their respective co-workers were considered (Figure 65)163,164 
Mechanistically, these reactions proceed via pre-coordination of the nitrogen atom to a 
directing ligand group, such as a hydrosilyl moiety. Immobilisation of the substrate 
enables directed borylation via a stable iridacycle (524) after C-H activation. Given the 
Lewis-basicity of the indazole heterocycle, it was speculated that application of these 
methodologies to indazole may enable a change in regioselectivity, with the azinyl 
nitrogen directing functionalisation to C-7 as opposed to the more favoured C-3 position. 
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Figure 65: Literatute protocols for the directed borylation of azinyl heterocycles 
 
Addition of diethylsilane and toluene to a vial containing indazole (402) and [Ru(p-
cymene)Cl2 gave a deep-red solution. The required indazole-silyl intermediate (528) was 
not observed by GC/MS analysis (Scheme 45). Speculating that the intermediate may 
be unstable to the GC/MS method, the reaction was continued with the removal of 
volatiles and subsequent addition of an aliquot of borylation catalyst stock solution. 
Disappointingly, 1H NMR spectroscopy and GC/MS analysis of the crude reaction 
mixture showed only unreacted starting indazole.  
 
 
Scheme 45: Attempted silyl-directed borylation of indazole 
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As a consequence, attempts were made to apply Ishiyama’s directed protocol. Indazole 
(402) was reacted with a stoichiometric equivalent of B2pin2 in the presence of 2 mol% 
iridium and Silica-SMAP ligand (525) at 60 °C. The suspended silica supported ligand 
was removed by celite filtration prior to removal of volatiles. Only the starting material 
was observed by 1H NMR spectroscopy and GC/MS analysis of the crude reaction 
mixture. Attempts with both protected and unprotected indazole were tried so as to 
ensure purported docking of indazole onto the iridium was ruled out as a limiting factor, 
however this returned neither the intended 7-(Bpin) product or (more surprisingly) the 
previously observed 3-Bpin product (Scheme 46). 
 
 
Scheme 46: Attempted Silica-SMAP directed borylation of indazoles 
 
Given that to this point selective borylation of the phenyl ring of the indazole framework 
had proved elusive without the use of steric directing groups, a new procedure was 
sought which exploited this. 
 
3.2.2.4.5 Attempted ipso-Deuteration of 3-(Bpin)-Indazole 
Whilst borylation at C-3 of the indazole occurred with good efficiency (in the absence of 
steric effects), the instability of the obtained boronate esters were notable. This was best 
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exemplified by the relative cross-coupling yields of 3-Bpin products versus the 6-Bpin 
product (511) obtained from borylation of the 4-bromo derivative (513) (c.f Figure 61 and 
Figure 63). It was speculated that due to the relative stability of the two Bpin ester 
moieties, strategies could be developed whereby selective hydrolytic cleavage of the 
unstable 3-Bpin of a polyborylated indazole would leave the more stable phenyl-Bpin 
functionality, which could then undergo cross-coupling. The net effect of this would be to 
enable access to alternate multiaryl scaffolds and substitution patterns. In order to devise 
the synthetic sequence, it was first of interest to develop conditions for controlled, facile 
protodeborylation of a 3-(Bpin)-indazole product. 
The propensity for ortho-boryl products to undergo fast, acid-mediated protodeborylation 
under mild conditions had been demonstrated previously with the synthesis of an ortho-
deuterated pyrazine (395), using D2O as a mild acid surrogate to mediate C-B bond 
cleavage (c.f Table 9). Speculating that this sequence may be applicable to 3-(Bpin)-
indazole products, an in-situ boronate ester was subjected to a variety of deuteration 
conditions based on the previously described procedure and the results are tabulated 
below (Table 15).  
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Table 15: Attempted ipso-deuteration of 3-(Bpin)-indazole 
 
Disappointingly, implementation of the previously described deuteration conditions failed 
to yield any deuterated product (530) by 1H or 2H NMR spectroscopy, which showed only 
unreacted boronate ester (405). Protodeborylated product was not even observed at 
trace levels by GC/MS (entry 1). Addition of D2O with subsequent heating to 80 °C was 
also unsuccessful (entry 2). Substituting in the stronger CD3COOD (acetic acid – d4) in 
place of D2O also failed to furnish the desired deuterated products (entries 3 and 4). 
Given the propensity of the protected indazoles to undergo protodeborylation during 
attempted purification of silica gel chromatography, addition of loose silica (with stirring) 
was added to attempt to induce protodeborylation (entry 5). Frustratingly, this was also 
unsuccessful with 3-borylated products remaining intact over several hours with stirring. 
Given that part of the attraction of C-H borylation is the potential for late-stage 
functionalisation of functionalised substrates, stronger acids were resisted as the 
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sensitivity of certain functional groups to acidic media may hinder applicability of such a 
method. Consequently, an alternative method of protodeborylation was sought.  
Having observed significant amounts of starting indazole in crude reaction mixtures after 
one-pot borylation/Suzuki-Miyaura cross-coupling reactions (speculated to be as a result 
of either metal or base-mediated protodeborylation during the Suzuki-Miyaura step), it 
was hypothesised that controlled exposure to base could facilitate protodeborylation of 
a 3-(Bpin) ester.  
 
3.2.2.4.6 Selective Protodeborylation of Polyborylated Indazoles 
Given the requirement for base in Suzuki-Miyaura cross-couplings, it was postulated that 
exposure of a polyborylated indazole (whereby one boryl group is situated at C-3) to 
base prior to addition of the metal catalyst and cross-coupling partner would therefore 
enable selective access to cross-coupled products arising from reaction with the more 
stable boronate ester.  
In order to test this hypothesis, 5-bromo-2-SEM-indazole (502) was initially reacted with 
an aliquot of catalyst stock solution containing an extra equivalent of B2pin2. Confirmation 
of bis-borylation was provided by 1H NMR spectroscopy. Consistent with conversion to 
a tris-functionalised indazole, two 4JH-H doublets (J = 1.9 Hz), corresponding to the 4-H 
and 6-H resonances, were observed in the crude 1H NMR spectrum of 5-bromo-3,7-
bisborylindazole (531) (Figure 66).  
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Figure 66: Crude 1H NMR spectrum of borylation of 5-bromo-indazole with excess B2pin2 
 
To the crude borylation reaction mixture was added a mixture of KOH (3 eq.) in 
DMAc:H2O (9:1). Subsequent heating led to full conversion to mono-boryl product (533) 
as confirmed by GC/MS analysis (m/z = 454). To complete the sequence, palladium 
catalyst and 2-bromopyridine (479) were added to the reaction mixture affording the 7-
aryl product 535, characterised by the diagnostic molecular ion peak (m/z = 404, [(79Br) 
M+H]+). The 3-H singlet resonance at 8.15 ppm in the 1H NMR spectrum confirmed 
selective protodeborylation at C-3. This protocol was also successfully applied to the 7-
bromo derivative (504) to afford the 5-aryl product (536) (Figure 67). 
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Figure 67: Selective protodeborylation of polyborylated indazoles 
 
Subsequent Suzuki-Miyaura cross-coupling of 535 with 4-
(trifluoromethyl)benzeneboronic acid (516), using the previously described method (c.f 
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Figure 64), afforded the 5,7-bisarylated indazole (537) in excellent yield, identified by a 
singlet resonance at −62.3 ppm in the 19F NMR spectrum.  
Attempts to apply this procedure to protected 6-bromoindazole (503), to allow direct 
functionalisation at C-4 was unsuccessful. Borylation with excess diboryl reagent 
afforded only the monoborylated 3-functionalised product (538). It was suggested that 
this initial borylation prevented subsequent borylation at C-4 due to steric inhibition 
(Figure 68). 
 
 
Figure 68: Attempted polyborylation of 6-bromoindazole 
 
Overall, a strategy for synthesis of mono and bis-arylated indazoles via a one-pot C-H 
borylation/Suzuki-Miyaura cross-coupling protocol has been developed. By exploiting 
the lability of ortho-azinyl boronate esters and the influence of steric effects in C-H 
borylation, products arising from direct functionalisation at C-3, 5, 6, and 7 may be 
obtained. 
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3.2.2.4.7 Synthesis of 1,3-bis-Arylindazoles 
Thus far, the multidirectional strategies discussed have focussed on tandem 
borylation/Suzuki-Miyaura cross-coupling reactions of functionalised starting materials 
Subsequent elaboration of the pre-existing bromide functionality enabled the 
construction of privileged tris(hetero)aryl scaffolds. Given the recalcitrance of the parent 
indazole to the borylation procedure, protecting groups have been employed to activate 
the substrate allowing borylation. Several groups have reported the N-arylation of 
nitrogenated heterocycles, using both Chan-Lam and Ullmann methodologies.44,165,166 N-
(hetero)aryl scaffolds are subunits in numerous biological and medicinal targets.167 
Reflecting this an alternative multi-directional strategy was proposed, whereby the N-H 
was capped with an aryl unit to facilitate borylation, with subsequent borylation providing 
expedient access to privileged 1,3-disubstituted products.  
Sequential addition of 4-iodoanisole (136) and amine ligand to a suspension of indazole 
(402), K3PO4 and CuI in toluene gave, after heating, the N-arylated product lacking the 
N-H stretch of the parent indazole (Scheme 47). Confirmation of arylation was provided 
by the observed singlet at 3.88 ppm of the 1H NMR spectrum, corresponding to the OCH3 
functionality.  
  
 
Scheme 47: N-H arylation/3-borylation and cross-coupling sequence 
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In order to complete the multidirectional sequence, compound 540 was reacted with an 
aliquot of borylation stock solution. Conversion was not clear by in-situ 1H NMR 
spectroscopy due to partial precipitation within the NMR tube. At this point, volatile 
material was removed in vacuo and the Suzuki-Miyaura reaction with 2-bromopyridine 
was carried out as previously described (c.f Figure 60). Two separate 4-spin systems 
(corresponding to the pyridyl and indazole rings), observed in the COSY spectrum of the 
product, and the loss of the 3-H singlet confirmed the product structure and the 
regioselectivity.  
 
3.2.3 Borylation of Pyrazolo[1,5-a]pyridine 
Having established strategies for direct indazole borylation, it was of interest to explore 
the reactivity of indazole isomers, such as pyrazolopyridines. Pyrazolopyridines are an 
important scaffold, due to its wide applications in medicinal chemistry168,169 and, 
therefore, methods for their late-stage functionalisation are of great value to organic 
chemists. 
Attention was first focussed on the borylation of pyrazolo[1,5-a]pyridine (543). Given the 
high cost of the parent heterocycle from commercial suppliers, the ring was synthesised 
from the more affordable 3-ethyl ester (542) by a decarboxylation reaction (Scheme 
48)169 
 
 
Scheme 48: Synthesis of pyrazolo[1,5-a]pyridine 
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542 was heated in aqueous acid for 2 h as per the literature method. Slow addition of 
sodium hydroxide solution over a 1 h time frame, required in order to maintain the 
temperature below 10 °C, resulted in a vigorous exotherm. GC/MS analysis carried out 
prior to work-up showed full consumption of starting material and provided confirmation 
of decarboxylation (m/z = 118, [M]+). 1H NMR spectroscopy carried out after purification 
showed a surprisingly small (J = 1.8 Hz) coupling between protons 2-H and 3-H (nuclear 
Overhauser effect spectroscopy (NOESY) experiments confirmed the protons were 
neighbouring despite the low coupling by observation of a through-space correlation).  
With compound 543 in hand, work focussed on screening conditions for C-H borylation 
of the substrate (Table 16). Reaction with a stoichiometric quantity of B2pin2 led to 
complex mixtures (as shown by 1H NMR spectroscopy) at both room temperature and 
80 °C (entries 1 and 2). Consequently, subsequent reactions used sub-stoichiometric 
B2pin2 in order to gauge the preferred regioselectivity and surpress competitive or bis-
borylation. The corresponding reaction with 0.5 equivalents of B2pin2 resulted in a 
fortuitous crystallisation of the 3-boryl product (544), observed after 16 h at room 
temperature. Filtration of the precipitate and subsequent recrystallisation from hot MTBE 
gave pure 544 in modest yield (entry 3). Observation of a downfield shift in the 2-H 
resonance, from 7.93 ppm in the starting material to 8.23 ppm in 544, is consistent with 
borylation at C-3. The broad singlet observed at 29.7 ppm in the 11B NMR spectrum was 
consistent with an aromatic boronate ester. The modest yields observed were attributed 
to the sluggish nature of the HBpin-mediated catalytic cycle (c.f Section 2.1.2.5) 
(prominent at low concentrations of B2pin2) and to possible losses incurred during the 
recrystallisation process.  
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Table 16: Borylation of pyrazolo[1,5-a]pyridine 
 
In order to correct for possible losses incurred in the filtration and recrystallisation steps, 
an in-situ trapping of the boronate adduct by Suzuki-Miyaura cross-coupling with 3-iodo-
fluorobenzene was carried out (422) (entry 4). Attempts to monitor the cross-coupling by 
LC/MS were complicated due to the intermediate boronate ester and desired product 
bearing the same retention time. Therefore, TLC analysis (1:1 hexanes:ethyl acetate), 
exploiting the superior longwave ultraviolet (UV) absorption of product 545, was chosen 
 [Ir(COD)OMe]2 1.5 mol%
dtbpy 3 mol%, 
B2pin2 0.5 or 1 eq.
MTBE, rt or 80 °C
24 h
N
N
N
N
Bpin
N
N
Bpin
Entry B2pin2 (eq.)
a Temperature (°C) Product(s)b
1 1 80 Complex mixturec
Complex mixturec2 1 rt
544 24%d
N
N
Bpin
544 31%e
3 0.5 rt
4 0.5 rt
a. Relative to starting heterocycle; b. As determined by 1H NMR 
spectroscopy; c. Structural elucidation of products not possible; d. Isolated 
after recrytallisation; e. Isolated after tandem suzuki-miyaura cross coupling: 
Conditions - Pd(Amphos)Cl2 (6 mol%), Na2CO3(aq)(2M, 2 eq.), 
3-iodo-fluorobenzene (422) (1.2 eq.), DME, 80 °C, 3h (see experimental 
section) (545)
543
N
N
545
F
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as an alternative analytical method. Cross-coupled product 545 was characterised by a 
multiplet at −112.8 ppm in the 19F NMR spectrum and the observation of the desired 
molecular ion peak by electrospray ionisation (ESI) fragmentation (m/z = 212, [M]+) 
The surprising activity of heterocycle 543 towards C-H borylation was attributed to two 
possible factors; firstly it was considered that the inductive withdrawing effect of the 
neighbouring bridgehead nitrogen significantly lowers the Lewis-basicity of the azinyl 
nitrogen disrupting inhibitory coordination to the iridium catalyst. Alternatively, it was 
postulated that the peri 7-H proton prevents coordination of the azinyl nitrogen to the 
iridium catalyst.  
 
3.2.4 Borylation of Pyrazolo[1,2-a]pyridine 
Reaction of the parent heterocycle pyrazolo[1,2-a]pyridine (546) with an aliquot of 
catalyst stock solution gave borylation products arising from preferential reaction at C-3 
(Figure 69). The preferred regioselectivity of the borylation was confirmed by 1H NMR 
spectroscopy, through observation of a downfield shift to higher frequency of the ortho 
2-H and peri 4-H resonances. A minor unidentifiable product was observed by both 
GC/MS (m/z = 244) and 1H NMR spectroscopy. Integration of the respective signals 
gives the approximate ratio 15:1 of major to minor borylation products.  
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Figure 69: Crude 1H NMR spectrum of borylation of pyrazolo[1,2-a]pyridine 
 
Attempts to purify the crude borylation mixture by flash column chromatography were 
unsuccessful, with full reversal by protodeborylation meaning only starting heterocycle 
was isolated after attempted column chromatography. Reflecting this, in-situ 
transformations of the boronate ester were sought (Table 17). After in-situ analysis 
confirmed the conversion to borylated products, the reaction media was concentrated 
and the crude residue subjected to a variety of conditions. Reaction of the crude boronate 
ester with aqueous oxone, CuCl2 and KHF2 as per the literature procedures,40,51,56 failed 
to yield the hydroxyl (548), chloro (549) or trifluoroborate species (560) respectively 
(entries 1-3). Analysis of the crude residues by LC/MS showed no desired product in any 
case with only the starting heterocycle (m/z = 119, [M+H]+) observed. This was attributed 
to the aqueous reaction media employed in each reaction, which may have mediated 
protodeborylation pathways. 
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Table 17: Attempted in-situ trapping of 3-(Bpin)-pyrazolo[1,2-a]pyridine 
 
Disappointingly, the previously described Suzuki-Miyaura conditions (c.f Figure 60 and 
Figure 61) were unsuccessful with both in-situ LC/MS and GC/MS analyses showing no 
conversion to the desired product (551) (entry 4). The use of a more active pre-catalyst 
 [Ir(COD)OMe]2 1.5 mol%
dtbpy 3 mol%, 
B2pin2 1 eq.
MTBE, 80 °C
22 h
N
N
Entry Desired product
1
2
3
4
a. Conditions: A - Oxoneâ 1 eq., Acetone:H2O (1:1), RT, 16 h; B - CuCl2 3 eq., 
MeOH:H2O (1:1), 90 °C, 72 h; C - KHF2 10 eq., THF:H2O (4:1), RT, 16 h; D - 
Pd(dppf)Cl2 10 mol%, Cs2CO3 2 eq., Methyl-4-iodobenzoate 2 eq., CuCl 1 eq., 
DMF, 100 °C, 1 h; E - 2nd Gen PdXPhos pre-cat 5 mol%, K3PO4 2eq.,
3-iodoanisole 1.1 eq., DMAc, 50 °C, 2 h; b. Based on starting material 546
546 547
N
N
Bpin
84% Conversion
1H NMR
Conditions N
N
R
Conditionsa Yieldb
N
N
OH
N
N
Cl
N
N
BF3K
N
N
CO2Me
N
N
OMe
5 41%
A
B
C
D
E
N/A
N/A
N/A
N/A
.
548-552
MAJOR
15:1 (major:minor)
548
549
550
551
552
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in conjunction with a milder base and lower temperatures helped to furnish the desired 
product (552) in moderate yields across the two-steps (entry 5). In process LC/MS 
analysis confirmed the presence of the desired molecular ion peak (m/z = 225 [M+H]+). 
The pure isolated product was characterised by the diagnostic OCH3 singlet resonance 
at 3.87 ppm in the 1H NMR spectrum. The promising conversion observed during stage 
1 borylation suggested the yield losses were incurred by protodeborylation during the 
Suzuki-Miyaura cross-coupling step. 
 
3.2.5 Borylation of Azaindazoles 
Having carried out in depth studies of the borylation of pyridine and indazole scaffolds, it 
was of interest to investigate the selectivity of various aza-indazole derivatives. This 
would enable application of methodologies developed for both pyridine and indazole 
borylation to a novel borylation substrate.  
 
3.2.5.1 Substrate Synthesis 
Given the high cost of azaindazoles from commercial suppliers, the heterocycles (555, 
556) were synthesised based on literature protocols from fluoropyridine carboxaldehyde 
starting materials (553, 554), as carried out previously (Scheme 49) (c.f Scheme 43)170 
 
 
Scheme 49: Synthesis of Boc-protected 4 and 7-azaindazoles 
N2H4.xH2O : Dioxane 
(1:1)
Reflux, 16 h
Boc2O 1.2 eq.
DMAP 0.1 eq.
Et3N 1 eq.
MeCN, rt, 16 hN
R'
R B
A
N
H
N
B
A
N
N
Boc
R = CHO, R' = F 553
R = F, R' = CHO 554
A = CH, B = N 555
A = N, B = CH 556
A = CH, B = N 557
A = N, B = CH 558
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Removal of dioxane in vacuo and extraction into ethyl acetate gave crude products that 
were clean by 1H NMR spectroscopy and suitable to carry through without further 
purification. The N-H protons were not observed by 1H NMR, however IR spectroscopy 
confirmed the presence of the functionality with broad peaks observed at 3141 and 3147 
cm −1 for compounds 555 and 556 respectively. The 3-H resonances observed at 8.14 
(555) and 8.36 ppm (556) were distinct from the usual chemical shift (ca. 10 ppm) of 
aldehyde CHO signals (thereby confirming conversion of the starting materials). 
Surprisingly, a small (J = 0.9 Hz) 5JH-H coupling was observed in compound 555 between 
protons 3-H and 7-H. 
Control reactions of azaindazoles 555 and 556 with an aliquot of borylation stock solution 
unsurprisingly failed to generate any borylation products even at trace levels. Reflecting 
this, in order to disrupt the coordinating capability of the azinyl nitrogens, both substrates 
were Boc-protected using the procedure described previously (c.f Scheme 40). IR 
spectroscopic analyses of Boc-protected compounds 557 and 558 confirmed the 
presence of the newly incorporated protecting group through the observation of strong 
carbonyl stretches at 1739 and 1751 cm−1 respectively (with a corresponding absence 
of the broad N-H stretch signals).  
Due to the high commercial cost of 3-fluoropyridine-4-carboxaldehyde, a different 
synthetic method was sought for the synthesis of the 6-azaindazole core. Acetylation of 
3-amino-4-methylpyridine with acetic anhydride gave full conversion to the 
monoacetylated intermediate by crude GC/MS (m/z = 150 [M]+). Reaction of this crude 
residue with tert-butyl nitrite and KOAc gave product 560, lacking the (pseudo)tolyl 
resonances at ca. 2-3 ppm by 1H NMR spectroscopy (Scheme 50). Observation of the 
3-H resonance at 8.19 ppm confirmed formation of the indazole motif. Given the outcome 
of the reaction was an N-protected indazole, no further elaborations were made prior to 
borylation. 
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Scheme 50: Synthesis of protected 6-azaindazole 
 
3.2.5.2 Attempted Borylation of 6-Azaindazole 
With the various protected aza-indazoles in hand, the substrates were then tested under 
standard C-H borylation conditions with an aliquot of stock solution. Consistent with 
previous observations, 6- azaindazole (560) was recalcitrant to the borylation conditions 
due to the presence of an encumbered azinyl nitrogen (Scheme 51). 
  
 
Scheme 51: Attempted borylation of protected 6-azaindazole 
 
3.2.5.3 Borylation of 4-Azaindazole 
Despite lacking an ortho-substituent (to disrupt azinyl coordination), the protected 4-
azaindazole substrate underwent borylation efficiently. It was postulated that the peri C-
H bond at C-3 prevented any inhibitory binding of the substrate to the iridium catalyst. 
In-situ 1H NMR spectroscopic analysis of the borylation of 562 showed similar relative 
rates for borylation at C-3 and C-6 (as evident by downfield shifts in 5 and 7-H 
resonances, as well as a small but noticeable 1.4 Hz 4JH-H coupling by 1H NMR 
 [Ir(COD)OMe]2 2.5 mol%
dtbpy 5 mol%, 
B2pin2 1 eq.
MTBE, 80 °C, 24 h
560 561
N
N
N
O
N
N
N
O
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spectroscopy). Attempts at selective cross-coupling of the more reactive 3-Bpin was 
unsuccessful with no desired product (563) observed by in process GC/MS analysis 
using the previously described methods (Figure 70) (c.f Figure 60 and Figure 61). 
 
 
Figure 70: Selective protodeborylation of polyborylated 4-azaindazole 
 
Reflecting this, compound 557 was reacted with an excess of B2pin2 which effected full 
conversion to the 3,6-bisboryl product (562). Using the previously described method (c.f 
Figure 67), reaction of the crude bis-boryl product with KOH afforded the monoboryl 
product 564 in-situ as evidenced by GC/MS (m/z = 325). Subsequent cross-coupling with 
methyl-4-iodobenzoate (267) afforded product 565, characterised by the observed 
CO2CH3 resonance at 3.96 ppm in the 1H NMR spectrum. 
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N
N
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H
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Conditions B - Pd(dppf)Cl2 (10 mol%), Cs2CO3 (2 eq.), 267 (2 eq.), DMAc, 70 °C, 2 h
I
CO2Me
(267), 1.2 eq.
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3.2.5.4 Borylation of 7-Azaindazole 
The reaction of 7-azaindazole (558) with a stoichiometric quantity of B2pin2 proceeded 
rapidly to give a complex mixture of products by 1H NMR spectroscopy. The efficient 
reaction was attributed to inhibition of azinyl coordination by the sterically large peri Boc-
protecting group. Regioselectivity of the major products (566 and 567) was assigned on 
the basis of downfield shifts in the respective peri resonances. In order to suppress the 
formation of minor products, the substrate was instead reacted with 0.7 equivalents of 
B2pin2, which provided the 3 and 4-boryl products exclusively in a 57:43 ratio by 1H NMR 
spectroscopy (Figure 71 and Figure 72).Disappointingly, application of the 
aforementioned cross-coupling strategies were unsuccessful and resulted in no-product 
formation by in-situ LC/MS or GC/MS analyses (c.f Figure 60, Figure 61 and Figure 67). 
Attempts to complete one-pot borylation/cross-coupling sequences of 7-azaindazole are 
ongoing within the group.  
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Figure 71: Borylation of 7-azaindazole 
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Figure 72: 1H NMR spectrum of borylation of 7-azaindazole 
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3.3 Conclusions and Future Work 
The borylation of protected-indazoles occurs efficiently and with good regioselectivity at 
the 3-position. Although the application of protecting groups is undesirable from a green 
chemistry perspective, this strategy avoids the requirement for pre-existing functionality 
within starting materials. Despite the presence of steric bulk ortho to the preferred site of 
activation, protected 2H-indazoles react faster and more completely than their 1-
protected counterparts. This is attributed to unfavourable interactions between a 
proximal emerging negative charge at C-3 and the neighbouring azinyl nitrogen lone-pair 
in protected 1H-indazoles. Protodeborylation on silica prevents chromatographic 
purification of most Bpin esters. However, the presence of a strongly electron-
withdrawing mesylate protecting group stabilises the 3-boryl product to allow its isolation 
in good yield. Alternatively, the boronate products may be elaborated in-situ by tandem 
Suzuki-Miyaura cross-coupling reactions with a variety of (hetero)aryl bromides and 
iodides.  
Published concurrently with these findings, was the work of Burton and co-workers, who 
reported similar one-pot borylation/cross-coupling reactions.171 Whilst the cross-coupling 
of 1-methyl-3-boryl indazole was favoured with a variety of (hetero)aryl iodides bromides 
and chlorides, the cross-coupling of the more reactive protected 2H-indazoles (453) was 
precluded due to dominating protodeborylation and fragmentation pathways. In addition, 
the cross-coupling stoichiometry used is not conducive to late stage functionalisation due 
to the requirement for a large excess of boronate ester (relative to aryl halide) (Figure 
73). 
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Figure 73: ‘One-pot’ borylation/Suzuki-Miyaura cross-coupling of indazoles by Burton and co-
workers 
 
Previously reported approaches to 3-arylindazoles, a structure of interest to the 
pharmaceutical industry (Figure 74), have required the use of toxic or explosive reagents, 
such as the condensation of hydrazines with fluorobenzophenones,172,173 or the 
cycloaddition of arynes with diazomethanes.174,175 In addition, direct metallation of C-3 of 
the indazole core has often been problematic, with several groups reporting 
fragmentation of the indazole framework due to the instability of the N-N bond, resulting 
in aminonitriles.176,177 Measures taken to circumvent this issue have relied on the use of 
toxic Negishi reagents,161 or direct C-H arylation,178-180 with widespread scope of the latter 
limited by the requirement for the more expensive aryl iodides and harsh reaction 
conditions. Arylation via boronate intermediates provides an elegant solution for these 
problems due to the lower toxicity, air stability and inert by-products associated with 
boron reagents as well as the milder conditions required to effect their coupling.  
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Figure 74: Biologically active 3-aryl indazoles 
 
Exploiting the functional group tolerance of C-H borylation the borylation of functionalised 
indazole reagents enabled the multi-directional synthesis of small libraries of 
multisubstituted indazoles. The steric bias and lability of ortho-azinyl boronate esters was 
exploited to enable a change in the regioselectivity of borylation and subsequent cross-
couplings. The net effect is that direct C-H functionalisation is possible at all positions on 
the indazole core with the exception of C-4.  
The C-H borylation of isomeric pyrazolo[1,5-a]pyridine and pyrazolo[1,2-a]pyridine was 
also achieved. The former affords the 3-boryl product in the presence of sub-
stoichiometric B2pin2 however the competitive side reactions precludes its isolation in 
high yields. Whilst the latter borylated more selectively, the instability of the resultant 
boronate ester limited the scope for one-pot transformations, with only the Suzuki-
Miyaura product obtainable in modest yield.  
Application of these strategies to the borylation of aza-indazoles enabled similar 
observations, with 6-azaindazole recalcitrant to borylation due to inhibitory binding to the 
iridium catalyst. Protected 4 and 7-azaindazoles provided product mixtures arising due 
to competitive borylation on the pyridyl ring. Selective Suzuki-Miyaura cross-coupling 
was unsuccessful, however, exploiting the relative lability of the 3-boryl product enabled 
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selective formation of products arising from arylation of the pyridyl ring. One-pot 
borylation/cross-coupling sequences of aza-indazoles are the subject of ongoing work 
within the group. 
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4 Development Towards a ‘One-pot’ C-H 
Borylation/Oxidative Heck Coupling Protocol 
4.1 Aims and objectives 
The development of robust, efficient and general combinatorial or array strategies for the 
formation of C-C bonds is an important strategy for the synthesis of compound libraries. 
Iridium-catalysed borylation is ideally suited to combinatorial chemistry as it circumvents 
the need for pre-existing functionality and is tolerant of a wide range of functional groups 
(c.f Sections 1.3.2.2 and 2.1.3). Moreover recent advances have enabled C-H borylation 
of both arenes and heteroarenes in good, reliable regioselectivity (c.f Section 2.3 and 
3.2.2.2). Exploiting the synthetic utility of the resulting boronate ester, a variety of one-
pot protocols have been reported, whereby in-situ elaboration enables access to a 
variety of functionalised (hetero)arenes.51,53,54,56,73,101,102,181-186 Furthermore the efficiency 
of any “one-pot” protocol may be improved by minimising the manipulation required, for 
example by using a single solvent. In addition, consistent with the recent drive towards 
sustainable chemistry and processes, there is an increased focus on greener processes, 
with fewer steps and reduced waste. Herein this chapter describes efforts undertaken 
towards the development of a one-pot single solvent C-H borylation/oxidative Heck 
cross-coupling protocol. 
 
4.2 Previous work in the group 
In early work undertaken towards the optimisation of a one-pot C-H borylation/Rh-
catalysed 1,4-conjugate addition sequence, Tajuddin noted that oxidative Heck coupled 
products (577) were commonly observed by-products (Scheme 52).129,181 
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Scheme 52: Oxidative Heck coupling by-product in Rh(I)-catalysed conjugate addition 
 
This was attributed to incomplete degassing of the solvent used in step 2. A subsequent 
literature review into the reported oxidative Heck couplings to date showed that no such 
one-pot C-H borylation/oxidative Heck-coupling protocol had been reported to date (c.f 
Section 1.4.2.4). Reflecting this, an investigation was embarked upon to enable selective 
formation of the complementary vinylation products. 
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4.3 Results and Discussion 
4.3.1 Preliminary Results 
Initial work in this area began by applying a crude boronate ester, synthesised by iridium-
catalysed C-H borylation, in Jung’s oxidative Heck protocol (c.f Figure 14). 106 This 
method was chosen as it was found to be general and applicable to a variety of boron 
nucleophiles, including pinacol boronate esters.  Addition of an aliquot of borylation stock 
solution to methyl-2-methoxynicotinate (304) gave, after 24 h stirring at room 
temperature, full conversion (1H NMR) to 5-borylated product (306). Consistent with 
previous observations, trace amounts of the minor 6-borylated product (307) were also 
observed (c.f Table 3) Concentration in vacuo and subsequent addition of Pd(OAc)2, 
Na2CO3, and DMAc gave, after evacuation/O2 backfill cycles (3 x) and subsequent 
addition of tert-butylacrylate (133), the desired product in 39% overall yield, as a 5:1 
mixture of E:Z isomers (578:579), based on the starting arene (Scheme 53) (N.B 
evacuation backfill cycles were performed without a cold trap to avoid condensation of 
liquid O2). 
 
 
Scheme 53: Initial attempts at a tandem ‘one-pot’ borylation/oxidative Heck coupling 
 
Isomers were differentiated based off of their respective vinylic 3J H-H coupling 
constants; 16.0 and 12.2 Hz for E-(578) and Z-isomers (579) respectively. In addition 
173 
 
each isomer possessed distinct singlets for C(CH3)3 resonances at 1.52 (578) and 1.47 
ppm (579). No evidence of α-arylation products were observed by 1H NMR (Figure 75). 
 
Figure 75: 1H NMR spectrum of E/Z isomeric mixture (aromatic enhancement) 
 
Mass spectrometry analysis was complicated due to the equivalence of the product and 
intermediate boronate ester molecular ion peaks (m/z = 293), however distinctions could 
be made upon analysis of the fragmentation patterns, for example the desired product 
spectrum possessed an ion peak arising from loss of the diagnostic tert-butyl cation (m/z 
= 237 [M−C(CH3)3]+). Conversely the boronate ester commonly fragments with initial loss 
of a methyl group (m/z = 278, [M−CH3]+). 
Whilst the early result was promising, yield losses accrued in the oxidative Heck-coupling 
step were problematic. Analysis of the crude product ratio by GC/MS, taken prior to 
chromatographic purification, showed ca. 22% staring arene, as a result of reversal by 
protodeborylation. Reflecting this the procedure was repeated with heating during the 
oxidative Heck coupling step in order to attempt to increase the rate of product formation 
relative to the rate of protodeborylation. 
Following the previously described procedure, with heating to 50 °C during step iii, the 
desired product (578) was produced in 46% yield as a single isomer (Scheme 54). 
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Scheme 54: Selective synthesis of E-isomer 
 
4.3.2 Optimisation Studies 
Whilst the isolation of the desired product as a single product was an improvement, the 
failure to observe a substantial improvement in yield remained problematic. In light of 
this, attempts were made to optimise the oxidative Heck reaction in isolation. In order to 
carry out optimisation studies, the simple boronate ester 3-(Bpin)-anisole (206) was 
chosen as a test substrate due to its ease of synthesis, in bulk, from the substituent 
boronic acid (Scheme 55). 
Under an argon atmosphere, a suspension of the substituent boronic acid (580), pinacol 
(581) and magnesium sulphate in Et2O was stirred at room temperature. Filtration 
through a silica pad with copious Et2O washings gave 206 in good yield.  
 
 
Scheme 55: Synthesis of 3-(Bpin)-anisole 
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The boronate ester (206) could be clearly ascertained by observation of a diagnostic 
singlet at 1.35 ppm, corresponding to the newly incorporated pinCH3 resonances, in the 
1H NMR spectrum. 
With the test substrate in hand, focus was turned to the oxidative Heck coupling 
optimisation study.  To a DMAc solution of boronate ester (206) and base under an 
oxygen atmosphere was added tert-butylacrylate (133). All experiments were run at 50 
°C over 6 h at the same concentration in order to minimise yield discrepancies. Work-
ups were carried out by celite filtration, to remove suspended base or metal salts, 
followed by direct loading onto silica in order to minimise yield losses and inconsistencies 
by aqueous work-up (Table 18).  
 
 
Table 18: Condition screening for oxidative Heck coupling 
 
A common limiting factor observed across most reactions was the gradual darkening of 
the reaction solution from light orange, reflecting the starting colour of the Pd(OAc)2, to 
black, coinciding with precipitation of the palladium catalyst as ‘palladium black’ (entries 
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1-4). This was avoided with the use of bipyridine (bpy) ligated catalysts, however, these 
reactions only furnished trace quantities of product(entries 5 and 6). 
Consistent with previous results, the Na2CO3 mediated reaction of the boronate ester 
produced the desired products in only modest yields (entry 1). Whilst base-free coupling 
protocols are well established,113,187 the absence of base in this case failed to generate 
any significant improvements in yield (entry 2). Conversely, changing the base to Cs2CO3 
resulted in a vast improvement in yield (entry 3). This was rationalised by the increased 
solubility of heavy metal bases, such as Cs2CO3, in organic solvents. Frustratingly a 
change in oxidant resulted in further yield reductions, in spite of use of copper and iron 
salts being well established in the literature (entry 4).109,110 Furthermore the use of ligating 
bipyridine ligands, reported to enhance both reaction rates and yields, failed to generate 
any isolable products (entries 5 and 6).107 GC/MS analysis of the crude reaction mixtures 
found only trace (<10%) conversion to desired product (m/z = 234, [M]+), with remaining 
mass balance satisfied by sole observation of unreacted starting material (m/z = 234, 
[M]+). Starting material and product mass spectrometry traces were distinguished as 
previously described (c.f Section 4.3.1). 
In light of the observed improved yields observed from simple substitution of Cs2CO3 into 
the reaction for Na2CO3, the previously described reaction involving methyl-2-
methoxynicotinate (304) was re-run, as previously described, invoking this base change 
(c.f Scheme 54). In order to eliminate the possibility of substrate specificity, a separate 
reaction was also run with styrene (131) as an alternative coupling partner (Scheme 56). 
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Scheme 56: Tandem ‘one-pot’ borylation/oxidative Heck coupling run with Cs2CO3 
 
Product 577 was characterised as previously described (c.f Section 4.3.1). Styrylation 
product 583 was confirmed by the observed characteristic molecular ion peak in GC/MS 
analysis (m/z = 269, [M]+). 
The improved yields obtained provided a good starting point for further development and 
movement towards a more efficient single solvent process. DMAc is not a suitable one-
pot solvent due to its poor performance in borylation chemistry (c.f Table 10). Solvents 
which perform well in C-H borylation have tended to be low polarity and non-coordinating, 
although the comparable performance of reactions run in NMP with reactions run in 
ethereal solvents was surprising. Reflecting this Dunleavy ran a solvent screening 
exercise of the oxidative Heck step in isolation using the preprepared 3-(Bpin)-anisole 
(304) (Table 19). 
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Table 19: Oxidative Heck solvent screen 
 
Disappointingly THF, despite being a suitable borylation solvent, is not applicable to one-
pot chemistry because of the poor performance observed in oxidative Heck coupling 
(entry 1). Addition of an aliquot of water to the reaction improved the yield but 
insufficiently to make for a viable one-pot process. Reactions utilising anhydrous ethereal 
solvents 1,4-dioxane and diglyme showed better performance (entries 3 and 4), with the 
best yields obtained with the more polar NMP (entry 5). Overall the role of water in the 
reaction was inconclusive from these results, for example whilst addition of water 
improved reactions utilising THF as solvent (entry 2), the presence of trace water in 
commercially purchased NMP completely shutdown any reactivity (entry 6). Due to these 
inconsistencies, and reflecting the intolerance of C-H borylation to even trace quantities 
of water, ensuing studies used only anhydrous reaction conditions.123 The role of base 
within cross-coupling reactions remains a topic of debate, with conflicting reports on the 
mechanism of transmetallation.7,188 Moreover the potential for mechanistic variability 
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between boron reagents is also problematic.189 It has also been shown that in certain 
cases the use of fluoride bases is permitted, whereby fluoride acts as a mechanistic 
substitute for the role of oxo-bases.190,191 In addition their ability to mediate reactions in 
anhydrous conditions is an added bonus. Reflecting this the test reaction was also 
conducted utilising both KF and CsF, with use of CsF in ahydrous diglyme giving the best 
result thus far (entries 7 and 8). 
 
4.3.3 Aromatic Substrate Screening Exercise 
Given the time constraints, further optimisation studies were postponed and focus was 
turned to exploring substrate scope. Given its appreciable performance in both the 
borylation and oxidative Heck screening experiments, diglyme was chosen as the one-
pot solvent. An aliquot of borylation stock solution was added to a thick walled microwave 
vessel containing the appropriate substrates. The borylation was monitored up to 
optimum conversion by a combination of 1H NMR spectroscopy (as per previously 
described method (c.f Section 2.3.1) and GC/MS. At this point both CsF and Pd(OAc)2 
were added and the atmosphere oxygenated prior to addition of methyl acrylate (575) 
(Table 20). Reactions were carried out with Dunleavy. 
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Table 20: Screening of aromatic substrates for ‘one-pot’ borylation/oxidative Heck 
reaction 
 
Products were characterised by GC/MS and observation of CO2CH3 resonances in the 
1H NMR spectrum, for example compound 585 possessed the characteristic resonance 
at 3.83 ppm and the diagnostic chlorine isotope ratio by mass spectrometry analysis (m/z 
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= 233 (37Cl, [M]+), 231 (35Cl, [M]+). E/Z isomer differentiation was achieved as per the 
previously described method (c.f Section 4.3.1). 
The inconsistent yields observed thus far are a limiting factor. In all cases yield losses 
are mostly accrued in step 2, with only minor improvements in yields corrected for 
incomplete stage 1 conversion. The formation of “palladium black”, observed by a 
darkening of the reaction solution and the formation of a black precipitate is also a 
hindrance that will have to be addressed in future modifications to this work. 
  
182 
 
4.4 Conclusions and future work 
The one-pot C-H borylation/oxidative Heck coupling has been demonstrated in a single 
solvent and reaction vessel with varying success. Non-coordinating solvents such as 
diglyme are required as these performed well both in C-H borylation and oxidative Heck 
couplings in isolation. Whilst the role of water in the cross-coupling step of the reaction 
is not yet well understood, the use of fluoride bases enabled the use of completely 
anhydrous solvents, a pre-requisite for C-H borylation. The visible formation of 
“palladium black” is a factor limiting widespread application and although this is 
prevented through the use of bipyridine ligands, the loss of reactivity observed is 
surprising. Further screening of ligands is required at this stage. Whilst solvents, bases 
and ligands have been explored in isolation, a high throughput statistical design of 
experiments (DoE) would enable a more thorough optimisation of this multi-factoral 
reaction. This would allow for an improvement in yields and substrate scope of the 
reaction. Due to time constraints variation in the olefinic component has not been 
explored and will be conducted in future investigations. 
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5 Experimental 
5.1 General Considerations 
All borylation reactions were carried out under a dry nitrogen atmosphere using standard 
Schlenk techniques or in an Innovative Technology Inc. System 1 double-length glove 
box. Glassware was oven dried before all borylation reactions. Solvents used for 
borylation reactions were anhydrous and degassed by multiple freeze-pump-thaw 
cycles. Solvents used for Suzuki-Miyaura reactions were used without drying but with 
multiple freeze-pump-thaw degassing cycles. 
Solvents  
Methyl-tert-butyl-ether (MTBE) was purchased anhydrous from Sigma Aldrich. DMF and 
DMAc were purchased from Sigma-Aldrich. All other reaction solvents were dried using 
an Innovative Technology Solvent Purification System (SPS) and stored under argon. 
Deuterated solvents were purchased from Apollo Scientific, dried over 4 Å molecular 
sieves and used without further treatment.  
Reagents 
 [Ir(COD)OMe]2 was synthesised, as previously described,192 from IrCl3.3H2O, obtained 
from Precious Metals Online. B2pin2 was supplied as a generous gift by AllyChem Co. 
Ltd. (P.R.China) and was used without further purification. All othere compounds were 
obtained from Sigma-Aldrich, Alfa Aesar, Fluorochem, Acros, Apollo Scientific or 
Lancaster and used without further purification. 
NMR Spectroscopy 
NMR spectra were recorded at ambient temperature on Bruker Avance-400 (1H, 11B, 
19F), Varian Inova-600 (1H, 13C[1H], HSQC, HMBC, COSY) or Varian VNMRS-700 (1H, 
13C[1H], HSQC, HMBC, COSY) spectrometers. The 1H and 13C chemical shifts are 
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reported in ppm using the residual solvent signal of the deuterated solvents (CDCl3: H 
= 7.26 ppm, C = 77.16 ppm; Acetone d6: H = 2.05 ppm, C = 206.26/29.84 ppm; DMSO 
d6: H = 2.50 ppm, C = 39.51 ppm ). All chemical shifts are reported in parts per million 
relative to tetramethylsilane (H = 0.00 ppm). All coupling constants are reported in Hz. 
11B NMR chemical shifts are referenced to external BF3•Et2O (B = 0.0 ppm). Multiplicities 
are reported using the following abbreviations; s (singlet), d (doublet), t (triplet), q 
(quartet), m (unresolved multiplet) and br (broad). Assignment of spectra was carried out 
using 2D COSY, HMBC, HSQC and NOESY techniques. 
Mass Spectrometry 
GC/MS analyses were performed on an Agilent 6890N gas chromatograph (column: HP-
5MS, 10 m, Ø 0.25 mm, film 0.25 μm; injector: 250 °C; oven: 70 °C (2 min), 70 °C to 250 
°C (20 °C min-1), 250 °C (5 min); carrier gas: helium (1.6 mL min-1) equipped with an 
Agilent 5973 inert mass selective detector operating in EI mode and a custom built 
Anatune liquid handling system functioning as autosampler/injector. Electrospray (ES) 
mass spectra were obtained on a Micromass LCT Mass Spectrometer. High Resolution 
mass spectra were obtained using a Thermo Finnigan LTQFT mass spectrometer or 
Xevo QToF mass spectrometer (Waters UK, Ltd) by the Durham University Mass 
Spectrometry Service.  
IR Spectroscopy 
Infrared spectra were measured on a Perkin-Elmer Paragon 1000 FT-IR spectrometer 
via the use of a Diamond ATR (attenuated total reflection) accessory (Golden Gate). 
Assigned peaks are reported in wavenumbers (cm-1). 
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Thin-Layer Chromatography (TLC) 
TLC was performed on ‘Polygram Sil G/UV’ plastic-backed silica plates with a 0.2 mm 
silica gel layer doped with a fluorescent indicator. Plates were purchased from VWR 
International.  
Flash Column Chromatography 
Flash column chromatography refers to purification by automated operation using a 
Teledyne Isco CombiFlash Rf machine on pre-packed silica Redisep® Rf cartridges with 
the stated solvent gradient and at a constant flow rate of 35 mL/min. Reverse phase 
chromatography used pre-packed C18 silica Redisep® Rf cartridges and a 0-100% 
MeOH in H2O (containing 0.1% HCOOH) gradient elution.  
Microwave Reactor 
Microwave reactions were carried out in septum-containing, crimp-capped, sealed vials 
in a monomodal EmrysTM Optimizer reactor from Personal Chemistry. The wattage was 
automatically adjusted to maintain the desired temperature for the desired period of time. 
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5.2 General Methods 
General Procedure for the Preparation of a Catalyst Stock Solution for C-H 
Borylation 
In a glovebox, a catalyst stock solution was prepared by weighing [Ir(COD)OMe]2, dtbpy 
and B2pin2 into a volumetric flask followed by the addition of MTBE to make up the 
volume to 25 mL of solution. Stock solutions of varying concentrations with respect to 
iridium were prepared; 
Solution A; [Ir(COD)OMe]2 (100 mg, 0.15 mmol), dtbpy (80 mg, 0.30 mmol) and B2pin2 
(2.54 g, 10.0 mmol) 
Solution B; [Ir(COD)OMe]2 (167 mg, 0.25 mmol), dtbpy (134 mg, 0.50 mmol) and B2pin2 
(2.54 g, 10.0 mmol) 
Solution C; [Ir(COD)OMe]2 (331 mg, 0.50 mmol), dtbpy (268 mg, 1.00 mmol) and B2pin2 
(2.54 g, 10.0 mmol) 
The flask was vigorously shaken until the solution developed a deep red colour and no 
more solid was visible. The solution was transferred to and stored in, a crimp-cap 
septum-sealed tube in a freezer and used within 2 weeks.  
General procedure for in-situ NMR Reaction Monitoring 
For all room temperature borylation reactions, an aliquot (0.5 mL) of the reaction mixture 
was removed and transferred (in a glovebox or by Schlenk techniques) to a Young’s Tap-
sealed NMR tube containing a coaxial tube filled with acetone-d6. The reactions were 
monitored for 24 h or until full consumption of starting material was observed by NMR 
spectroscopy. 
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General Procedure A: C-H Borylation using pre-prepared stock-solution 
In a glovebox, a thick-walled microwave synthesis vial was charged with the stated 
heterocycle followed by the addition of an aliquot of the stated catalyst stock solution. 
The vessel was sealed with a crimp top septum cap and shaken until all of the substrate 
was dissolved. The reaction mixture was stirred on a magnetic stirring block for the time 
stated at the stated temperature or irradiated in a microwave reactor for the stated time. 
In-situ reaction monitoring by 1H NMR spectroscopy was carried out as previously 
described. Upon completion, the volatiles were removed in vacuo to afford the crude 
product. Where stated, the crude product was dry-loaded onto silica gel and purified by 
silica gel flash column chromatography using the stated conditions to afford the purified 
product. 
General Procedure B: C-H Borylation using sub-stoichiometric B2pin2 
In a glovebox, a premixed solution of [Ir(COD)OMe]2  (1.5 mol%), dtbpy (3 mol%) and 
B2pin2 (0.5 eq.) (or HBpin (1.0 eq) where stated) in MTBE (2.5 mL) was added to a thick-
walled microwave synthesis vial containing the stated heterocycle (1 eq.). The mixture 
was shaken vigorously to ensure complete mixing, and then the mixture was stirred at 
room temperature or heated at 80 ˚ C for the stated time. In-situ NMR reaction monitoring 
was carried out as previously described.  
General Procedure C: Esterification under general acid catalysis 
A substoichiometric quantity (ca. 0.1 mL) of concentrated sulphuric acid was added to a 
solution of carboxylic acid in methanol (10 mL). The solution was heated at reflux for the 
time stated. The solution was cooled to room temperature and charged with saturated 
NaHCO3(aq) solution until pH 7. The mixture was concentrated in vacuo to remove 
methanol. The aqueous mixture was extracted with DCM (2 x 10 mL). The combined 
organic extracts were washed with brine (5 mL), dried over anhydrous magnesium 
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sulfate and filtered through celite. Concentration in vacuo gave the methyl ester which 
was carried through without further purification. 
General Procedure D: Esterification via in-situ acid chloride formation 
Procedure carried out under an argon atmosphere. At 0 °C, oxalyl chloride (1.2 eq.) was 
added dropwise to a DCM (5 mL) solution of carboxylic acid (1 eq.) and DMF (10 drops. 
The water bath was then removed and the reaction was stirred at room temperature for 
3 h. Toluene (5 mL) was charged and the reaction concentrated to dryness in vacuo. 
The crude residue was redissolved in DCM (5 mL) and added dropwise to a DCM (5 mL) 
solution of MeOH (5 eq.) and DIPEA (2 eq.) at 0 °C. The reaction was stirred at room 
temperature for 0.5 h then quenched with saturated NaHCO3(aq) (5 mL). The layers were 
separated and the aqueous layer re-extracted with DCM (5 mL). The combined organics 
were washed with brine (10 mL), dried over MgSO4, filtered and concentrated in vacuo. 
The crude residue was purified by flash column chromatography using the stated solvent 
system.  
General Procedure E for the tandem “one-pot” C-H Borylation/Suzuki-Miyaura 
Cross-Coupling 
The borylation step was carried out as per General Procedure A. Upon completion, 
volatiles were removed in vacuo. To the crude mixture under N2, was added palladium 
catalyst (5 or 10 mol%), base (2 eq.), aryl halide (1.1 - 2 eq.) and the stated solvent. The 
reaction was heated at the stated temperature for the stated time. The reaction mixture 
was diluted with water and extracted into EtOAc. The organic phase was dried over 
MgSO4, filtered and concentrated in vacuo to give the crude product. This was dry-loaded 
onto silica gel and purified by silica gel flash column chromatography using the stated 
solvent system. 
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General Method F SNAr substitution of 2-fluorinated pyridines 
A mixture of the 2-fluorinated pyridine (1 eq.), K2CO3 (2 eq.) and amine (2 eq.) were 
refluxed in dioxane for 6 h. The reaction was cooled to room temperature and filtered 
through celite. The organic residue was then dry loaded onto silica and purified by flash 
column chromatograph using the stated solvent system.  
General Method G for the Boc-protection of N-heterocycles 
Under an argon atmosphere, heterocycle (1 eq.), DMAP (5 mol%), Boc2O (1.1 eq.) and 
Et3N (1 eq.) were stirred in MeCN (10 mL) for 16 h. The reaction was then dry loaded 
onto silica and purified by flash column chromatography using the stated solvent system.  
General Method H for the protection of indazole by deprotonation and alkylation 
Procedure performed under a nitrogen atmosphere. A solution of indazole (1 eq.) in 
anhydrous THF (10 mL) was added dropwise, to a suspension of sodium hydride (60% 
oil dispersion, 1 eq.) in anhydrous THF (10 mL). The reaction was cooled to 0 ˚C in an 
ice bath and the appropriate halide (1.1 eq.) was added dropwise. The reaction was 
allowed to warm to room temperature and stirred for 3 hours. The reaction was quenched 
with an IPA:H2O mixture (1:1, 10 mL) and concentrated in vacuo to remove the THF. The 
aqueous residues were extracted with DCM (2 x 15 mL). The combined organic extracts 
were washed with brine (10 mL), dried, filtered and concentrated in vacuo to yield the 
crude product. Purified by flash column chromatography using the stated solvent system. 
General Method I for the regioselective SEM protection of 2H-indazole 
Procedure carried out in oven-dried glassware under an argon atmosphere. 
Dicyclohexylamine (1.2 eq.) followed by 2-(trimethylsily)ethoxymethyl chloride (1.2 eq.) 
were added slowly to a solution of the indazole (1 eq.) in anhydrous THF (5 mL). The 
reaction was stirred at room temperature for 3 h before being quenched with aqueous 
sodium hydroxide solution (0.5 M, 5 mL). The aqueous mixture was concentrated in 
vacuo to remove the THF then extracted with ethyl acetate (2 x 10 mL). The combined 
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organic extracts were washed with brine (10 mL), dried over anhydrous magnesium 
sulphate and filtered through celite to yield the crude product. Purification was carried 
out by flash column chromatography using the stated solvent system. 
General Procedure J for the one-pot C-H Borylation/Suzuki-Miyaura Cross-
Coupling of protected indazoles 
The borylation step was carried out as per General Procedure B with additional B2pin2 
(0.2 eq.) and heating at 80 ˚ C for 3 h. Upon completion, volatiles were removed in vacuo. 
To the crude mixture under N2, was added Pd(dppf)Cl2 (10 mol%), Cs2CO3 (2 eq.) and 
aryl halide (1.1 eq.). Where stated, the reaction was carried out with CuCl (1 eq.). The 
vessel was sealed and DMF (3 mL) was added. The reaction was irradiated at 100 °C 
for 1 h in a microwave reactor. The reaction mixture was worked up and purified as per 
General Method E. 
General Method K for the formation of the (aza)indazole core 
The starting 2-fluorobenzaldehyde (or 2-fluoronicotinaldehyde) was refluxed (24 h) in 
hydrazine hydrate:DME (1:1) (20 mL). The reaction mixture was left to cool, diluted with 
water (5 mL) before removal of DME was carried out in vacuo. The aqueous residue was 
extracted with DCM (2 x 5 mL). The combined organic extracts were washed with brine 
(10 mL), dried over anhydrous magnesium sulphate and filtered through celite to yield 
the crude product carried through without further purification. 
General Procedure L for the one-pot C-H Borylation/Suzuki-Miyaura Cross-
Coupling of protected bromo-2H-indazoles 
The borylation step was carried out as per General Procedure B with additional B2pin2 
(0.2 eq.) and heating at 80 ˚ C for 3 h. Upon completion, volatiles were removed in vacuo. 
To the crude mixture under N2, was added Pd(PPh3)4 (10 mol%), K3PO4 (2 eq.) and aryl 
halide (1.1 eq.) and DMAc (3 mL). The reaction was heated at 70 °C for 2 h. The reaction 
mixture was worked up and purified as per General Method E. 
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General Method M for the Suzuki-Miyaura cross-coupling of n-bromo-3-
arylindazoles 
Under an argon atmosphere, the bromo-arylindazole (1 eq.), Pd(dppf)Cl2 (5 mol%), 
Cs2CO3 (2 eq.) and arylboronic acid (2 eq.) were reacted at 100 °C in DMAc for 2 h. The 
reaction was worked up as per General Method E and purified by flash column 
chromatography using the stated solvent system. 
General Method N for the deborylation and Suzuki-Miyaura cross coupling of bis-
borylated heterocycles 
As per General Method A, the starting heterocycle (1 eq.) was reacted with an aliquot of 
the stated stock solution and additional B2pin2 (1 eq.) at 80 ˚C for 16 h. The reaction was 
concentrated in vacuo to yield the crude boronate ester which was then reacted with 
KOH (3 eq.) at 70 ˚ C for 15 min in DMAc:H2O (9:1). Pd(dppf)Cl2 (5 mol%) and aryl halide 
(2 eq.) were then added and reaction continued for a further 1 h. The reaction was 
worked up as per General Method E and purified by flash column chromatography using 
the stated solvent system. 
General Procedure O for the tandem “one-pot” C-H Borylation/Oxidative Heck 
coupling 
The borylation step was carried out as per General Procedure A. Upon completion, 
volatiles were removed in vacuo. To the crude mixture was added Pd(OAc)2 (10 mol%), 
Na2CO3 or Cs2CO3 (2 eq.) and alkene (2 eq.) in DMAc. The vessel was sealed and 
evacuated/backfilled with O2 (x 3 cycles). The reaction was heated at 50 °C for the stated 
time. The reaction mixture was cooled to room temperature then diluted with water and 
extracted into ether (2 x 10 mL). The combined organic extracts were washed with brine 
(10 mL), dried over MgSO4, filtered and concentrated in vacuo to give the crude product. 
This was dry-loaded onto silica gel and purified by silica gel flash column 
chromatography using the stated solvent system. 
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5.3 Experimental Details 
Borylation of Azinyl Heterocycles 
Borylation of 2-methoxypyridine (274) 
 
General procedure A was applied to 274 (109 mg, 1 mmol) using Stock Solution A with 
additional B2pin2 (51 mg, 0.2 mmol). The reaction mixture was stirred at room 
temperature for 24 h giving full conversion (1H NMR) to 285, 286, 287 and 288 in a 
43:17:31:9 ratio. 
 
Borylation of 2-methoxypyridine (274) under boron-limiting conditions 
 
General procedure B was applied to 274 (109 mg, 1 mmol). The reaction mixture was 
stirred at room temperature for 24 h giving 42% conversion (1H NMR) to afford 285 and 
287 in a 73:27 ratio.  
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Borylation of 2-chloropyridine (275) 
 
General procedure A was applied to 275 (114 mg, 1 mmol) using Stock Solution A with 
additional B2pin2 (51 mg, 0.2 mmol). The reaction mixture was stirred at room 
temperature for 24 h giving full conversion (1H NMR) to 289, 290, 291 and 292 in a 
28:38:27:7 ratio. 
 
Borylation of 2-chloropyridine (275) under boron-limiting conditions 
 
General procedure B was applied to 275 (114 mg, 1 mmol). The reaction mixture was 
stirred at room temperature for 24h giving 55% conversion (1H NMR) to afford 289 and 
291 in a 75:25 ratio.  
 
Borylation of 2-(trifluoromethyl)pyridine (276) 
 
General procedure A was applied to 276 (147 mg, 1 mmol) using Stock Solution A with 
additional B2pin2 (51 mg, 0.2 mmol). The reaction mixture was stirred at room 
temperature for 24 h giving full conversion (1H NMR) to 293, 294 and 295 in a 25:36:39 
ratio. 
194 
 
Borylation of 2-(trifluoromethyl)pyridine (276) under boron-limiting conditions 
 
General procedure B was applied to (276) (147 mg, 1 mmol). The reaction mixture was 
stirred at room temperature for 24 h giving 83% conversion (1H NMR) to afford 293 and 
295 in a 65:35 ratio.  
 
Borylation of 2-fluoropyridine (277) 
 
General procedure A was applied to 277 (97 mg, 1 mmol) using Stock Solution A with 
additional B2pin2 (51 mg, 0.2 mmol). The reaction mixture was stirred at room 
temperature for 24 h giving full conversion (1H NMR) to afford 297, 298, 299, 300 and 
301 in a 45:15:10:19:11 ratio. 
 
Borylation of 2-fluoropyridine (277) under boron-limiting conditions 
 
General procedure B was applied to 277 (97 mg, 1 mmol). The reaction mixture was 
stirred at room temperature for 24 h giving 89% conversion (1H NMR) to afford 297, 298, 
299, 300 and 301 in a 57:2:19:5:17 ratio. 
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Methyl-2-methoxynicotinate (304) 
 
General method C applied to 2-methoxynicotinic acid (302) (1.53 g, 10 mmol). 304 
isolated as pale yellow oil (1.58 g, 95%) 
δH (700 MHz, CDCl3) 8.31 (1H, dd, J = 4.9, 1.9, 6-H), 8.16 (1H, dd, J = 7.5, 1.9, 4-H), 
6.95 (1H, dd, J = 7.5, 4.9, 5-H), 4.05 (3H, s, OCH3), 3.90 (3H, s, CO2CH3); δC (176 MHz, 
CDCl3) 165.6 (CO2CH3), 162.5 (C-2), 150.8 (C-6), 141.4 (C-4), 116.5 (C-5), 141.2 (C-3), 
54.4 (OCH3), 52.4 (CO2CH3); νmax (ATR) 1731, 1577, 1469, 1406, 1318, 1268, 1129, 
1084, 1012 cm−1; Accurate Mass (ESI) m/z found [M+H]+ 168.0640; C8H10NO3 requires 
M, 168.0661. 
 
Methyl-2-fluoronicotinate (305) 
 
General procedure D was applied to 2-fluoronicotinic acid (303) (1.1 g, 7.8 mmol). 
Column eluent 0-50% Et2O in hexanes. 305 (0.79 g, 65%) isolated as a white amorphous 
solid. 
δH (600 MHz, CDCl3) 8.38 (2H, m, 4, 6-H), 7.29 (1H, m, 5-H), 3.94 (3H, s, CO2CH3); δC 
(151 MHz, CDCl3) 163.8 (d, J = 8.1, CO2CH3), 161.7 (d, J = 249.7, C-2), 151.8 (d, J = 
15.4, ArC), 143.3 (d, J = 1.6, ArC), 121.5 (d, J = 4.9, C-5); 113.9 (d, J = 25.0, C-3), 52.9 
(CO2CH3); δF (376 MHz, CDCl3), −61.8 (s); νmax 1723, 1600, 1430, 1312, 1294, 1277, 
1134, 1088, 1059 cm−1; Accurate Mass (ESI) m/z found [M+H]+ 156.0460; C7H7FNO3 
requires M, 156.0461. 
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Methyl-2-chloro-5-(Bpin)nicotinate (311) 
 
General procedure A was applied to methyl-2-chloronicotinate (310) (172 mg, 1 mmol) 
using Stock Solution A. The reaction mixture was stirred at room temperature for 24 h 
giving 75% conversion (1H NMR) to 5-(Bpin) (311) and 6-(Bpin) products (312) in a 94:6 
ratio. The crude product was purified by reverse phase column chromatography to give 
pure 311 (155 mg, 52%) as a white amorphous solid. 
δH (400 MHz, CDCl3) 8.80 (1H, d, J = 1.9, 6-H), 8.49 (1H, d, J = 1.9, 4-H), 3.95 (3H, s, 
CO2CH3), 1.36 (12H, s, pinCH3); δC (101 MHz, CDCl3) 165.1 (CO2CH3), 157.4 (C-6), 
152.6 (C-2), 146.3 (C-4), 126.2 (C-3), 84.8 (C(CH3)2), 52.8 (CO2CH3), 24.9 (pinCH3); 11B 
NMR (128 MHz, CDCl3) δ 30.4 (s(br)); νmax (neat) 1738, 1694, 1588, 1548, 1426, 1359, 
1255, 1138, 1108, 1062, 971 cm−1; Accurate Mass (ESI) m/z found [M]+ 297.1047; 
C13H1810B35ClNO4 requires M, 297.1054. 
 
2,3-Dichloro-5-(Bpin)-pyridine (317) 
 
General procedure A was applied to 2,3-dichloropyridine (316) (148 mg, 1 mmol) using 
Stock Solution A. The reaction mixture was stirred at room temperature for 5 h giving full 
conversion (1H NMR) to 317. The crude product was purified by flash column 
chromatography (eluent; 0-5% MeOH in DCM) to give pure 317 (0.12 g, 44%) as a white 
amorphous solid. 
δH (700 MHz, CDCl3) 8.57 (1H, d, J = 1.5, 6-H), 8.09 (1H, d, J = 1.5, 4-H), 1.33 (12H, s, 
pinCH3); δC (176 MHz, CDCl3) 152.9 (C-6), 151.8 (C-2), 144.6 (C-4), 130.5 (C-3), 84.9 
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(C(CH3)2), 25.0 (pinCH3); δB (128 MHz, CDCl3) 30.0 (s (br)); GC/MS (EI) m/z 277 ([M]+, 
37Cl2), (275 ([M]+, 37Cl35Cl), 273 ([M]+, 35Cl2), 262 ([M-CH3]+, 37Cl2), 260 ([M-CH3]+, 
37Cl35Cl), 258 ([M-CH3]+, (35Cl2)); Accurate Mass (ASAP) m/z found [M+H]+ 273.0625; 
C11H1510BNO235Cl2 requires M, 273.0609. 
 
Methyl-2-methoxy-5-(4’-methoxyphenyl)nicotinate (319) 
 
General procedure E was applied to methyl-2-methoxynicotinate (304) (184 mg, 1.1 
mmol). Borylation with Stock Solution A for 24 h at room temperature gave full conversion 
(1H NMR) to 5-(Bpin) (306) and 6-(Bpin) (307) products in a 93:7 ratio. Suzuki-Miyaura 
step was carried out for 2 h with Pd(dppf)Cl2 (40 mg, 0.06 mmol, 5 mol%), Cs2CO3 (720 
mg, 2.2 mmol) and 4-iodoanisole (280 mg, 1.2 mmol) in DMF (3 mL) at 70 ˚C. Column 
eluent 0-15% EtOAc in heptane. 319 (229 mg, 76%) isolated as a white amorphous solid. 
δH (700 MHz, CDCl3) 8.49 (1H, d, J = 2.2, 6-H), 8.34 (1H, d, J = 2.2, 4-H), 7.48 (2H, m, 
2’, 6’-H), 7.00 (2H, m, 3’, 5’-H), 4.10 (3H, s, 2-COCH3), 3.93 (3H, s, CO2CH3), 3.86 (3H, 
s, 4’-COCH3); δC (176 MHz, CDCl3) 165.7 (CO2CH3), 161.4 (C-2), 159.7 (C-4’), 148.2 (C-
6), 139.7 (C-4), 129.8 (C-5), 129.3 (C-1’), 128.0 (C-2’, 6’), 114.7 (C-3’, 5’), 113.9 (C-3), 
55.5 (4’-COCH3), 54.6 (2-COCH3), 52.5 (CO2CH3); νmax (ATR) 1732, 1606, 1563, 1519, 
1474, 1417, 1327, 1285, 1245, 1181, 1087, 1060, 1014 cm−1; Accurate Mass (ASAP) 
m/z found [M+H]+ 274.1075; C15H16NO4 requires M, 274.1079. 
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Methyl-2-fluoro-5-(4’-methoxyphenyl)nicotinate (320) 
 
General procedure E was applied to methyl-2-fluoronicotinate (305) (682 mg, 4.4 mmol). 
Borylation with Stock Solution A for 45 min at room temperature gave full conversion (1H 
NMR) to 5-(Bpin) (308) and 6-(Bpin) (309) products in a 91:9 ratio. The Suzuki-Miyaura 
step was carried out for 2 h with Pd(dppf)Cl2 (161 mg, 0.22 mmol), Cs2CO3 (2.87 g, 8.8 
mmol) and 4-iodoanisole (1.13 g, 4.8 mmol) in DMF (10 mL) at 70 ˚C. Column eluent 0-
20% EtOAc in heptane. 320 (715 mg, 62%) isolated as an off-white amorphous solid. 
δH (700 MHz, CDCl3) 8.51 (2H, m, 4, 6-H), 7.50 (2H, m, 2’, 6’-H), 7.01 (2H, m, 3’, 5’-H), 
3.98 (3H, s, CO2CH3), 3.86 (OCH3); δC (176 MHz, CDCl3) 164.0 (d, J = 8.1, CO2CH3), 
160.5 (d, J = 249.8, C-2), 160.3 (C-4’), 149.1 (d, J = 15.4, ArC), 141.7 (d, J = 1.6, ArC), 
135.0 (C-5), 128.3 (C-2’, 6’), 128.0 (C-1’), 114.9 (C-3, 5’), 113.4 (d, J = 25.6, C-3), 55.6 
(OCH3), 53.0 (CO2CH3); δF (376 MHz, CDCl3) −66.3 (s); νmax (neat) 1722, 1603, 1459, 
1446, 1327, 1292, 1249, 1179, 1089, 1042, 977 cm−1; Accurate Mass (ASAP) m/z found 
[M]+ 261.0824; C14H12FNO3 requires M, 261.0801 
 
Methyl-2-(trifluoromethyl)-5-(4’-methoxyphenyl)nicotinate (321) 
 
General procedure E was applied to methyl-2-(trifluoromethyl)nicotinate (313) (287 mg, 
1.4 mmol). Borylation with Stock Solution A for 1 h at room temperature gave full 
conversion (1H NMR) to the 5-(Bpin) (314) product. Suzuki-Miyaura step carried out for 
3 h using Pd(dppf)Cl2 (51 mg, 0.07 mmol), Cs2CO3 (910 mg, 2.8 mmol) and 4-iodoanisole 
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(360 mg, 1.5 mmol)in DMF (5 mL) at 70 ˚C. Crude product purified by reverse phase 
column chromatography. 321 (332 mg, 75%) isolated as a white amorphous solid. 
δH (700 MHz, CDCl3) 8.96 (1H, d, J = 2.1, 6-H), 8.22 (1H, d, J = 2.1, 4-H), 7.58 (2H, m, 
2’, 6’-H), 7.05 (2H, m, 3’, 5’-H), 3.99 (3H, s, CO2CH3), 3.88 (3H, s, COCH3); δC (176 MHz, 
CDCl3) 166.2 (CO2CH3), 161.0 (C-4’), 148.6 (C-6), 143.4 (m, C-2), 138.9 (C-5), 135.7 (C-
4), 128.7 (C-2’, 6’), 127.8 (C-3), 127.6 (C-1’), 121.4 (q, J = 274.6, CF3), 115.1 (C-3’, 5’), 
55.6 (OCH3), 53.4 (CO2CH3); δF (376 MHz, CDCl3) −64.3 (s); νmax (neat) 1738, 1609, 
1519, 1440, 1324, 1252, 1142, 1065, 1049 cm−1; Accurate Mass (ASAP) m/z found [M]+ 
311.0768; C15H12F3NO3 requires M, 311.0769. 
 
Borylation of methyl-2-methoxynicotinate (304) with HBpin 
 
General Procedure B was applied to 304 (1 mmol) using HBpin. The reaction mixture 
was stirred at room temperature for 24 h giving 48% conversion (1H NMR) to afford 306 
and 307 in a 54:46 ratio. 
 
Borylation of methyl-2-chloronicotinate (310) with HBpin 
 
General Procedure B was applied to 310 (1 mmol) using HBpin. The reaction mixture 
was stirred at room temperature for 24 h giving 15% conversion (1H NMR) to afford 311 
and 312 in a 76:24 ratio. 
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Methyl-2-methoxyisonicotinate (325) 
 
General procedure C applied to 2-methoxyisonicotinic acid (322) (500 mg, 3.3 mmol). 
325 (518 mg, 95%) isolated as a pale yellow oil. 
δH (700 MHz, CDCl3) 8.27 (1H, d, J = 5.1, 6-H), 7.39 (1H, d, J = 5.1, 5-H), 7.30 (1H, s, 3-
H), 3.96 (3H, s, OCH3), 3.93 (3H, s, CO2CH3); δC (176 MHz, CDCl3) 165.7 (CO2CH3), 
165.0 (C-2), 147.8 (C-6), 140.2 (C-4), 115.8 (C-5), 111.4 (C-3), 54.0 (OCH3), 52.8 
(CO2CH3); νmax (ATR) 1732, 1708, 1588, 1576, 1467, 1404, 1308, 1258, 1237, 1126, 
1082, 1011 cm−1; Accurate Mass (ESI) m/z found [M+H]+ 168.0660; C8H10NO3 requires 
M, 168.0661. 
 
Methyl-2-(trifluoromethyl)isonicotinate (326) 
 
General procedure C applied to 2-(trifluoromethyl)isonicotinic acid (323) (400 mg, 2.1 
mmol). 326 (380 mg, 88%) isolated as a colourless oil. 
δH (700 MHz, CDCl3) 8.90 (1H, d, J = 4.9, 6-H), 8.23 (1H, m, 3-H), 8.06 (1H, m, 5-H), 
4.00 (3H, s, CO2CH3); δC (176 MHz, CDCl3) 164.4 (CO2CH3), 151.1 (C-6), 149.5 (q, J = 
35.4, C-2), 139.2 (C-4), 125.9 (C-5), 121.4 (q, J = 247.3, CF3), 120.1 (q, J = 3.5, C-3), 
53.3 (CO2CH3); δF (376 MHz, CDCl3) −68.1 (s); νmax (ATR) 1734, 1442, 1334, 1295, 
1256, 1179, 1130, 1082, 970 cm−1; Accurate Mass (ASAP) m/z found [M+H]+ 206.0426; 
C8H7F3NO2 requires M, 206.0429. 
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Methyl-2-fluoroisonicotinate (327) 
 
General procedure D was applied to 2-fluoroisonicotinic acid (324) (0.99 g, 7.0 mmol). 
Column eluent 0-10% EtOAc in hexanes. 327 (0.68 g, 65%) isolated as a colourless oil. 
δH (600 MHz, CDCl3) 8.37 (1H, d, J = 5.1, 6-H), 7.74 (1H, dt, J = 5.1, 1.5, 5-H), 7.49 (1H, 
m, 3-H), 3.97 (3H, s, CO2CH3); δC (151 MHz, CDCl3) 164.4 (d, J = 4.1, CO2CH3), 164.3 
(d, J = 240.1, C-2), 148.8 (d, J = 14.5, C-6), 142.9 (d, J = 7.8, C-4), 120.9 (d, J = 4.7 Hz, 
C-5), 110.0 (d, J = 39.2, C-3), 53.2 (CO2CH3); δF (376 MHz, CDCl3) −66.3 (s); νmax (ATR) 
1733, 1573, 1438, 1399, 1288, 1214, 1095, 985, 900 cm−1; Accurate Mass (ESI) m/z 
found [M+H]+ 156.0456; C7H7FNO3 requires M, 156.0461. 
 
Methyl-2-fluoro-6-(Bpin)isonicotinate (339) 
 
General procedure A was applied to methyl 2-fluoroisonicotinate (327) (170 mg, 1.1 
mmol) using Stock Solution A. The reaction mixture was stirred at room temperature for 
18 h giving full conversion (1H NMR) to 339. Column eluent (0-10% MeOH in DCM) 
afforded 339 (89 mg) as an off white solid containing minor impurities. 
δH (700 MHz, CDCl3) 8.23 (1H, s, 5-H), 7.52 (1H, m, 3-H), 3.96 (3H, s, CO2CH3), 1.38 
(12H, s, pinCH3); δC (176 MHz, CDCl3) 164.7 (d, J = 4.0, CO2CH3), 164.3 (d, J = 241.1, 
C-2); 141.9 (d, J = 7.0, C-4), 127.7 (d, J = 3.5, C-5), 111.9 (d, J = 40.5, C-3), 85.3 
(C(CH3)2), 53.1, (CO2CH3), 25.0 (pinCH3). 
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2-Chloro-4-(trifluoromethyl)-6-(3’-methoxyphenyl)pyridine (341) 
 
General procedure E was applied to 2-chloro-4-(trifluoromethyl)pyridine (328) (182 mg, 
1 mmol). Borylation with Stock Solution A for 24 h at room temperature gave 72% 
conversion (1H NMR) to 6-(Bpin) product 330. The Suzuki-Miyaura step was carried out 
for 3 h using Pd(dppf)Cl2 (37 mg, 0.05 mmol), Cs2CO3 (650 mg, 2 mmol) and 3-
iodoanisole (260 mg, 1.1 mmol) in DMF (3 mL) at 70 ˚C. Column eluent 0-3% Et2O in 
heptane. 341 (147 mg, 51%) isolated as an off-white amorphous solid. 
δH (700 MHz, CDCl3) 7.83 (1H, s, 5-H), 7.59 (1H, t, J = 2.3, 2’-H), 7.58 (1H, d, J = 7.9, 
6’-H), 7.48 (1H, s, 3-H), 7.41 (1H, t, J = 7.9, 5’-H), 7.03 (1H, dd, J = 7.9, 2.3, 4’-H), 3.91 
(3H, s, OCH3); δC (176 MHz, CDCl3) 160.4 (C-3’), 159.4 (C-6), 152.4 (C-2), 141.8 (q, J = 
34.3, C-4), 138.0 (C-1’), 130.2 (C-5’), 122.3 (q, J = 274.0, CF3), 119.6 (C-6’), 118.7 (q, J 
= 3.7, C-3), 116.6 (C-4’), 114.8 (q, J = 3.5, C-5), 112.6 (C-2’), 55.6 (OCH3); δF (376 MHz, 
CDCl3) −64.7 (s); νmax (ATR) 1600, 1561, 1459, 1400, 1333, 1274, 1221, 1177, 1142, 
1102 cm−1; Accurate Mass (ASAP) m/z found [M]+ 287.0330; C13H935ClF3NO requires M, 
287.0325. 
 
Methyl-2-methoxy-6-(3’-methoxyphenyl)isonicotinate (342) 
 
General procedure E applied to methyl-2-methoxyisonicotinate (325) (167 mg, 1 mmol). 
Borylation with Stock Solution A for 24 h at room temperature gave 57% conversion (1H 
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NMR) to 6-(Bpin) product 335. The Suzuki-Miyaura step was carried out for 16 h using 
Pd(dppf)Cl2 (37 mg, 0.05 mmol), Cs2CO3 (650 mg, 2 mmol) and 3-iodoanisole (260 mg, 
1.1 mmol) in DMF (3 mL) at 70 ˚C. Column eluent 7% EtOAc in heptane. 342 (112 mg, 
41%) isolated as an off-white amorphous solid. 
δH (700 MHz, CDCl3) 7.88 (1H, s, 5-H), 7.67 (2H, m, 2’, 6’-H), 7.38 (1H, t, J = 8.0, 5’-H), 
7.25 (1H, s, 3-H), 6.97 (1H, dd, J = 8.0, 2.4, 4’-H), 4.07 (3H, s, 2-COCH3), 3.96 (3H, s, 
CO2CH3), 3.89 (3H, s, 3’-COCH3); δC (176 MHz, CDCl3) 165.9 (CO2CH3), 164.5 (C-2), 
160.1 (C-3’), 155.5 (C-6), 141.0 (C-4), 139.9 (C-1’), 129.8 (C-5’), 119.4 (C-6’), 115.0 (C-
4’), 112.6 (C-2’), 112.3 (C-5), 109.8 (C-3), 55.5 (2-COCH3), 53.9 (3’-COCH3), 52.8 
(CO2CH3); νmax (ATR) 1731, 1568, 1452, 1386, 1354, 1258, 1225, 1208, 1108, 1045 
cm−1; Accurate Mass (ASAP) m/z found [M]+ 273.1008; (C15H5NO4) requires M, 
273.1001. 
 
Methyl-2-(trifluoromethyl)-6-(4’-methoxyphenyl)isonicotinate (343) 
 
General procedure E was applied to methyl-2-(trifluoromethyl)isonicotinate (326) (83 mg, 
0.4 mmol). Borylation with Stock Solution A for 24 h at room temperature gave 93% 
conversion (1H NMR) to 6-(Bpin) product 337. The Suzuki-Miyaura step was carried out 
for 16 h with Pd(dppf)Cl2 (37 mg, 0.05 mmol), K3PO4 (170 mg, 0.8 mmol,), 4-iodoanisole 
(100 mg, 0.44 mmol) in DMAc (2 mL) at 70 ˚C. Column eluent 3% EtOAc in heptane. 
343 (82 mg, 66%) isolated as a white amorphous solid. 
δH (600 MHz, CDCl3) 8.42 (1H, s, 5-H), 8.10 (2H, m, 2’, 6’-H), 8.05 (1H, d, J = 0.9, 3-H), 
7.02 (2H, m, 3’, 5’-H), 4.02 (3H, s, CO2CH3), 3.88 (3H, s, OCH3); δC (151 MHz, CDCl3) 
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164.9 (CO2CH3), 161.7 (C-4’), 158.8 (C-6), 149.1 (q, J = 35, C-2), 139.8 (C-4), 129.7 (C-
1’), 128.8 (C-2’, 6’), 121.6 (C-5), 121.5 (m, CF3), 117.1 (q, J = 2.7, C-3), 114.5 (C-3’, 5’), 
55.6 (OCH3), 53.2 (CO2CH3); δF (376 MHz, CDCl3) −68.2 (s); νmax (ATR) 1735, 1609, 
1565, 1519, 1429, 1373, 1257, 1187, 1144, 1072, 1032, 979, 914 cm−1; Accurate Mass 
(ASAP) m/z found [M]+ 311.0784; C15H12F3NO3 requires M, 311.0769. 
 
Methyl-2-fluoro-6-[4’-(methoxycarbonyl)phenyl]isonicotinate (344) 
 
General procedure E was applied to methyl 2-fluoroisonicotinate (327) (170 mg, 1.1 
mmol). Borylation with Stock Solution A for 18 h at room temperature gave full conversion 
(1H NMR) to 6-(Bpin) product 339. Suzuki-Miyaura cross-coupling was carried out for 1 
h using Pd(dppf)Cl2 (40 mg, 0.06 mmol), Cs2CO3 (717 mg, 2.2 mmol,) 4-iodoanisole (510 
mg, 2.2 mmol) in DMF (5 mL) at 100 ˚C in a microwave reactor. Column eluent 0-20% 
EtOAc in hexanes. 344 (157 mg, 55%) isolated as a colourless oil. 
δH (700 MHz, CDCl3) 8.13 (1H, m, 5-H), 8.03 (2H, m, 2’, 6’-H), 7.32 (1H, m, 3-H), 7.00 
(2H, m, 3’, 5’-H), 4.00 (3H, s, CO2CH3), 3.88 (3H, s, COCH3); δC (176 MHz, CDCl3) 164.8 
(d, J = 4.2, CO2CH3), 162.3 (d, J = 247.0, C-2), 161.5 (C-4’), 157.2 (d, J = 14.0, C-6), 
143.4 (d, J = 8.0, C-4), 129.5 (C-1’), 128.6 (C-2’, 6’), 116.3 (d, J = 5.0, C-5), 114.4 (C-3’, 
5’), 106.7 (d, J = 40.0 Hz, C-3), 55.6 (CO2CH3), 53.1 (OCH3); δF (376 MHz, CDCl3) -66.2 
(s); νmax (ATR) 1733, 1608, 1568, 1520, 1420, 1396, 1352, 1252, 1206 1177 cm−1; 
GC/MS (EI) m/z 261 [M]+, 246 [M−CH3]+, 230 [M−OCH3], 218, 203, 187, 159; Accurate 
Mass (ASAP) m/z found [M]+ 261.0811; C14H12FNO3 requires M, 261.0801 
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Methyl-6-fluoronicotinate (346) 
 
General procedure D was applied to 6-fluoronicotinic acid (345) (0.99 g, 7.0 mmol). 
Column eluent 0-10% EtOAc in hexanes. 346 (0.65 g, 60%) isolated as a colourless oil. 
δH (600 MHz, CDCl3) 8.88 (1H, d, J = 2.4, 2-H), 7.40 (1H, ddd, J = 8.5, 7.7, 2.4, 4-H), 
7.00 (1H, dd, J = 8.5, 2.9, 5-H) 3.95 (3H, s, CO2CH3); δC (151 MHz, CDCl3) 165.8 (d, J = 
246, C-6), 164.7 (CO2CH3), 150.3 (d, J = 16.5, C-2), 142.5 (d, J = 9.3, C-4), 124.4 (d, J 
= 4.5, C-3); 109.5 (d, J = 37.5, C-5), 52.5 (CO2CH3); νmax (ATR) 1721, 1601, 1430, 1311, 
1277, 1220, 1134, 1058 cm−1; Accurate Mass (ESI) m/z found [M+H]+ 156.0458; 
C7H7FNO3 requires M, 156.0461. 
 
Borylation of 2,5-dichloropyridine (347) 
 
General procedure A was applied to 347 (148 mg, 1 mmol) using Stock Solution A. The 
reaction mixture was stirred at room temperature for 24 h giving 93% conversion (1H 
NMR) to 348 and 349 in a 16:84 ratio. GC/MS analysis showed trace amounts of bis-
borylated products. 
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Borylation of 2,5-lutidine (350) 
 
General procedure A was applied to 350 (107 mg, 1 mmol) using Stock Solution A. The 
reaction mixture was stirred at room temperature for 24 h giving 10% conversion (1H 
NMR) to 352. 
 
Borylation of 2,5-difluoropyridine (356) 
 
General procedure A was applied to 2,5-difluoropyridine (356) (115 mg, 1mmol) using 
Stock Solution A. The reaction mixture was stirred at room temperature for 8 h giving full 
conversion (1H NMR) to 357, 358, 361 and 362 in a 19:72:6:3 ratio. 
 
Methyl-6-fluoro-5-(Bpin)nicotinate (359) 
 
General procedure A was applied to methyl 6-fluoronicotinate (346) (109 mg, 0.7 mmol) 
using Stock Solution A. The reaction mixture was stirred at room temperature for 3 h 
giving full conversion (1H NMR) to 359. Column eluent 0-10% MeOH in DCM afforded 
359 (141 mg, 77%) as a white amorphous solid. 
δH (600 MHz, CDCl3) 8.91 (1H, d, J = 2.5, 6-H), 8.74 (1H, dd, J = 7.9, 2.5, 4-H), 3.93 (3H, 
s, CO2CH3), 1.36 (12H, s, pinCH3); δC (151 MHz, CDCl3) 169.1 (d, J = 251.0, C-6), 164.9 
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(CO2CH3), 153.1 (d, J = 17.0, C-2), 150.0 (d, J = 9.0, C-4), 124.2 (d, J = 5.0, C-3), 84.9 
(C(CH3)2), 52.5, (CO2CH3), 24.9 (pinCH3); δB (128 MHz, CDCl3) 29.7 (s(br)); δF (564 MHz, 
CDCl3) −52.2 (m); max (ATR) 1722, 1604, 1578, 1444, 1421, 1393, 1392, 1390, 1349, 
1336, 1260, 1215, 1188, 1171, 1145, 1123, 1079 cm−1. GC/MS (EI) m/z 281 [MH]+, 266 
[M−CH3], 250 [M−OCH3]+, 238, 222 [M−CO2CH3]+, 208, 197, 182, 150; Accurate Mass 
(ASAP) m/z found [M+H]+ 281.1340; C13H1810BNO4F requires M, 281.1349. 
 
Methyl-6-chloro-5-(3’-methoxyphenyl)nicotinate (363) 
 
General procedure E was applied to methyl-6-chloronicotinate (353) (172 mg, 1 mmol). 
Borylation with Stock Solution A for 24 h at room temperature gave 46% conversion (1H 
NMR) to 5-(Bpin) product 354. The Suzuki-Miyaura step was carried out for 1 h using 
Pd(dppf)Cl2 (37 mg, 0.05 mmol), Cs2CO3 (652 mg, 2 mmol) and 3-iodoanisole (257 mg, 
1.1 mmol) in DMF (3 mL) at 70 ˚ C. Column eluent 0-15% EtOAc in heptane. 363 (89 mg, 
32%) isolated as a white amorphous solid.  
δH (700 MHz, CDCl3) 8.98 (1H, d, J = 2.2, 2-H), 8.27 (1H, d, J = 2.2, 4-H), 7.39 (1H, m, 
5’-H), 7.03 (1H, m, 6’-H), 6.99 (2H, m, 2’, 4’-H), 3.97 (3H, s, CO2CH3), 3.86 (3H, s, 
COCH3); δC (176 MHz, CDCl3) 165.2 (CO2CH3), 159.7 (C-3’), 153.9 (C-6), 149.6 (C-2), 
140.5 (C-4), 137.9 (C-1’), 136.9 (C-5), 129.8 (C-5’), 125.4 (C-3), 121.7 (C-6’), 115.1 
(ArC), 114.4 (ArC), 55.5 (OCH3), 52.8 (CO2CH3); νmax (ATR) 1728, 1590, 1394, 1316, 
1265, 1228, 1129, 1036, 907 cm−1; Accurate Mass (ASAP) m/z found [M+H]+ 277.0497; 
C14H1235ClNO3 requires M, 277.0506. 
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Methyl-6-fluoro-5-(4’-methoxyphenyl)nicotinate (364) 
 
General procedure E was applied to methyl 6-fluoroisonicotinate (346) (109 mg, 0.7 
mmol). Borylation with Stock Solution A for 3 h at room temperature gave full conversion 
(1H NMR) to 359. The Suzuki-Miyaura step was carried out for 1 h using Pd(dppf)Cl2 (26 
mg, 0.04 mmol), Cs2CO3 (460 mg, 1.4 mmol,) 4-iodoanisole (330 mg, 1.4 mmol) in DMF 
(3 mL) in DMF (3 mL) at 70 ˚C. Column eluent 0-50% EtOAc in hexanes. 364 (107 mg, 
58%) isolated as a pale yellow amorphous solid.  
δH (600 MHz, CDCl3) 8.77 (1H, m, 6-H), 8.45 (1H, m, 4-H), 7.54 (2H, d, J = 8.6, 2’, 5’-H), 
7.01 (2H, d, J = 8.6, 3’, 5’-H), 3.96 (3H, s, CO2CH3), 3.86 (3H, s, OCH3); δC (151 MHz, 
CDCl3) 165.0 (CO2CH3), 162.6 (d, J = 246.2, C-6), 160.3 (C-4’), 147.8 (dd, J = 16.7, 5.1, 
C-6), 141.5 (d, J = 6.4, C-4), 130.2 (d, J = 6.4, C-2’, 6’), 125.1 (m, C-1’), 123.7 (d, J = 
28.6, C-3), 114.5 (C-3’, 5’), 55.5 (OCH3), 52.7 (CO2CH3); δF (376 MHz, CDCl3) −65.4 (s); 
max (ATR) 1725, 1609, 1518, 1434, 1411, 1313, 1250, 1200, 1181, 1120, 1047, 1029 
cm−1; Accurate Mass (ASAP) m/z found [M]+ 261.0819; C14H12FNO3 requires M, 
261.0801 
 
Methyl 2-(4’-methoxyphenyl)isonicotinate (366) 
 
General procedure E was applied to methyl-2-chloroisonicotinate (266) (344 mg, 2 
mmol). Borylation with Stock Solution A for 24 h at room temperature gave 73% 
conversion (1H NMR) to 6-(Bpin) product 267. The Suzuki-Miyaura step was carried out 
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for 1 h using Pd(dppf)Cl2 (73 mg, 0.1 mmol), Cs2CO3 (1.3 g, 4 mmol) 4-iodoanisole (940 
mg, 4 mmol) in DMF (5 mL) at 100 ˚C in a microwave reactor. Without purification, the 
crude cross-coupling reaction product was dissolved in ethanol (20 mL) and ammonium 
formate (2.5 g, 40 mmol) was added. The reaction vessel was evacuated and backfilled 
with nitrogen (x 3 cycles) before 10% Pd/C (106 mg, 0.1 mmol) was slowly added under 
a positive pressure of nitrogen. The reaction was stirred at room temperature for 2 h then 
filtered through a plug of celite and absorbed onto silica. Purification by flash column 
chromatography (0-20 % ethyl acetate in hexanes) afforded 366 as a white amorphous 
solid (0.23 g, 47%). 
δH (700 MHz, CDCl3) 8.77 (1H, d, J = 5.0 6-H), 8.22 (1H, s, 3-H), 8.01 (2H, m, 2’, 6’-H), 
7.69 (1H, d, J = 5.0, 5-H), 7.00 (2H, m, 3’, 5’-H), 3.97 (3H, s, CO2CH3), 3.86 (3H, s, 
OCH3); δc (176 MHz, CDCl3) 166.0 (CO2CH3), 161.0 (C-4’), 158.2 (C-2), 150.4 (C-6), 
138.1 (C-4), 131.2 (C-1’), 128.4 (C-2’, 6’), 120.4 (C-5), 119.0 (C-3), 114.3 (C-3’, 5’), 55.5 
(OCH3), 52.8 (CO2CH3); max (ATR) 1730, 1607, 1580, 1557, 1516, 1467, 1436, 1421, 
1390, 1301, 1274, 1249, 1176, 1111, 1060, 1031 cm−1; Accurate Mass (ASAP) m/z found 
[M+H]+ 244.0957; C14H14NO3 requires M, 244.0974. 
 
Methyl-2-methoxy-5-(4’-methoxyphenyl)nicotinate (319) 
 
320 (115 mg, 0.44 mmol), and NaOMe (119 mg, 2.20 mmol) were refluxed in MeOH (5 
mL) for 16 h. The reaction mixture was dry loaded onto silica and purified by flash column 
chromatography 0-15% EtOAc in heptane. 319 (229 mg, 81%) isolated as a white 
amorphous solid. Data as previously stated. 
 
210 
 
Methyl-2-(N-morpholinyl)-5-(4’’-methoxyphenyl)nicotinate (369) 
 
General Method F applied to 320 (120 mg, 0.46 mmol) with morpholine (368). Column 
eluent 20-30% EtOAc in heptane. 369 (141 mg, 93%) isolated as a white amorphous 
solid. 
δH (700 MHz, CDCl3) 8.51 (1H, s, 6-H), 8.20 (1H, s, 4-H), 7.47 (2H, d, J = 8.0, 2’’,6’’-H), 
6.98 (2H, d, J = 8.0, 3’’, 5’’-H), 3.91 (3H, s, CO2CH3), 3.85 (7H, m, OCH3, 3’, 5’-H), 3.44 
(4H, m, 2’, 6’-H); δC (176 MHz, CDCl3) 167.5 (CO2CH3), 159.3 (C-4’’), 158.2 (C-2), 148.4 
(C-6), 138.8 (C-4), 129.5 (C-1’’), 127.6 (C-5), 127.4 (C-2’’, 6’’), 114.5 (C-3’’, 5’’), 113.6 
(C-3), 66.9 (C-3’, 5’), 55.4 (OCH3), 52.2 (CO2CH3), 49.9 (C-2’’, 6’’); max (ATR) 1717, 
1601, 1472, 1440, 1246, 1212, 1182, 1114, 1087 cm−1; Accurate Mass (ESI) m/z found 
[M+H]+ 329.1510; C18H21N2O4 requires M, 329.1501. 
 
Methyl-2-(N-piperazinyl)-5-(4’’-methoxyphenyl)nicotinate (371) 
 
General Method F applied to 320 (51 mg, 0.20 mmol) with piperazine (370). Column 
eluent 0-15% EtOAc in heptane. 371 (57 mg, 89%) isolated as a yellow amorphous solid. 
δH (700 MHz, CDCl3) 8.47 (1H, d, J = 2.4, 6-H), 8.11 (1H, d, J = 2.4, 4-H), 7.45 (2H, d, J 
= 8.6, 2’’, 6’’-H), 6.97 (2H, d, J = 8.6, 3’’, 5’’-H), 3.91 (3H, s, CO2CH3), 3.84 (3H, s, OCH3), 
3.39 (4H, m, 2’, 6’-H), 1.68 (6H, m, 3’, 4’, 5’-H); δC (176 MHz, CDCl3) 168.4 (CO2CH3), 
159.2 (C-4’’), 158.6 (C-2), 148.3 (C-6), 138.7 (C-4), 130.0 (C-1’’), 127.5 (C-2’’, 6’’), 126.4 
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(C-5) 114.6 (C-3’’, 5’’), 113.4 (C-3), 55.5 (OCH3), 52.3 (CO2CH3), 50.7 (C-2’, 6’), 26.1 
(AlkC), 24.7 (AlkC); max (ATR) 1716, 1694, 1608, 1441, 1247, 1180 cm−1; Accurate Mass 
(ESI) m/z found [M+H]+ 327.1701; C19H23N2O3 requires M, 327.1709. 
 
2,3-Dimethyl-5-(4’-methoxyphenyl)pyrazine (391) 
 
General procedure E was applied to 2,3-dimethylpyrazine (383) (108 mg, 1 mmol). 
Borylation with Stock Solution B for 24 h at room temperature gave 90% conversion (1H 
NMR) to 5-(Bpin) product 384. The Suzuki-Miyaura step was carried out for 1 h using 
Pd(dppf)Cl2 (73 mg, 0.1 mmol), K3PO4 (420 mg, 2 mmol), 4-iodoanisole (260 mg, 1.1 
mmol) and CuCl (99 mg, 1 mmol) in DMAc (2.5 mL) at 70 ˚ C. Column eluent 15% EtOAc 
in hexanes. 391 (94 mg, 44%) isolated as a grey amorphous solid.  
δH (600 MHz, CDCl3) 8.65 (1H, s, 6-H), 7.94 (2H, d, J = 8.8, 2’, 6’-H), 7.00 (2H, d, J = 
8.8, 3’, 5’-H), 3.86 (3H, s, OCH3), 2.58 (3H, s, CH3), 2.55 (3H, s, CH3); δC (151 MHz, 
CDCl3) 160.8 (C-4’), 151.6 (C-3), 149.7 (C-2), 149.3 (C-5), 137.8 (C-6), 129.6 (C-1’), 
128.1 (C-2’, 6’), 114.5 (C-3’, 5’), 55.5 (OCH3), 22.4 (CH3), 21.8 (CH3); νmax (ATR) 1609, 
1514, 1456, 1290, 1251, 1177, 1033, 906 cm−1; Accurate Mass (ASAP) m/z found [M+H]+ 
215.1187; C13H15N2O requires M, 215.1184. 
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2,5-Dimethyl-3-(4’-methoxyphenyl)pyrazine (392) 
 
General procedure E was applied to 2,5-dimethylpyrazine (386) (108 mg, 1 mmol). 
Borylation with Stock Solution B for 16 h at 80 ˚C gave 56% conversion (1H NMR) to 3-
(Bpin) product 387. The Suzuki-Miyaura step was carried out for 16 h with Pd(dppf)Cl2 
(37 mg, 0.05 mmol), K3PO4 (420 mg, 2 mmol), 4-iodoanisole (260 mg, 1.1 mmol) in 
DMAc:H2O (9:1) (2.5 mL) at 70 ˚C. Column eluent 10-25% EtOAc in heptane. 392 (59 
mg, 28%) isolated as a pale yellow oil. 
δH (600 MHz, CDCl3) 8.28 (1H, s, 6-H), 7.52 (2H, m, 2’, 6’-H), 7.00 (2H, m, 3’, 5’-H), 3.86 
(3H, s, OCH3), 2.58 (3H, s, CH3), 2.56 (3H, s, CH3); δC (151 MHz, CDCl3) 160.1 (C-4’), 
152.6 (C-3), 150.4 (ArC), 148.2 (ArC), 141.5 (C-6), 131.5 (C-1’), 130.5 (C-2’, 6’), 114.0 
(C-3’, 5’), 55.5 (OCH3), 22.9 (2-CCH3), 21.3 (5-CCH3); νmax (ATR) 1610, 1513, 1448, 
1407, 1372, 1290, 1249, 1176, 1161, 1068, 1033, 968, 908 cm−1; Accurate Mass (ASAP) 
m/z found [M+H]+ 215.1183; C13H15N2O requires M, 215.1184. 
 
2-Chloro-3-methyl-6-naphthalen-1’-yl-pyrazine (393) 
 
General procedure E was applied to 2-chloro-3-methylpyrazine (388) (185 mg, 1.44 
mmol). Borylation with Stock Solution C for 24 h at room temperature gave 91% 
conversion (1H NMR) to 5-(Bpin) (389) and 6-(Bpin) (390) products in a 1:3 ratio. The 
Suzuki-Miyaura step was carried out for 1 h with Pd(dppf)Cl2 (110 mg, 0.14 mmol), K3PO4 
(611 mg, 2.88 mmol), 1-bromonaphthalene (600 mg, 2.88 mmol) and CuCl (143 mg, 1.44 
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mmol) in DMAc (3 mL) at 70 ˚C. Column eluent 0-20% Et2O in hexanes. 393 (85 mg, 
23%) isolated as a white amorphous solid. Product tentatively assigned as 6-
naphthalenyl isomer. 
δH (700 MHz, CDCl3) 8.69 (1H, s, 5-H), 8.10 (1H, m, ArH), 7.96 (1H, d, J = 8.2, ArH), 
7.93 (1H, m, ArH), 7.64 (1H, d, J = 8.2 Hz, ArH), 7.57 (1H, m, 3’-H), 7.53 (2H, m, ArH) 
2.78 (3H, s, CH3); δC (176 MHz, CDCl3) 152.0 (ArC), 151.1 (ArC), 148.3 (ArC), 142.7 (C-
5), 134.1 (ArC), 133.4 (ArC), 131.03 (ArC), 130.3 (ArC), 128.7 (ArC), 128.4 (ArC), 127.3 
(ArC), 126.4 (ArC), 125.4 (C-3’), 124.9 (ArC), 22.2 (CH3); GC/MS (EI) m/z 256 [M(37Cl)]+, 
254 [M(35Cl)]+, 219 [M−Cl]+, 127 [C10H8]+; Accurate Mass (ASAP) m/z found [M+H]+ 
255.0676; C15H1235ClN2 requires M, 255.0689. 
 
Borylation of 2,3-dimethylpyrazine (383): Synthesis of 2,3-dimethyl-5-(Bpin)-pyrazine 
(384) 
A solution of [Ir(COD)OMe]2 (17 mg, 0.025 x 10 mmol) and dtbpy (13 mg, 0.05 mmol) in 
MTBE (2 mL) was added to a solution of B2pin2 (254 mg, 1 mmol) and 383 (108 mg, 1 
mmol) in MTBE (3 mL). After stirring at room temperature for 24 h 1H NMR spectroscopic 
analysis revealed 76% conversion to 384. The reaction was quenched with D2O (2 drops) 
before being concentrated and analysed by both 1H and 2H NMR spectroscopy; D 
(Acetone d6, 92.1 MHz):  8.30 ppm (s, 1D). 
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Solvent Screen using m-xylene (198) 
 
General Method A was applied to 198 (106 mg, 1 mmol) using Stock Solution B prepared 
in a series of solvents. The reactions were irradiated at 80 °C for 1 h in a microwave 
reactor and analysed by in-situ 1H NMR analysis.  
 
2-Phenylpyrimidine (398) 
 
A mixture of 2-chloropyrimidine (396) (1g, 8.7 mmol), phenylboronic acid (4) (1.3 g, 10.4 
mmol) Na2CO3(aq) (2M, 1.84 g, 17.4 mmol) and PdCl2(PPh3)2 (310 mg, 0.44 mmol) in 
dioxane (8.7 mL) was heated at 90 °C for 16 h. The reaction was then cooled to room 
temperature and the volume was then reduced in vacuo. The aqueous residue was 
diluted with water (10 mL) and extracted with EtOAc (2 x 10 mL). The combined organics 
were washed with brine (10 mL), dried over MgSO4, filtered and concentrated in vacuo. 
The crude product was purified by flash column chromatography (10% EtOAc in 
hexanes) to give 398 (0.99g, 73%) as a white amorphous solid. 
δH (700 MHz, CDCl3) 8.79 (2H, d, J = 4.8, 4, 6-H), 8.45 (2H, m, 2’, 6’-H), 7.49 (3H, m, 3’, 
4’, 5’-H), 7.15 (1H, t, J = 4.8, 5-H); δC (176 MHz, CDCl3) 164.8 (C-2), 157.3 (C-4, 6), 
137.7 (C-1’), 130.9 (ArC), 128.7 (ArC), 128.2 (C-2’, 6’), 119.2 (C-5); νmax (ATR) 1566, 
1553, 1414, 1407, 1317, 1173, 1026 cm−1; Accurate Mass (ESI) m/z found [M+H]+ 
157.0765; C10H9N2 requires M, 157.0766. 
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2-Phenyl-5-pyridin-3’’-yl-pyrimidine (401) 
 
General procedure B was applied to 2-phenylpyrimidine (398) (94 mg, 0.6 mmol) using 
additional B2pin2 (15 mg, 0.06 mmol). The reaction was stirred at room temperature for 
24 h. NMR spectroscopic analysis of the crude mixture showed 76% conversion to 5-
(Bpin) product 399. As per General Method E, Pd(amphos)Cl2 (21 mg, 0.03 mmol), 
K3PO4 (254 mg, 1.2 mmol), 3-iodopyridine (135 mg, 0.66 mmol) and DMAc:H2O (9:1) (5 
mL) were added to the crude mixture and the reaction was heated to 70 °C for 2 h. Flash 
column chromatography heptane:EtOAc (1:1) provided 401 as an orange amorphous 
solid (110 mg, 47%). 
δH (700 MHz, CDCl3) 9.03 (2H, s, 4, 6-H), 8.92 (1H, s, 2’’-H), 8.72 (1H, d, J = 4.6, 6’’-H), 
8.50 (2H, m, 2’, 6’-H), 7.95 (1H, d, J = 7.8, 4’’-H), 7.53 (3H, m, 3’, 5’, 4’-H), 7.48 (1H, dd, 
J = 7.8, 4.6, 5’’-H); δC (176 MHz, CDCl3) 164.4 (C-2), 155.4 (C-4, 6), 150.0 (C-6’’), 147.9 
(C-2’’), 137.1 (C-1’), 134.3 (C-4’’), 131.2 (C-4’), 130-7 (C-5), 128.9 (C-3’, 5’, 3’’), 128.4 
(C-2’, 6’), 124.2 (C-5’’); νmax (ATR) 1534, 1442, 1425, 1374, 1334 cm−1; Accurate Mass 
(ASAP) m/z found [M]+ 233.0954; (C15H11N3) requires M, 233.0953. 
 
3-Methyl-5-(Bpin)-pyridazine (410) 
 
General procedure A was applied to 3-methylpyridazine (407) (94 mg, 1.0 mmol) using 
Stock Solution B. The reaction mixture was stirred at room temperature for 24 h at which 
point the observed precipitate was filtered and washed copiously with cold MTBE. The 
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crude solid was recrystallized from hot MTBE, then filtered and washed copiously again 
with cold MTBE. 410 (139 mg, 63%) was isolated as a powdered beige solid containing 
minor impurities. 
δH (700 MHz, CDCl3) 9.22 (1H, s, 6-H), 7.64 (1H, s, 4-H), 2.71 (3H, s, CH3), 1.35 (12H, 
s, pinCH3); δC (176 MHz, CDCl3) 159.8 (C-3), 152.7 (C-6), 132.5 (C-4), 85.2 (C(CH3)2), 
25.0 (pinCH3), 22.4 (CH3); δB (128 MHz, CDCl3) 30.2 (s(br)).  
 
3-Methyl-5-naphthalen-2’-ylpyridazine (413) 
 
General procedure E was applied to 3-methylpyridazine (407) (94 mg, 1 mmol). 
Borylation with Stock Solution B for 24 h at room temperature gave full conversion to 5-
(Bpin) product 410. The Suzuki-Miyaura step was carried out for 3 h with Pd(amphos)Cl2 
(35 mg, 0.05 mmol), K3PO4 (420 mg, 2 mmol), 2-bromonaphthalene (230 mg, 1.1 mmol) 
in DMAc:H2O (9:1) (2.5 mL). Column eluent 60% EtOAc in heptane. 413 (96 mg, 44%) 
was isolated as an orange amorphous solid. 
δH (700 MHz, CDCl3) 9.43 (1H, d, J = 2.0, 6-H), 8.16 (1H, s, 1’-H), 8.00 (1H, d, J = 8.5, 
4’-H), 7.93 (2H, m, 5’, 8’-H), 7.75 (1H, dd, J = 8.5, 1.7, 3’-H), 7.63 (1H, d, J = 2.0, 4-H), 
7.58 (2H, m, 6’, 7’-H), 2.83 (3H, s, CH3); δC (176 MHz, CDCl3) 160.0 (C-3), 148.0 (C-6), 
138.5 (C-5), 133.7 (C-4a), 133.4 (C-1a), 132.0 (C-2’), 129.4 (C-4’), 128.5 (ArC), 127.8 
(ArC), 127.4 (ArC), 127.0 (ArC), 126.9 (C-1’), 124.0 (C-3’), 123.8 (C-4), 22.4 (CH3); νmax 
(ATR) 1590 cm−1; Accurate Mass (ASAP) m/z found [M]+ 220.0999; C15H12N2 requires 
M, 220.1000. 
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3-Methyl-6-(3’-fluorophenyl)isoquinoline (423) and 3-Methyl-7-(3’-
fluorophenyl)isoquinoline (424) 
 
General procedure E was applied to 3-methylisoquinoline (419) (143 mg, 1 mmol). 
Borylation with Stock Solution B for 24 h at room temperature gave a 75% conversion to 
6-(Bpin) (420) and 7-(Bpin) (421) products in 53:47 ratio. The Suzuki-Miyaura step was 
carried out for 1 h with 2nd Generation PdXPhos (39 mg, 0.05 mmol), K3PO4 (420 mg, 2 
mmol), 3-fluoro-iodobenzene (244 mg, 1.1 mmol) in dioxane:H2O (5:1) (2.5 mL) at 70 ˚ C. 
Reverse phase column chromatography gave 423 and 424 as an inseparable mixture 
(150 mg, 63%). 
δH (600 MHz, CDCl3) 9.23 (1H, s, 424, 1-H), 9.20 (1H, s, 423, 1-H), 8.09 (1H, s, 424, 8-
H), 7.99 (1H, m, 423, 8-H), 7.86 (2H, m, 423, 5-H and 424, 6-H), 7.80 (1H, m, 424, 5-H), 
7.73 (1H, m, 423, 7-H), 7.51 (1H, s, 423, 4-H), 7.50 (1H, s, 424, 4-H), 7.47 (4H, m, 423, 
5’, 6’-H and 424, 5’, 6’-H), 7.40 (1H, s, 2’-H), 7.38 (1H, s, 2’-H), 7.10 (2H, m, 423, 4’-H 
and 424, 4’-H), 2.72 (6H, s, 423, CH3 and 424, CH3); δC (151 MHz, CDCl3) 163.3 (d, J = 
247.6, C-3’), 163.2 (d, J = 247.6, C-3’), 152.3 (423, C-3), 152.3 (424, C-1), 152.1 (424, 
C-3), 151.7 (423, C-1), 142.6 (d, J = 13.6, 423, C-1’), 142.6 (d, J = 13.6, 424, C-1’), 141.6 
(d, J = 3.0, 423, C-6), 137.7 (d, J = 3.0, 424, C-7), 136.8 (423, C-4a), 135.9 (424, C-4a), 
130.5 (ArC), 130.4 (ArC), 129.6 (424, C-6), 128.2 (423, C-8), 127.00 (424, C-1a), 126.7 
(424, C-5), 126.1 (423, C-1a), 125.8 (423, C-7), 125.4 (424, C-8), 123.9 (423, C-5), 123.2 
(d, J = 3.0, ArC), 122.9 (d, J = 3.0, ArC), 118.6 (423, C-4), 118.2 (424, C-4), 114.9 (d, J 
= 21.1, C-4’), 114.5 (d, J = 21.1, C-4’), 114.4 (d, J = 21.1, C-2’), 114.1 (d, J = 22.7, C-2’), 
24.3 (CH3), 24.2 (CH3); δF (376 MHz, CDCl3): −112.6 (m, 423, C-F and 424, C-F); νmax 
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(ATR) 1630, 1587, 1479, 1447, 1262, 1173, 1159, 904 cm−1; Accurate Mass (ESI) m/z 
found [M+H]+ 238.1032; C16H13NF requires M, 238.1034.  
 
3-(3’-Methoxyphenyl)-1,8-naphthyridine (427) 
 
General procedure E was applied to 1,8-naphthyridine (425) (130 mg, 1 mmol). 
Borylation with Stock Solution C (in THF) for 24 h at room temperature gave an 
approximate 65% conversion to 3-(Bpin) product 426. The Suzuki-Miyaura step was 
carried out for 1 h with 2nd Generation PdXPhos (39 mg, 0.05 mmol), K3PO4 (420 mg, 2 
mmol), 3-iodoanisole (257 mg, 1.1 mmol) in dioxane:H2O (5:1) (2.5 mL) at 70 ˚ C. Column 
eluent 0-3% MeOH in DCM. 427 (110 mg, 47%) isolated as an orange amorphous solid. 
δH (700 MHz, (CD3)2CO): 9.41 (1H, d, J = 2.6, 2-H), 9.10 (1H, dd, J = 4.1, 2.0, 7-H), 8.65 
(1H, d, J = 2.6, 4-H), 8.49 (1H, dd, J = 8.1, 2.0, 5-H), 7.64 (1H, dd, J = 8.1, 4.1, 6-H), 
7.49 (1H, m, 5’-H), 7.44 (2H, m, 2’, 6’-H), 7.05 (1H, m, 4’-H), 3.92 (3H, s, OCH3); δC (176 
MHz, (CD3)2CO) 161.5 (C-3’), 156.6 (C-1a), 154.2 (C-7), 153.4 (C-2), 139.4 (C-1’), 138.4 
(C-5), 135.2 (C-3), 135.1 (C-4), 131.2 (C-5’), 123.5 (C-4a), 123.5 (C-6), 120.5 (ArC), 
114.9 (C-4’), 113.8 (ArC), 55.8 (OCH3); νmax (ATR) 1599, 1581, 1479, 1469, 1358, 1326, 
1285, 1208, 1171, 1043, 1031 cm−1; Accurate Mass (ESI) m/z found [M+H]+ 237.1028; 
C15H13N2O requires M, 237.1025. 
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N-Ethoxy-pyridinium hexafluorophosphate (431) 
 
Under N2, a solution of pyridine-N-oxide (428) (1 g, 10.5 mmol) and triethyloxonium 
hexafluorophosphate (430) (3.13 g, 12.6 mmol) in DCM (10 mL) was stirred at room 
temperature for 6 h. The reaction was then concentrated in vacuo. The resulting pink 
solid was crystallised at room temperature overnight from EtOAc (10 mL). The crystals 
were filtered and washed with cold EtOAc (3 x 15 mL) to give 431 as a white amorphous 
solid (1.72 g, 61%).  
δH (600 MHz, CDCl3) 9.44 (2H, m, 2, 6-H), 8.63 (1H, m, 4-H), 8.26 (2H, m, 3, 5-H), 4.71 
(2H, q, J = 7.0, OCH2CH3), 1.39 (3H, t, J = 7.0, OCH2CH3); δC (151 MHz, CDCl3) 145.6 
(C-4), 142.1 (C-2, 6), 129.7 (C-3, 5), 79.5 (OCH2CH3), 13.3 (OCH2CH3); δF (376 MHz, 
CDCl3) −70.6 (d, J = 713.6Hz); δP (162 MHz, CDCl3) 164.6 (hept, J = 713.6) ; Accurate 
Mass (ESI) m/z found [M-PF6]+ 124.0754; C7H10NO requires M, 124.0762. 
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Borylation of Indazoles 
tButyl-1H-indazole-1-carboxylate (450) 
 
General Method G applied to indazole (402) (500 mg, 4.0 mmol). Column eluent 0-20% 
Et2O in hexanes. 450 (850 mg, 98%) isolated as a colourless oil. 
δH (600 MHz, CDCl3) 8.12 (1H, d, J = 7.9, 7-H), 8.09 (1H, s, 3-H), 7.63 (1H, d, J = 7.9, 4-
H), 7.43 (1H, t, J = 7.9, 6-H), 7.21 (1H, t, J = 7.9, 5-H), 1.66 (9H, s, C(CH3)3); δC (151 
MHz, CDCl3) 149.1 (CO2tBu), 139.6 (C-1a), 139.4 (C-3), 128.7 (C-6), 125.7 (C-3a), 123.5 
(C-5), 120.9 (C-4) 114.5 (C-7), 84.6 (C(CH3)3), 28.1 (C(CH3)3); LC/MS (ES+) m/z 
460[M2Na]+, 241 [MNa]+, 219 [M]+, 164 [M−C4H9]+, 119 [M−COC4H9]+; Accurate Mass 
(ESI) m/z found [M+Na]+ 241.0974; C12H14N2O2Na requires M, 241.0953. 
 
Borylation of tbutyl-1H-indazole-1-carboxylate (450) 
 
General procedure A was applied to 450 (97 mg, 0.4 mmol) using Stock Solution A. In-
situ 1H NMR monitoring showed full conversion to 451 after 2 h. 
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1-Methyl-1H-indazole (404) and 2-Methyl-2H-indazole (453)193,194 
 
General Method H applied to indazole (402) (1 g, 8.5 mmol) with methyl iodide (452). 
Column eluent 20% EtOAc in hexanes. 404 (0.54 g) and 453 (0.34 g) (total yield 0.88 g, 
78%) isolated as white amorphous solids.  
404: δH (700 MHz, CDCl3) 7.99 (1H, s, 3-H), 7.73 (1H, d, J = 8.0, 4-H), 7.39 (2H, m, 6, 7-
H), 7.15 (1H, ddd, J = 8.0, 5.0, 2.6, 5-H), 4.08 (3H, s, NCH3); δC (176 MHz, CDCl3) 140.0 
(C-1a), 132.8 (C-3), 126.3 (C-6), 124.1 (C-3a), 121.2 (C-4), 120.5 (C-5), 109.0 (C-7), 
35.6 (NCH3); LC/MS (ES+) m/z 133 [M]+. 
453: δH (700 MHz, CDCl3): 7.87 (1H, s, 3-H), 7.69 (1H, d, J = 8.9, 7-H), 7.63 (1H, d, J = 
8.2, 4-H), 7.27 (1H, m, 6-H), 7.07 (1H, m, 5-H), 4.21 (3H, s, NCH3); δC (176 MHz, CDCl3): 
149.2 (C-1a), 126.0 (C-6), 123.6 (C-3), 122.3 (C-3a), 121.8 (C-5), 120.1 (C-4), 117.4 (C-
7), 40.5 (NCH3); LC/MS (ES+) m/z 134 [M+H]+. 
 
1-(3’, 5’-Dimethylbenzyl)-1H-indazole (455) and 2-(3’, 5’-Dimethylbenzyl)-2H-indazole 
(456) 
 
General procedure H was applied to indazole (402) (1 g, 8.5 mmol) with 3,5-
dimethylbenzyl bromide (454). Column eluent 10% EtOAc in hexanes. 455 (0.70 g) and 
456 (1.05 g) (total yield 1.75 g, 87%) isolated as colourless oils.  
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455: δH (700 MHz, CDCl3) 8.04 (1H, s, 3-H), 7.74 (1H, m, 4-H), 7.38 (1H, m, 7-H), 7.34 
(1H, m, 6-H), 7.14 (1H, m, 5-H), 6.89 (1H, s, 4’-H), 6.84 (2H, s, 2’, 6’-H), 5.52 (2H, s, 
NCH2Ar), 2.25 (6H, s, CH3); δC (176 MHz, CDCl3) 139.7 (C-1a), 138.5 (C-3’, 5’), 136.9 
(C-1’), 133.4 (C-3), 129.6 (C-4’), 126.5 (C-6), 125.3 (C-2’, 6’), 124.50 (C-3a), 121.3 (C-
4), 120.7 (C-5), 109.5 (C-7), 53.1 (NCH2Ar), 21.5 (CH3); GC/MS (EI) m/z: 236 [M]+, 119 
[M−CH2C6H3(CH3)2]+, 91 [CH2C6H5]+, 77 [C6H5]+; Accurate Mass (ESI) found [M]+ 
236.1321; C16H16N2 requires M, 236.1313. 
456: δH (700 MHz, CDCl3) 7.88 (1H, s, 3-H), 7.73 (1H, m, 7-H), 7.63 (1H, m, 4-H), 7.28 
(1H, m, 6-H), 7.07 (1H, m, 5-H), 6.96 (1H, s, 4’-H), 6.92 (2H, s, 2’, 6’-H), 5.52 (2H, s, 
NCH2Ar), 2.29 (6H, s, CH3); δC (176 MHz, CDCl3): 149.1 (C-1a), 138.8 (C-3’, 5’), 135.7 
(C-1’), 130.2 (C-4’), 126.1 (C-2’, 6’), 126.0 (C-6), 122.9 (C-3), 122.3 (C-3a), 121.8 (C-5), 
120.3 (C-4), 117.8 (C-7), 57.8 (NCH2Ar), 21.4 (CH3); GC/MS (EI) m/z 236 [M]+, 119 
[M−CH2C6H3(CH3)2]+, 91 [CH2C6H5]+, 77 [C6H5]+; Accurate Mass (ESI) found [M]+ 
236.1318; C16H16N2 requires M, 236.1313. 
 
1-{[2-(Trimethylsilyl)ethoxy]methyl}-1H-indazole (458) 
 
General Method H was applied to indazole (402) (0.5 g, 4.2 mmol) with 2-
(trimethylsilyl)ethoxymethyl chloride (457). Column eluent 0-50% EtOAc in hexanes. 458 
(0.69 g, 66%) isolated as a colourless oil. 
δH (700 MHz, CDCl3) 8.02 (1H, s, 3-H), 7.75 (1H, d, J = 7.9, 4-H), 7.59 (1H, d, J = 7.9, 7-
H), 7.42 (1H, t, J = 7.9, 6-H), 7.20 (1H, t, J = 7.9, 5-H), 5.75 (2H, s, NCH2O), 3.55 (2H, t, 
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J = 8.2, OCH2CH2), 0.88 (2H, t, J = 8.2, CH2Si(CH3)3), −0.07 (9H, s, Si(CH3)3); δC (176 
MHz, CDCl3) 139.9 (C-1a), 134.2 (C-3), 126.9 (C-6), 125.0 (C-3a), 121.5 (C-5), 121.2 
(C-4), 109.8 (C-7), 77.9 (NCH2O), 66.6 (OCH2CH2), 18.0 (CH2Si(CH3)3), −1.3 (Si(CH3)3); 
GC/MS (EI) m/z 248 [M]+, 175 [M−SiMe3]+, 148 [M−CH2CH2SiMe3]+, 132 
[M−OCH2CH2SiMe3]+, 118 [M−CH2OCH2CH2SiMe3]+; Accurate Mass (ESI) m/z found 
[M+H]+ 249.1470; C13H21N2OSi requires M, 249.1423. 
 
2-{[2-(Trimethylsilyl)ethoxy]methyl}-2H-indazole (459) 
 
General procedure I was applied to indazole (402) (0.5 g, 4.2 mmol). Column eluent 0-
10% EtOAc in hexanes. 459 (0.77 g, 74%) isolated as a colourless oil. 
δH (700 MHz, CDCl3) 8.10 (1H, s, 3-H), 7.73 (1H, d, J = 8.1, 7-H), 7.68 (1H, d, J = 8.1, 4-
H), 7.30 (1H, t, J = 8.1, 6-H), 7.10 (1H, t, J = 8.1, 5-H), 5.73 (2H, s, NCH2O), 3.63 (2H, t, 
J = 8.3, OCH2CH2), 0.94 (2H, t, J = 8.3, CH2Si(CH3)3), −0.03 (9H, s, Si(CH3)3); δC (176 
MHz, CDCl3) 149.0 (C-1a), 126.5 (C-6), 122.7 (C-3), 122.4 (C-3a), 122.3 (C-5), 120.6 
(C-4), 118.1 (C-7), 82.0 (NCH2O), 67.6 (OCH2CH2), 18.0 (CH2Si(CH3)3), −1.3 (Si(CH3)3); 
GC/MS (EI) m/z 248 [M]+, 175 [M−SiMe3]+, 148 [M−CH2CH2SiMe3]+, 132 
[M−OCH2CH2SiMe3]+, 118 [M−CH2OCH2CH2SiMe3]+; Accurate Mass (ESI) m/z found 
[M+H]+ 249.1390; C13H21N2OSi requires M, 249.1423. 
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1-(Methanesulfonyl)-1H-indazole (461) 
 
Methanesulfonyl chloride (460) (0.23 g, 0.15 mL, 2 mmol) was added to dropwise to a 
solution of indazole (402) (0.24 g, 2 mmol) and anhydrous triethylamine (0.2 g, 0.28 mL, 
2 mmol) in anhydrous DCM (5 mL). The reaction was stirred for 18 h at room temperature 
before the mixture was dry loaded onto silica and purified by flash column 
chromatography (0-20% Et2O in Hexanes). 461 (0.21g, 54%) was isolated as a pink oil. 
δH (700 MHz, CDCl3) 8.28 (1H, d, J = 0.9, 3-H), 8.06 (1H, dd, J = 8.2, 0.9, 7-H), 7.76 (1H, 
dd, J = 8.2, 0.9, 4-H), 7.54 (1H, ddd, J = 8.2, 7.1, 0.9, 6-H), 7.36 (1H, ddd, J = 8.2, 7.1, 
0.9, 5-H), 3.23 (3H, s, SO2CH3); δC (176 MHz, CDCl3) 141.3 (C-3), 140.2 (C-1a), 129.5 
(C-6), 125.6 (C-3a), 124.4 (C-5), 121.5 (C-4), 113.0 (C-7), 41.0 (SO2CH3); νmax (ATR) 
1606, 1498, 1362, 1282, 1247, 1144, 1122, 1064, 958, 901 cm−1; GC/MS (EI) m/z 196 
[M]+, 118 [M−SO2CH3]+; Accurate Mass (ESI) m/z found [M+H]+ 197.0378; C8H9N2O2S 
requires M, 197.0385. 
 
1-(Tetrahydro-2H-pyran-2’-yl)-1H-indazole (464) and 2-(Tetrahydro-2H-pyran-2’-yl)-2H-
indazole (465) 
 
p-toluenesulfonic acid hydrate (p.TSA) (0.25 g, 1.3 mmol) was added to a solution of 
indazole (402) (1.53 g, 13 mmol) and 3,4-dihydro-2H-pyran (463) (1.31 g, 15.6 mmol) in 
DCM (10 mL). Reaction was stirred at room temperature for 24 hours at which point 
additional pTSA (0.25 g, 1.3 mmol) was added. The reaction was stirred for a further 6 
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hours at which point TLC analysis (eluent 7:3 Hexanes:Et2O) showed full consumption 
of the parent indazole. The reaction was then quenched with aqueous sodium hydroxide 
(0.5 M, 10 mL). The layers were separated and the aqueous layer was re-extracted with 
DCM (15 ml). The combined organic extracts were washed with brine (10 mL), dried, 
filtered and concentrated in vacuo to yield crude product as orange oil. Purification by 
column chromatography (gradient elution 0-15% Et2O in Hexane) afforded 464 (0.67 g) 
and 465 (0.65 g) (total yield 1.32 g, 50 %). 
464: δH (700 MHz, CDCl3) 8.03 (1H, s, 3-H), 7.73 (1H, d, J = 8.0, 4-H), 7.60 (1H, d, J = 
8.0, 7-H), 7.39 (1H, t, J = 8.0, 6-H), 7.16 (1H, t, J = 8.0, 5-H), 5.73 (1H, dd, J = 9.4, 2.7, 
2’-H), 4.04 (1H, m, 6’-HA), 3.75 (1H, m, 6’-HB), 2.59 (1H, m, 3’-HA), 2.17 (1H, m, 4’-HA), 
2.09 (1H, m, 3’-HB), 1.76 (3H, m, 4’-HB, 5’-H2); δC (176 MHz, CDCl3) 139.6 (C-1a), 134.1 
(C-3), 126.6 (C-6), 124.9 (C-3a), 121.3 (C-5), 121.2 (C-4), 110.2 (C-7), 85.4 (C-2’), 67.7 
(C-6’), 29.6 (C-3’), 25.3 (C-5’), 22.8 (C-4’); GC/MS (EI) m/z 202 [M]+, 118 [M−THP]+; 
Accurate Mass (ESI) m/z found [M+H]+ 203.1213; C12H15N2O2 requires M, 203.1184. 
465: δH (700 MHz, CDCl3) 8.16 (1H, s, 3-H), 7.73 (1H, d, J = 8.6 Hz, 7-H), 7.66 (1H, d, J 
= 8.6 Hz, 4-H), 7.28 (1H, m, 6-H), 7.07 (1H, m, 5-H), 5.69 (1H, dd, J = 7.5, 4.8 Hz, 2’-H), 
4.14 (1H, m, 6’-HA), 3.79 (1H, m, 6-HB), 2.23 (2H, m, 3’-H2), 2.06 (1H, m, 4’-HA), 1.76 
(2H, m, 4’-HB, 5’-HA), 1.67 (1H, m, 5’-HB); δc (176 MHz, CDCl3): 148.7 (C-1a), 126.4 (C-
6), 122.1 (C-5), 121.7 (C-3a), 121.1 (C-3), 120.7 (C-4), 118.1 (C-7), 89.2 (C-2’), 68.2 (C-
6’), 31.6 (C-3’), 25.2 (C-5’), 22.4 (C-4’); GC/MS (EI) m/z 202 [M]+, 118 [M−THP]+; 
Accurate Mass (ESI) m/z found [M+H]+ 203.1208; C12H15N2O2 requires M, 203.1184. 
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Borylation of 1-methyl-1H-indazole (404) 
 
General procedure A was applied to 404 (135 mg, 1 mmol) using Stock Solution A. In-
situ 1H NMR monitoring showed 67% to 405 conversion after 24 h. 
 
Borylation of 1-(3’, 5’-dimethylbenzyl)-1H-indazole (455) 
 
General procedure A was applied to 455 (185 mg, 0.8 mmol) using Stock Solution A. In-
situ 1H NMR monitoring showed 61% conversion to 466 after 24 h. 
 
Borylation of 1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-indazole (458) 
 
General procedure A was applied to 458 (250 mg, 1 mmol) using Stock Solution A. In-
situ 1H NMR monitoring showed 63% conversion to 467 after 24 h. 
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1-(Methanesulfonyl)-3-(Bpin)-1H-indazole (468) 
 
General procedure A was applied to 1-(methanesulfonyl)-1H-indazole (461) (185 mg, 0.8 
mmol) using Stock Solution A. In-situ 1H NMR spectroscopy showed full conversion to 
468 in 1 h at room temperature. Column eluent 0-5% MeOH in CHCl3. 468 (154 mg, 
62%) isolated as an off-white amorphous solid. 
δH (400 MHz, CDCl3) 8.13 (1H, d, J = 8.0, 4-H), 8.08 (1H, d, J = 8.5, 7-H), 7.53 (1H, m, 
6-H), 7.38 (1H, m, 5-H), 3.33 (3H, s, SO2CH3), 1.42 (12H, s, pinCH3); δC (176 MHz, 
CDCl3) 140.2 (C-1a), 130.5 (C-3a), 129.0 (C-6), 124.3 (C-5), 123.2 (C-4), 112.8 (C-7), 
85.0 (C(CH3)2), 41.5 (SO2CH3), 25.0 (CH3); δB (128 MHz, CDCl3): 28.9 (s(br)); νmax (ATR) 
1503, 1373, 1325, 1266, 1176, 1142, 1078, 956, 907 cm−1; Accurate Mass (ASAP) m/z 
found [M]+ 321.1177; C14H1910BN2O4S requires M, 321.1195. 
 
Borylation of 1-(tetrahydro-2H-pyran-2’-yl)-1H-indazole (464) 
 
General procedure A was applied to 464 (138 mg, 0.7 mmol) using Stock Solution A. In-
situ 1H NMR monitoring showed 83% conversion to 469 after 24 h. 
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Borylation of 2-(methyl)-2H-indazole (453) 
 
General procedure A was applied to 453 (114 mg, 0.9 mmol) using Stock Solution A. In-
situ 1H NMR monitoring showed full conversion to 470 after 1 h. 
 
Borylation of 2-(3’, 5’-dimethylbenzyl)-2H-indazole (456) 
 
General procedure A was applied to 445 (209 mg, 0.9 mmol) using Stock Solution A. In-
situ 1H NMR monitoring showed full conversion to 471 after 0.25 h. 
 
Borylation of 2-{[2-(trimethylsilyl)ethoxy]methyl}-2H-indazole (459) 
 
General procedure A was applied to 459 (93 mg, 0.4 mmol) using Stock Solution A. In-
situ 1H NMR monitoring showed full conversion to 472 after 6 h. 
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Borylation of 2-(tetrahydro-2H-pyran-2’-yl)-2H-indazole (465) 
 
General procedure A was applied to 465 (116 mg, 0.6 mmol) using Stock Solution A. In-
situ 1H NMR monitoring showed full conversion to 473 after 20 h. 
 
1-Methyl-3-phenyl-1H-indazole (481) 
 
General procedure J was applied to 404 (121 mg, 0.9 mmol). The Suzuki-Miyaura step 
was run with iodobenzene in the presence of CuCl. Column eluent 5% EtOAc in hexanes. 
481 (0.08 g, 43%) isolated as a pale yellow oil. 
δH (700 MHz, CDCl3) 8.03 (1H, d, J = 8.0, 4-H), 7.98 (2H, d, J = 7.6, 2’, 6’-H), 7.51 (2H, 
t, J = 7.6, 3’, 5’-H), 7.42 (3H, m, 6, 7, 4’-H), 7.22 (1H, ddd, J = 8.0, 5.4, 2.2, 5-H), 4.14 
(3H, s, NCH3); δC (176 MHz, CDCl3) 143.9 (C-3), 141.6 (C-1a), 133.8 (C-1’), 128.9 (C-3’, 
5’), 127.9 (ArC), 127.5 (C-2’, 6’), 126.4 (ArC), 121.8 (C-3a), 121.5 (C-4) 121.0 (C-5), 
109.3 (ArC), 35.7 (NCH3); GC/MS (EI) m/z 208 [M]+, 131 [M−C6H5]+, 77 [C6H5]+; Accurate 
Mass (ASAP) m/z found [M]+ 208.0995; C14H12N2 requires M, 208.1000. 
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1-Tetrahydropyran-2’-yl-3-[4’-(trifluoromethyl)phenyl]-1H-indazole (483) 
 
General procedure J was applied to 464 (263 mg, 1.3 mmol). The Suzuki-Miyaura step 
was run with 4-bromo-(trifluoromethyl)benzene in the presence of CuCl. Column eluent 
0-3% Et2O in hexanes. 483 (0.19 g, 42%) isolated as an off white amorphous solid. 
δH (600 MHz, CDCl3) 8.11 (2H, d, J = 8.2, 2’’,6’’-H), 7.99 (1H, d, J = 8.0, 4-H), 7.74 (2H, 
d, J = 8.2, 3’’,5’’-H), 7.67 (1H, d, J = 8.0, 7-H), 7.45 (1H, t, J = 8.0, 6-H), 7.28 (1H, t, J = 
8.0, 5-H), 5.81 (1H, dd, J = 9.3, 2.7, 2’-H), 4.07 (1H, m, 6’-H), 3.79 (1H, m, 6’-H), 2.68 
(1H, m, 3’-H), 2.21 (1H, m, 4’-H), 2.13 (1H, m, 3’-H), 1.79 (2H, m, 4’, 5’-H), 1.69 (1H, m, 
5’-H); δC (151 MHz, CDCl3): 143.2 (C-3), 141.2 (C-1a), 137.4 (C-1’’), 129.9 (q, J = 31.7, 
C-4’’), 127.9 (C-2’’, 6’’), 126.9 (C-6), 125.8 (q, J = 3.0, C-3’’, 5’’), 124.3 (q, J = 273.3, 
CF3), 122.5 (C-3a), 122.3 (C-5), 121.1 (C-4), 110.8 (C-7), 85.7 (C-2’), 67.7 (C-6’), 29.5 
(C-3’), 25.3 (C-5’), 22.7 (C-4’); δF (376 MHz, CDCl3): −62.5 (s); νmax (ATR) 2948, 2866, 
1615, 1332, 1066 cm−1; Accurate Mass (ASAP) m/z found 347.1363; C19H18F3N2O 
requires M, 347.1371. 
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1-Tetrahydropyran-2’-yl-3-pyridin-2’’-yl-1H-indazole (485) 
 
General procedure J was applied to 464 (220 mg, 1.1 mmol). The Suzuki-Miyaura step 
was run with 2-bromopyridine in the presence of CuCl. Column eluent 0-10% EtOAc in 
hexanes. 485 (0.15 g, 48%) was isolated as a colourless oil. 
δH (700 MHz, CDCl3) 8.74 (1H, d, J = 4.7, 6’’-H), 8.67 (1H, d, J = 8.0, 4-H), 8.23 (1H, d, 
J = 7.9, 3’’-H), 7.76 (1H, m, 4’’-H), 7.62 (1H, d, J = 8.0, 7-H), 7.43 (1H, t, J = 8.0, 6-H), 
7.29 (1H, t , J = 8.0, 5-H), 7.24 (1H, m, 5’’-H), 5.81 (1H, dd, J = 9.2, 2.7, 2’-H), 4.07 (1H, 
m, 6’-H), 3.78 (1H, m, 6’-H), 2.68 (1H, m, 3’-H), 2.21 (1H, m, 4’-H), 2.12 (1H, m, 3’-H), 
1.79 (2H, m, 4’, 5’-H), 1.69 (1H, m, 5’-H); δC (176 MHz, CDCl3) 153.7 (C-2’’), 149.3 (C-
6’’), 143.6 (C-3), 141.2 (C-1a), 136.4 (C-4’’), 126.8 (C-6), 123.9 (C-4), 123.2 (C-3a), 
122.4 (C-5’’), 122.3 (C-5), 121.4 (C-3’’), 110.1 (C-7), 85.7 (C-2’), 67.6 (C-6’), 29.5 (C-3’), 
25.3 (C-5’), 22.7 (C-4’); νmax (ATR) 1592, 1562, 1510, 1490, 1459, 1442, 1378, 1315, 
1279, 1235, 1206, 1172, 1148, 1112, 1080, 1040, 1003, 906, cm−1; Accurate Mass 
(ASAP) m/z found [M+H]+ 280.1441; C17H18N3O requires M, 280.1450. 
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2-Methyl-3-phenyl-2H-indazole (487) 
 
General procedure J was applied to 453 (92 mg, 0.7 mmol). The Suzuki-Miyaura step 
was run with iodobenzene. Column eluent 0-10% Et2O in hexanes. 487 (64 mg, 44%) 
was isolated as a pale yellow oil. 
δH (700 MHz, CDCl3) 7.71 (1H, d, J = 8.7, 7-H), 7.59 (1H, d, J = 8.4, 4-H), 7.55 (4H, m, 
2’,3’,5’,6’-H), 7.50 (1H, m, 4’-H), 7.32 (1H, m, 6-H), 7.08 (1H, m, 5-H), 4.19 (3H, s, NCH3); 
δC (176 MHz, CDCl3): 148.3 (C-1a), 136.2 (C-3), 129.9 (C-1’), 129.8 (ArC), 129.2 (ArC), 
128.9 (C-4’), 126.4 (C-6), 122.0 (C-5), 121.4 (C-3a), 120.3 (C-4), 117.2 (C-7), 38.7 
(NCH3); νmax (ATR) 1500, 1361, 1287, 1009, 904 cm−1; Accurate Mass (ASAP) m/z found 
[M+H]+ 209.1077; C14H13N2 requires M, 209.1079. 
 
2-{[2-(Trimethylsilyl)ethoxy]methyl}-3-[4’-(methoxycarbonyl)phenyl]-2H-indazole (488) 
 
General procedure J was applied to 459 (273 mg, 1.1 mmol). The Suzuki-Miyaura step 
was run with methyl-4-iodobenzoate. Column eluent 0-10% EtOAc in hexanes. 488 (0.21 
g, 51%) was isolated as an off-white amorphous solid. 
δH (700 MHz, CDCl3) 8.22 (2H, m, 3’, 5’-H), 7.86 (2H, m, 2’, 6’-H), 7.77 (1H, d, J = 8.7, 
7-H), 7.68 (1H, d, J = 8.5, 4-H), 7.36 (1H, m, 6-H), 7.15 (1H, m, 5-H), 5.71 (2H, s, 
NCH2O), 3.97 (3H, s, CO2CH3), 3.87 (2H, t, J = 8.3, OCH2CH2), 0.97 (2H, t, J = 8.3, 
CH2Si(CH3)3), −0.01 (9H, s, Si(CH3)3); δC (176 MHz, CDCl3) 166.7 (CO2CH3), 148.3 (C-
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1a), 135.7 (C-3), 134.0 (ArC), 130.3, (C-3’, 5’), 130.2 (ArC), 129.8 (C-2’, 6’), 127.1 (C-6), 
123.1 (C-5), 121.5 (C-3a), 120.5 (C-4), 118.2 (C-7), 79.6 (NCH2O), 67.9 (OCH2CH2), 
52.5 (CO2CH3), 18.1 (CH2Si(CH3)3), −1.3 (Si(CH3)3); νmax (ATR) 1717, 1612, 1490, 1436, 
1276, 1249, 1228, 1175, 1149, 1080, 1018, 906 cm−1; Accurate Mass (ASAP) m/z found 
[M+H]+ 383.1803; C21H27N2O3Si requires M, 383.1791. 
 
2-{[2-(Trimethylsilyl)ethoxy]methyl}-3-pyridin-2’-yl-2H-indazole (489) 
 
General procedure J was applied to 459 (270 mg, 1.1 mmol). The Suzuki-Miyaura step 
was run with 2-bromopyridine. Column eluent 20% Et2O in hexanes. 489 (0.16 g, 47%) 
was isolated as a colourless oil. 
δH (700 MHz, CDCl3) 8.80 (1H, m, 6’-H), 7.88 (3H, m, 4, 7, 4’-H), 7.79 (1H, d, J = 8.7, 3’-
H), 7.34 (2H, m, 6, 5’-H), 7.18 (1H, m, 5-H), 6.15 (2H, s, NCH2O), 3.68 (2H, t, J = 8.3, 
OCH2CH2), 0.86 (2H, t, J = 8.3, CH2SiMe3), −0.10 (9H, s, Si(CH3)3); δC (176 MHz, CDCl3) 
150.3 (C-6’), 149.5 (C-2’), 148.3 (C-1a), 137.0 (ArC), 134.4 (C-3), 126.8 (ArC), 124.4 
(ArC), 123.4 (C-5), 122.7 (ArC), 121.7 (C-3a), 120.8 (ArC), 118.4 (C-3’), 80.3 (NCH2O), 
67.4 (OCH2CH2), 18.0 (CH2Si(CH3)3), −1.4 (Si(CH3)3); νmax (ATR) 1586, 1490, 1459, 
1364, 1306, 1249, 1152, 1088, 1021, 906 cm−1; Accurate Mass (ASAP) m/z found [M+H]+ 
326.1692; C18H24N3OSi requires M, 326.1689. 
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2-{[2-(Trimethylsilyl)ethoxy]methyl}-3-thiophen-3’-yl-2H-indazole (490) 
 
General procedure J was applied to 459 (234 mg, 0.9 mmol). The Suzuki-Miyaura step 
was run with 3-bromothiophene. Column eluent 0-5% EtOAc in hexanes afforded 490 
(0.13 g, 41%) as a pale yellow oil. 
δH (700 MHz, CDCl3) 7.85 (1H, m, 2’-H), 7.73 (2H, m, 4, 7-H), 7.58 (1H, m, 5’-H), 7.52 
(1H, m, 4’-H), 7.33 (1H, m, 6-H), 7.12 (1H, m, 5-H), 5.73 (2H, s, NCH2O), 3.82 (2H, t, J 
= 8.3, OCH2CH2), 0.96 (2H, t, J = 8.3, CH2SiMe3), −0.02 (9H, m, Si(CH3)3); δC (176 MHz, 
CDCl3) 148.1 (C-1a), 132.4 (C-3), 129.8 (C-3’), 128.3 (C-5’), 127.0 (C-4’), 126.7 (C-6), 
125.8 (C-2’), 122.4 (C-5), 121.2 (C-3a), 120.9 (ArC), 118.0 (ArC), 79.6 (NCH2O), 67.6 
(OCH2CH2), 18.2 (CH2Si(CH3)3), −1.3 (Si(CH3)3); νmax (ATR) 1627, 1478, 1408, 1293, 
1267, 1249, 1080, 1021, 907 cm−1; Accurate Mass (ASAP) m/z found [M+H]+ 331.1266; 
C17H23N2OSSi requires M, 331.1300. 
 
4-Bromo-1H-indazole (497) 
 
General procedure K was applied to 2-bromo-6-fluorobenzaldehyde (496) (1.76 g, 8.7 
mmol) to give 497 (1.20 g, 70%) as an orange amorphous solid. 
δH (700 MHz, CDCl3) 10.67 (1H, br, s, NH), 8.13 (1H, s, 3-H), 7.45 (1H, d, J = 7.8, ArH), 
7.33 (1H, d, J = 7.8, ArH), 7.24 (1H, m, 6-H); δC (176 MHz, CDCl3): 140.8 (C-1a), 135.3 
(C-3), 128.0 (C-6), 124.7 (ArC), 124.1 (ArC), 114.8 (ArC), 109.0 (ArC); GC/MS (EI) m/z 
199 ([M]+, 81Br), 198 [M+H]+, 197 ([M]+, 79Br), 196, 117 [M−Br]+. 
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4-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}indazole (501) 
 
General procedure I was applied on to 497 (0.17 g, 0.9 mmol). Column eluent 0-10% 
Et2O in hexanes. 501 (0.18 g, 64%) isolated as a colourless oil. 
δH (700 MHz, CDCl3) 8.13 (1H, s, 3-H), 7.68 (1H, d, J = 8.8, 7-H), 7.27 (1H, m, 5-H), 7.16 
(1H, dd, J = 8.8, 7.1, 6-H), 5.72 (2H, s, NCH2O), 3.64 (2H, m, OCH2CH2), 0.96 (2H, m, 
CH2Si(CH3)3), −0.02 (9H, s, Si(CH3)3); δC (176 MHz, CDCl3) 148.9 (C-1a), 127.2 (C-6), 
124.9 (C-5), 124.5 (C-3a), 123.9 (C-3), 117.4 (C-7), 113.5 (C-4), 82.2 (NCH2O), 67.9 
(OCH2CH2), 17.8 (CH2Si(CH3)3), −1.5 (Si(CH3)3); GC/MS (EI) m/z 329 ([M]+, 81Br), 327 
([M]+, 79Br), 255 ([M−SiMe3]+, 81Br), 253 ([M−SiMe3]+, 79Br), 228 ([M−CH2CH2SiMe3]+, 
81Br), 226 ([M−CH2CH2SiMe3]+, 79Br), 212 ([M−OCH2CH2SiMe3]+, 81Br), 210 
([M−OCH2CH2SiMe3]+, 79Br), 73 [SiMe3]+; Accurate Mass (ASAP) m/z found [M]+ 
327.0537; C13H2079BrN2OSi requires M, 327.0528. 
 
6-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}indazole (503) 
 
General procedure I was applied to 6-bromo-1H-indazole (499) (2.50 g, 12.7 mmol). 
Column eluent 5% EtOAc in hexanes. 503 (3.15 g, 76%) isolated as a pale orange oil. 
δH (600 MHz, CDCl3) 8.09 (1H, s, 3-H), 7.91 (1H, m, 7-H), 7.56 (1H, d, J = 8.9, 4-H), 7.18 
(1H, dd, J = 8.9, 1.6, 5-H), 5.70 (2H, s, NCH2O), 3.62 (2H, m, OCH2CH2), 0.94 (2H, m, 
CH2Si(CH3)3), −0.03 (9H, s, Si(CH3)3); δC (151 MHz, CDCl3) 149.6 (C-1a), 126.1 (C-5), 
123.3 (C-3), 122.1 (C-4), 120.9 (C-3a), 120.6 (C-6), 120.5 (C-7), 82.1 (NCH2O), 67.8 
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(OCH2CH2), 18.0 (CH2Si(CH3)3), −1.3 (Si(CH3)3); GC/MS (EI) m/z 329 ([M]+, 81Br), 327 
([M]+, 79Br), 255 ([M−SiMe3]+, 81Br), 253 ([M−SiMe3]+, 79Br), 228 ([M−CH2CH2SiMe3]+, 
81Br), 226 ([M−CH2CH2SiMe3]+, 79Br), 212 ([M−OCH2CH2SiMe3]+, 81Br), 210 
([M−OCH2CH2SiMe3]+, 79Br), 73 [SiMe3]+; Accurate Mass (ASAP) m/z found [M]+ 
327.0527; C13H2079BrN2OSi requires M, 327.0528. 
 
6-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}-3-[4’-(methoxycarbonyl)phenyl]-2H-
indazole (508) 
 
General Method L applied to 503 (200 mg, 0.61 mmol). The Suzuki-Miyaura step was 
run with methyl-4-iodobenzoate. Column eluent 0-10% EtOAc in hexanes. 508 (124 mg, 
44%) isolated as a white amorphous solid. 
δH (600 MHz, CDCl3) 8.22 (2H, d, J = 8.2, 3’,5’-H), 7.94 (1H, s, 7-H), 7.82 (2H, d, J = 8.2, 
2’, 6’-H), 7.54 (1H, d, J = 8.9, 4-H), 7.21 (1H, d, J = 8.9, 5-H), 5.67 (2H, s, NCH2O), 3.98 
(3H, s, CO2CH3), 3.85 (2H, t, J = 8.3, OCH2CH2), 0.96 (2H, t, J = 8.3, CH2Si(CH3)3), −0.01 
(9H, s, Si(CH3)3); δC (151 MHz, CDCl3) 166.6 (CO2CH3), 148.9 (C-1a), 136.4 (C-3), 133.4 
(C-1’), 130.6 (C-4’), 130.4 (C-3’, 5’), 129.8 (C-2’, 6’), 126.8 (C-5), 122.0 (C-4), 121.2 
(ArC), 120.6 (C-7), 120.1 (ArC), 79.6 (NCH2O), 68.0 (OCH2CH2), 52.5 (CO2CH3), 18.1 
(CH2Si(CH3)3), −1.2 (Si(CH3)3); νmax (ATR) 1717, 1608, 1461, 1436, 1273, 1243, 1185, 
1080, 996 cm−1; Accurate Mass (ASAP) m/z found [M+H]+ 461.0882; C21H2679BrN2O3Si 
requires M, 461.0896. 
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6-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}-3-pyridin-2’-yl-2H-indazole (509) 
 
General Method L was applied to 503 (280 mg, 0.85 mmol). The Suzuki-Miyaura step 
was run with 2-bromopyridine. Column eluent 15% EtOAc in hexanes. 509 (179 mg, 
52%) isolated as a pale yellow oil. 
δH (700 MHz, CDCl3) 8.80 (1H, d, J = 5.4, 6’-H), 7.95 (1H, s, 7-H), 7.87 (2H, m, 3’, 4’-H), 
7.79 (1H, d, J = 8.9, 4-H), 7.35 (1H, t, J = 5.4, 5’-H), 7.24 (1H, d, J = 8.9, 5-H), 6.08 (2H, 
s, NCH2O) 3.68 (2H, t, J = 8.3, OCH2CH2), 0.87 (2H, t, J = 8.3, CH2Si(CH3)3), −0.09 (9H, 
s, Si(CH3)3); δC (176 MHz, CDCl3) 150.4 (C-6’), 148.9 (C-2’), 148.8 (C-1a), 137.2 (ArC), 
135.1 (C-3), 127.1 (C-5), 124.4 (ArC), 123.1 (C-5’), 122.5 (C-4), 120.9 (ArC), 120.7 (C-
7), 120.3 (ArC), 80.3 (NCH2O), 67.6 (OCH2CH2), 18.0 (CH2Si(CH3)3), −1.3 (Si(CH3)3); 
νmax (ATR) 1584, 1470, 1244, 1092, 1014, 908 cm−1; Accurate Mass (ASAP) m/z found 
[M+H]+ 404.0789; C18H2379BrN3OSi requires M, 404.0794.  
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4-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}-3-[4’-(methoxycarbonyl)phenyl]-2H-
indazole (505) and 4-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}-6-[4’-
(methoxycarbonyl)phenyl]-2H-indazole (511)  
 
General Method L was applied to 501 (328 mg, 1.0 mmol). The Suzuki-Miyaura step was 
run with methyl-4-iodobenzoate. Column eluent 0-25% Et2O in hexanes. 505 and 511 
(226 mg, 49%) isolated as a 31:69 mixture of isomers (1H NMR). 
 
4-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}-6-[4’-(methoxycarbonyl)phenyl]-2H-
indazole (511) 
 
Borylation of 501 (310 mg, 0.95 mmol) was carried out with an aliquot of Stock Solution 
C at room temperature for 24 h. The reaction mixture was concentrated in vacuo and 
GC/MS analysis confirmed 69% conversion to 6-(Bpin) 513. The Suzuki-Miyaura cross-
coupling step was carried out as per General Method L for 3 h with methyl-4-
iodobenzoate. Column eluent 0-25% Et2O in hexanes. 511 (267 mg, 61%) isolated as 
an off white amorphous solid. 
δH (700 MHz, CDCl3) 8.16 (1H, s, 3-H), 8.13 (2H, m, 3’, 5’-H), 7.89, (1H, s, ArH), 7.71 
(2H, m, 2’, 6’-H), 7.57 (1H, d, J = 1.1, ArH), 5.74 (2H, s, NCH2O), 3.95 (3H, s, CO2CH3), 
3.67, (2H, t, J = 8.3, OCH2CH2), 0.97 (2H, t, J = 8.3, CH2Si(CH3)3), −0.01 (9H, s, 
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Si(CH3)3); δC (176 MHz, CDCl3) 167.0 (CO2CH3), 149.1 (C-1a), 144.9 (C-1’), 139.6 (C-6), 
130.4 (C-3’, 5’), 129.5 (C-4’), 127.4 (C-2’, 6’), 125.1 (ArC), 124.1 (C-3), 124.0 (ArC), 
115.7 (ArC), 114.2 (ArC), 82.3 (NCH2O), 68.0 (OCH2CH2), 52.3 (CO2CH3), 18.0 
(CH2Si(CH3)3), −1.3 (Si(CH3)3); νmax (ATR) 1723, 1610, 1555, 1436, 1369, 1285, 1250, 
1197, 1104, 1079, 1018, 930 cm−1; Accurate Mass (ASAP) m/z found [M+H]+ 461.0893; 
C21H2679BrN2O3Si requires M, 461.0896. 
 
2-{[2-(Trimethylsilyl)ethoxy]methyl}-6-[4’-(methoxycarbonyl)phenyl]-2H-indazole (514) 
 
511 (130 mg, 0.28 mmol), was dissolved in ethanol (10 mL) and ammonium formate (353 
mg, 5.6 mmol) was charged. The reaction vessel was evacuated and backfilled with 
nitrogen (x 3 cycles) before 10% Pd/C (15 mg, 0.014 mmol, 5 mol%) was slowly added 
under a positive pressure of nitrogen. The reaction was stirred at room temperature for 
2 h then filtered through a plug of celite and dry-loaded onto silica for purification by flash 
column chromatography (15% ethyl acetate in hexane) giving 514 as a viscous clear oil 
(94 mg, 88%) 
δH (700 MHz, CDCl3) 8.13 (3H, m, 3, 3’, 5’-H), 7.97 (1H, s, 7-H), 7.78 (1H, d, J = 8.7, 4-
H), 7.74 (2H, m, 2’, 6’-H), 7.40 (1H, dd, J = 8.7, 1.4, 5-H), 5.75 (2H, s, NCH2O), 3.95 (3H, 
s, CO2CH3), 3.66 (2H, t, J = 8.3, OCH2CH2), 0.96 (2H, t, J = 8.3, CH2Si(CH3)3), −0.02 
(9H, s, Si(CH3)3); δC (176 MHz, CDCl3) 167.2 (CO2CH3), 149.3 (C-1a), 146.2 (C-1’), 138.4 
(C-6), 130.3 (C-3’, 5’), 129.0 (C-4’), 127.4 (C-2’, 6’), 122.9 (C-3), 122.6 (C-5), 122.0 (C-
3a), 121.3 (C-4), 116.5 (C-7), 82.1 (NCH2O), 67.8 (OCH2CH2), 52.3 (CO2CH3), 18.0 
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(CH2Si(CH3)3), −1.3 (Si(CH3)3); νmax (ATR) 1720, 1607, 1435, 1281, 1108, 932 cm−1; 
Accurate Mass (ASAP) m/z found [M+H]+ 383.1787; C21H27N2O3Si requires M, 383.1791.  
 
2-{[2-(Trimethylsilyl)ethoxy]methyl}-4-(4’-methylphenyl)-6-[4’’-
(methoxycarbonyl)phenyl]-2H-indazole (518) 
 
General Method M was applied to 511 (115 mg, 0.25 mmol) with 4-tolylboronic acid 
(105). Column eluent 0-10% ethyl acetate in hexanes afforded 518 as a colourless oil 
(85 mg, 72%) 
δH (700 MHz, CDCl3) 8.27 (1H, s, 3-H), 8.14 (2H, d, J = 8.3, 3’’, 5’’-H), 7.93 (1H, s, 7-H), 
7.79 (2H, d, J = 8.3, 2’’, 6’’-H), 7.64 (2H, d, J = 8.0, 2’, 6’-H), 7.45 (1H, s, 5-H), 7.33 (2H, 
d, J = 8.0, 3’, 5’-H), 5.75 (2H, s, NCH2O), 3.95 (3H, s, CO2CH3), 3.67 (2H, t, J = 8.3, 
OCH2CH2), 2.45 (3H, s, PhCH3) 0.96 (2H, t, J = 8.3, CH2Si(CH3)3), −0.02 (9H, s, 
Si(CH3)3); δC (176 MHz, CDCl3) 167.2 (CO2CH3), 150.0 (C-1a), 146.3 (C-1’’), 138.9 (C-
6), 138.0 (C-4’), 137.3 (C-1’), 135.6 (C-4), 130.3 (C-3’’, 5’’), 129.8 (C-3’, 5’), 129.1 (C-
4’’), 128.1 (C-2’, 6’), 127.5 (C-2’’, 6’’), 123.2 (C-3), 121.6 (C-3a), 121.2 (C-5), 115.3 (C-
7), 82.2 (NCH2O), 67.8 (OCH2CH2), 52.3 (CO2CH3), 21.4 (PhCH3), 18.0 (CH2Si(CH3)3), 
−1.3 (Si(CH3)3); νmax (ATR) 1719, 1612, 1511, 1435, 1278, 1102, 912 cm−1; Accurate 
Mass (ASAP) m/z found [M+H]+ 473.2249; C28H33N2O3Si requires M, 473.2260. 
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2-{[2-(Trimethylsilyl)ethoxy]methyl}-3-pyridin-2’-yl-6-[4’’-(methoxycarbonyl)phenyl]-2H-
indazole (521) 
 
General Method M was applied to 509 (158 mg, 0.39 mmol) with 4-
(methoxycarbonyl)phenylboronic acid. Column eluent 0-20% EtOAc in hexanes. 521 
(137 mg, 76%) isolated as an off-white amorphous solid. 
δH (700 MHz, CDCl3) 8.82 (1H, d, J = 4.5, 6’-H), 8.14 (2H, d, J = 8.3, 3’’, 5’’-H), 8.02 (1H, 
s, 7-H), 7.99 (1H, d, J = 8.3, 4-H), 7.91 (2H, m, 3’, 4’-H), 7.77 (2H, d, J = 8.3, 2’’, 6’’-H), 
7.47 (1H, d, J = 8.3, 5-H), 7.35 (1H, ddd, J = 6.6, 4.5, 1.4, 5’-H), 6.16 (2H, s, NCH2O), 
3.95 (3H, s, CO2CH3), 3.71 (2H, t, J = 8.3, OCH2CH2), 0.88 (2H, t, J = 8.3, CH2Si(CH3)3), 
−0.09 (9H, s, Si(CH3)3); δC (176 MHz, CDCl3): 167.1 (CO2CH3), 150.4 (C-6’), 149.3 (C-
2’), 148.6 (C-1a), 146.1 (C-1’’), 138.7 (C-6), 137.1 (ArC), 134.6 (C-3), 130.3 (C-3’’, 5’’), 
129.1 (C-4’’), 127.4 (C-2’’, 6’’), 124.4 (ArC), 123.6 (C-5), 122.9 (C-5’), 121.6 (C-4), 121.4 
(C-3a), 116.7 (C-7), 80.4 (NCH2O), 67.5 (OCH2CH2), 52.3 (CO2CH3), 18.0 (CH2Si(CH3)3), 
−1.3 (Si(CH3)3); νmax (ATR) 1719, 1607, 1536, 1478, 1280, 1102 cm−1; Accurate Mass 
(ASAP) m/z found [M+H]+ 460.2046; C26H30N3O3Si requires M, 460.2056. 
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5-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}-7-pyridin-2’-yl-2H-indazole (535) 
 
General Method N applied to 502 (295 mg, 0.9 mmol). Borylation was carried out with 
Stock Solution C. The Suzuki-Miyaura step was run with 2-bromopyridine. Column eluent 
0-20% EtOAc in hexanes. 535 (259 mg, 71%) isolated as a colourless oil. 
δH (700 MHz, CDCl3) 8.80 (1H, d, J = 6.5, 3’-H), 8.74 (1H, d, J = 6.5, 6’-H), 8.36 (1H, s, 
6-H), 8.15 (1H, s, 3-H), 7.91 (1H, s, 4-H), 7.82 (1H, t, J = 6.5, 4’-H), 7.27 (1H, m, 5’-H), 
5.77 (2H, s, NCH2O), 3.70 (2H, t, J = 8.2, OCH2CH2), 0.97 (2H, t, J = 8.2, CH2Si(CH3)3), 
−0.02 (9H, s, Si(CH3)3); δC (176 MHz, CDCl3) 154.0 (C-2’), 149.7 (C-6’), 145.5 (C-1a), 
136.6 (C-4’), 130.3 (C-7), 129.8 (C-6), 125.0 (C-3’), 124.9 (C-3a), 123.5 (C-4), 122.9 (C-
5’), 122.5 (C-3), 116.4 (C-5), 82.1 (NCH2O), 67.9 (OCH2CH2), 18.0 (CH2Si(CH3)3), −1.3 
(Si(CH3)3); νmax (ATR) 1584, 1511, 1470, 1343, 1249, 1133, 1094, 1071 cm−1; Accurate 
Mass (ESI) m/z found [M+H]+ 404.0788; C18H23N3OSi79Br requires M, 404.0794. 
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2-{[2-(Trimethylsilyl)ethoxy]methyl}-7-pyridin-2’-yl-5-[4’’-(trifluoromethyl)phenyl]-2H-
indazole (537) 
 
General Method M was applied to 535 (120 mg, 0.30 mmol) with 4-
(trifluoromethyl)benzeneboronic acid. Column eluent 15% EtOAc in hexanes. 537 (126 
mg, 89%) isolated as a yellow amorphous solid. 
δH (600 MHz, CDCl3) 8.84 (1H, d, J = 8.0, 3’-H), 8.77 (1H, d, J = 4.4, 6’-H), 8.56 (1H, d, 
J = 1.4, 6-H), 8.29 (1H, s, 3-H), 7.97 (1H, d, J = 1.4, 3-H), 7.85 (3H, m, 4’, 2’’, 6’’-H), 7.71 
(2H, d, J = 8.1, 3’’, 5’’-H), 7.29 (1H, m, 5’-H), 5.82 (2H, s, NCH2O), 3.74 (2H, t, J = 8.3, 
OCH2CH2), 1.00 (2H, t, J = 8.3, CH2Si(CH3)3), 0.00 (9H, s, Si(CH3)3); δC (151 MHz, CDCl3) 
155.0 (C-2’), 149.6 (C-6’), 146.6 (C-1a), 145.1 (C-1’’), 136.8 (C-4’), 134.4 (C-5), 129.2 
(q, J = 33.2, C-4’’), 129.2 (C-7), 127.7 (C-2’’, 6’’), 126.7 (C-7), 125.8 (C-3’’, 5’’), 125.0 (C-
3’), 124.5 (q, J = 271.8, CF3), 124.3 (C-3a), 124.0 (C-3), 122.7 (C-5’), 120.0 (C-4), 82.1 
(NCH2O), 67.9 (OCH2CH2), 18.0 (CH2Si(CH3)3), −1.3 (Si(CH3)3); δF (328 MHz, CDCl3) 
−62.3 (s); νmax (ATR) 1616, 1586, 1435, 1325, 1251, 1165, 1112, 1070, 904 cm−1; 
Accurate Mass (ESI) m/z found [M+H]+ 470.1879; C25H27F3N3OSi requires M, 470.1876. 
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N-(4’-Methoxyphenyl)-1H-indazole (540)  
 
A dry sealed microwave vial containing indazole (402) (400 mg, 3.40 mmol), CuI (65 mg, 
0.34 mmol), K3PO4 (1.52 g, 7.10 mmol), 4-iodoanisole (950 mg, 4.10 mmol) and N,N-
dimethyl-1,2-ethanediamine (60 mg, 0.68 mmol) was degassed with 3 evacuation/argon 
backfill cycles. Toluene (17 mL) was charged and the reaction heated to 110 °C for 24 
h. The reaction mixture was cooled to room temperature, diluted with EtOAc (20 mL) and 
filtered through a silica plug. The liquors were dry loaded onto silica and the crude 
product purified by flash column chromatography (0-5% EtOAc in hexanes) to give 540 
(674 mg, 88%) as a colourless oil. 
δH (600 MHz, CDCl3) 8.18 (1H, s, 3-H), 7.80 (1H, d, J = 8.0, 4-H), 7.65 (1H, d, J = 8.0, 7-
H), 7.61 (2H, d, J = 8.8, 2’, 6’-H), 7.41 (1H, t, J = 8.0, 6-H), 7.21 (1H, t, J = 8.0, 5-H), 7.06 
(2H, d, J = 8.8, 3’, 5’-H), 3.88 (3H, s, OCH3); δC (151 MHz, CDCl3) 158.5 (C-4’), 139.1 
(C-1a), 134.9 (C-3), 133.5 (C-1’), 127.0 (C-6), 125.1 (C-3a), 124.6 (C-2’, 6’), 121.4 (ArC), 
121.3 (ArC), 114.7 (C-3’, 5’), 110.3 (C-7), 55.7 (OCH3); Accurate Mass (ESI) m/z found 
[M+H]+ 225.1028; C14H13N2O requires M, 225.1030. 
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3-Pyridin-2’-yl-N-(4’’-methoxyphenyl)-1H-indazole (541)  
 
General procedure J was applied to 540 (207 mg, 0.92 mmol). The Suzuki-Miyaura step 
was run with 2-bromopyridine. Column eluent 0-7% EtOAc in hexanes. 541 (114 mg, 
41%) isolated as a colourless oil. 
δH (600 MHz, CDCl3) 8.76 (2H, m, 4, 6’-H), 8.27 (1H, d, J = 7.7, 3’-H), 7.78 (1H, t, J = 
7.7, 4’-H), 7.69 (2H, d, J = 8.6, 2’’, 6’’-H), 7.65 (1H, d, J = 7.8, 7-H), 7.44 (1H, t, J = 7.8, 
6-H), 7.33 (1H, t, J = 7.8, 5-H), 7.26 (1H, m, 5’-H), 7.08 (2H, d, J = 8.6, 3’’, 5’’-H), 3.89 
(3H, s, OCH3); δC (151 MHz, CDCl3) 158.8 (C-4’’), 153.6 (C-2’), 149.5 (ArC), 144.5 (C-
3), 140.9 (C-1a), 136.4 (C-4’), 133.3 (C-1’’), 127.2 (C-6), 125.1 (C-2’’, 6’’), 124.1 (ArC), 
123.4 (C-3a), 122.5 (C-5’), 122.4 (C-5), 121.3 (C-3’), 114.8 (C-3’’, 5’’), 110.3 (C-7), 55.8 
(OCH3); νmax (ATR) 1590, 1519, 1504, 1458, 1442, 1248, 1180, 1115, 1018, 905 cm−1; 
Accurate Mass (ESI) m/z found [M+H]+ 302.1293; C19H16N3O requires M, 302.1285. 
 
Pyrazolo[1,5-a]pyridine (543) 
 
A mixture of ethyl pyrazolo[1,5-a]pyridine-3-carboxylate (542) (250 mg, 1.32 mmol) in 
sulphuric acid (50% v/v in water)(5 mL) was heated to reflux for 2 h. The reaction was 
cooled to room temperature and NaOH (50% w/w solution) was added until basic whilst 
maintaining the temperature below 10 °C. The resulting suspension was stirred until 
everything dissolved. The aqueous mixture was extracted with Et2O (2 x 20 mL) and the 
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combined organics were washed with water (15 mL) then brine (15 mL) before being 
dried over magnesium sulphate, filtered and concentrated in vacuo to yield the crude 
product as an orange oil. The crude was plugged through silica and washed copiously 
with Et2O. The liquors were concentrated in vacuo to give 543 (110 mg, 71%) as a yellow 
oil. 
δH (700 MHz, CDCl3) 8.47 (1H, dd, J = 6.8, 1.1, 7-H), 7.94 (1H, d, J = 1.8, 2-H), 7.52 (1H, 
dd, J = 8.9, 1.1, 4-H), 7.08 (1H, ddd, J = 8.9, 6.8, 1.1, 5-H), 6.72 (1H, ddd, J = 6.8, 6.8, 
1.1, 6-H), 6.50 (1H, d, J = 1.8, 3-H); δC (176 MHz, CDCl3) 141.9 (C-2), 140.2 (C-3a), 
128.7 (C-7), 123.3 (C-5), 118.2 (C-4), 117.1 (C-6), 96.8 (C-3); νmax (ATR) 1634, 1516, 
1434, 1372, 1338, 1252, 1226 cm−1; Accurate Mass (ESI) m/z found [M+H]+ 119.0589; 
C7H7N2 requires M, 119.0609.  
 
3-(Bpin)-Pyrazolo[1,5-a]pyridine (544) 
 
General Method B was applied to pyrazolo[1,5-a]pyridine (543) (95 mg, 0.81 mmol). The 
reaction was stirred at room temperature for 16 h at which point the observed precipitate 
was filtered by vacuum filtration. The filtered solid was recrystallised from hot MTBE (5 
mL) and washed with cold MTBE (3 x 3 mL) to give 544 (48 mg, 24%) as a deep red 
amorphous solid. 
δH (700 MHz, CDCl3) 8.51 (1H, d, J = 7.5 Hz, 7-H), 8.23 (1H, s, 2-H), 7.96 (1H, d, J = 7.5, 
4-H), 7.21 (1H, t, J = 7.5, 5-H), 6.81 (1H, t, J = 7.5, 6-H), 1.36 (12H, s, pinCH3); 148.9 
(C-2), 145.7 (C-3a), 128.9 (C-7), 124.9 (C-5), 120.2 (C-4), 112.6 (C-6), 83.2 (C(CH3)2), 
25.1 (pinCH3); δB (128 MHz, CDCl3) 29.7 (s(br)); νmax (ATR) 1517, 1473, 1456, 1373, 
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1338, 1146, 983 cm−1; Accurate Mass (ASAP) m/z found [M]+ 243.1424; C13H1710BN2O2 
requires M, 243.1419. 
 
3-(3’-Fluorophenyl)pyrazolo[1,5-a]pyridine (545) 
 
General Method B was applied to pyrazolo[1,5-a]pyridine (543) (110 mg, 0.93 mmol). 
The reaction was stirred for 16 h at room temperature before being concentrated in 
vacuo. A tandem Suzuki-Miyaura cross-coupling reaction was then carried out as per 
General Method E; Pd(Amphos)Cl2 (40 mg, 0.056 mmol), Na2CO3(aq) (2M, 197 mg, 1.86 
mmol), 3-iodo-fluorobenzene (248, 1.12 mmol) in DME (3 mL) at 80 °C for 3 h. 
Purification by reverse phase column chromatography. 545 (61 mg, 31%) isolated as a 
pale yellow oil. 
δH (600 MHz, CDCl3) 8.38 (1H, d, J = 7.7, 7-H), 8.03 (1H, s, 2-H), 7.69 (1H, d, J = 7.7, 4-
H), 7.35 (2H, m, 2’, 6’-H), 7.24 (1H, m, 4’-H), 7.16 (1H, t, J = 7.7, 5-H), 6.95 (1H, m, 5’-
H), 6.77 (1H, t, J = 7.7, 6-H); δC (151 MHz, CDCl3) 163.4 (d, J = 246.0, C-3’), 140.6 (C-
2), 137.1 (C-3a), 135.5 (d, J = 8.4, C-3), 130.6 (d, J = 8.7, ArC), 129.3 (C-7), 124.5 (C-
5), 122.7 (d, J = 2.7, ArC), 117.4 (C-4), 113.7 (d, J = 22.0, C-4’), 113.0 (d, J = 21.1, C-
5’), 112.3 (C-6), 111.9 (d, J = 2.3, C-1’); δF (376 MHz, CDCl3): −112.8 (m); νmax (ATR) 
1634, 1613, 1584, 1546, 1531, 1453, 1366, 1260, 1217, 1178, 1017, 904 cm−1; Accurate 
Mass (ESI) m/z found [M+H]+ 213.0814; C13H10N2F requires M, 213.0828. 
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3-(3’-Methoxyphenyl)pyrazolo[1,2-a]pyridine (552) 
 
General Method E applied to pyrazolo[1,2-a]pyridine (546) (118 mg, 1 mmol); Borylation 
with Stock Solution B for 24 h at room temperature gave ca. 85% conversion (1H NMR) 
to the 3-(Bpin) product (547). The Suzuki-Miyaura step was carried out for 2 h with 
PdXPhos G2 (39 mg, 0.05 mmol), K3PO4 (425 mg, 2 mmol), 3-iodoanisole (257 mg, 1.1 
mmol) in DMAc:H2O (10:1) (2.5 mL) at 50 °C. Column eluent 0-50% EtOAc in hexanes. 
552 (92 mg, 41%) isolated as a grey amorphous solid. 
δH (700 MHz, CDCl3) 8.37 (1H, d, J = 7.6, 4-H), 7.70 (1H, s, 2-H), 7.67 (1H, d, J = 7.6, 7-
H), 7.43 (1H, t, J = 7.9, 5’-H), 7.20 (1H, m, 6-H), 7.15 (1H, d, J = 7.9, 6’-H), 7.09 (1H, m, 
2’-H), 6.96 (1H, dd, J = 7.9, 1.9, 4’-H), 6.81 (1H, t, J = 7.6, 5-H), 3.87 (3H, s, OCH3); δC 
(176 MHz, CDCl3) 160.2 (C-3’), 146.2 (C-1a), 132.6 (C-2), 130.6 (C-1’), 130.2 (C-5’), 
125.6 (C-3), 124.2 (C-6), 123.5 (C-4), 120.2 (C-6’), 118.3 (C-7), 113.7 (C-2’), 113.5 (C-
4’), 112.5 (C-5), 55.4 (OCH3); νmax (ATR) 1602, 1580, 1501, 1299, 1283, 1237, 1165, 
1047 cm−1; Accurate Mass (ESI) m/z found [M+H]+ 225.1019; C14H13N2O requires M, 
225.1030. 
 
4-Aza-1H-indazole (555)195 
 
General Method K was applied to 3-fluoropyridine-2-carboxaldehyde (553) (1.03 g, 8.24 
mmol) to give crude 555 (522 mg, 53%) as a yellow amorphous solid. 
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δH (700 MHz, CDCl3) 8.62 (1H, dd, J = 4.3, 1.1 Hz, 5-H), 8.36 (1H, d, J = 1.1 Hz, 3-H), 
7.88, (1H, ddd, J = 8.5, 1.1, 1.1, 7-H), 7.31 (1H, dd, J = 8.5, 4.3, 6-H); δC (176 MHz, 
CDCl3) 145.8 (C-5), 141.1 (C-3), 135.1 (C-3a), 133.1 (C-1a), 121.3 (C-6), 118.5 (C-7); 
νmax (ATR) 3141, 1577, 1507, 1409, 1387, 1344, 1310, 1185, 1127, 935 cm−1. 
 
7-Aza-1H-indazole (556)196  
 
General Method K was applied to 2-fluoropyridine-3-carboxaldehyde (554) (1.12 g, 8.96 
mmol) to give crude 556 (971 mg, 91%) as an orange amorphous solid.  
δH (700 MHz, CDCl3) 8.68 (1H, dd, J = 4.6, 1.5, 6-H), 8.18 (1H, dd, J = 8.0, 1.5, 4-H), 
8.14, (1H, s, 3-H), 7.21 (1H, dd, J = 8.0, 4.6, 5-H); δC (176 MHz, CDCl3) 151.6 (C-1a), 
148.7 (C-6), 134.1 (C-3), 130.9 (C-4), 117.2 (C-5), 115.6 (C-3a); νmax (ATR) 3147, 1606, 
1590, 1430, 1315, 1291, 938 cm−1. 
 
4-Aza-1-(tert-butoxycarbonyl)-1H-indazole (557)  
 
General Method G was applied to 555 (500 mg, 4.2 mmol). Column eluent 0-40% EtOAc 
in hexanes. 557 (832 g, 90%) isolated as a yellow oil. 
δH (600 MHz, CDCl3) 8.67 (1H, d, J = 4.5, 5-H), 8.46 (1H, d, J = 8.5, 7-H), 8.40 (1H, s, 3-
H), 7.44 (1H, dd, J = 8.5, 4.5, 6-H), 1.72 (9H, s, C(CH3)3); δC (151 MHz, CDCl3) 148.8 
(CO2tBu) 147.8 (C-5), 143.7 (C-3a), 140.3 (C-3), 133.3 (C-1a), 123.0 (C-6), 122.6 (C-7) 
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85.9 (C(CH3)3), 28.3 (C(CH3)3); νmax (ATR) 1739, 1411, 1368, 1340, 1285, 1140, 1023, 
912 cm−1; Accurate Mass (ESI) m/z found [M+H]+ 220.1113; C11H14N3O2 requires M, 
220.1086. 
 
7-Aza-1-(tert-butoxycarbonyl)-1H-indazole (558)  
 
General Method G was applied to 556 (920 mg, 7.7 mmol). Column eluent 30% EtOAc 
in hexanes. 558 (1.53 g, 91%) isolated as a yellow oil. 
δH (700 MHz, CDCl3) 8.76 (1H, dd, J = 4.6, 1.6, 6-H), 8.17 (1H, s, 3-H), 8.09 (1H, dd, J = 
7.9, 1.6, 4-H), 7.30 (1H, dd, J = 7.9, 4.6, 5-H), 1.72 (9H, s, C(CH3)3); δC (176 MHz, CDCl3) 
152.0 (C-1a), 150.8 (C-6), 148.0 (CO2C(CH3)3) 137.5 (C-3), 130.4 (C-4), 119.4 (C-5), 
117.9 (C-3a) 85.5 (C(CH3)3), 28.2 (C(CH3)3); νmax (ATR) 1751, 1601, 1579, 1457, 1394, 
1369, 1256, 1157, 1145, 1057 cm−1; Accurate Mass (ESI) m/z found [M+H]+ 220.1112; 
C11H14N3O2 requires M, 220.1086. 
 
6-Aza-1-acetyl-1H-indazole (560) 
 
Pyridine (3.9 mL, 3.86 g, 48.8 mmol) then Ac2O (2.8 mL, 2.99 g, 29.3 mmol) were added 
dropwise to a solution of 3-amino-4-methylpyridine (2.63 g, 24.4 mmol) in DCM (20 mL). 
The reaction was stirred at room temperature for 16 h then concentrated in vacuo. The 
crude solid was taken into EtOAc (20 mL) then washed with sat. NaHCO3 solution (10 
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mL) then brine (10 mL). The organic layer was then dried over MgSO4, filtered through 
celite and concentrated in vacuo to yield the crude product. Tert-butylnitrite (2.8 mL, 2.45 
g, 23.8 mmol), Ac2O (4.2 mL, 4.6 g, 44.7 mmol) and KOAc (1.76 g, 17.9 mmol) were 
added sequentially to a suspension of the crude solid (2.23 g, 14.9 mmol) in toluene (15 
mL). The mixture was heated at 80 °C for 16 h, before being cooled to room temperature 
and diluted with EtOAc (20 mL). The organic mixture was washed sequentially with sat. 
NaHCO3 solution (15 mL), water (15 mL) and brine (15 mL) before being dried over 
MgSO4, filtered and concentrated in vacuo. The crude product was purified by flash 
column chromatography (10-60% EtOAc in hexanes) to give 560 (841 mg, 35%) as a 
white amorphous solid. 
δH (700 MHz, CDCl3) 9.83 (1H, s, 7-H), 8.58 (1H, d, J = 5.5, 5-H), 8.20 (1H, s, 3-H), 7.67 
(1H, dd, J = 5.5, 1.2, 4-H), 2.82 (3H, s, COCH3); δC (176 MHz, CDCl3) 170.6 (COCH3), 
143.3 (C-5), 139.0 (C-7), 138.8 (C-3), 135.6 (C-1a), 130.9 (C-3a), 114.8 (C-4), 22.8 
(COCH3); GC/MS (EI) m/z 161 [M]+, 119 [M−COCH3]+, 92; Accurate Mass (ASAP) found 
[M]+ 161.0587; C8H7N3O requires M, 161.0589. 
 
4-Aza-6-[4’-(methoxycarbonyl)phenyl]-1-(tert-butoxycarbonyl)-1H-indazole (565) 
 
General Method N applied to 557 (204 mg, 0.93 mmol). Borylation was carried out using 
Stock Solution B to give full conversion (1H NMR) to 3,6-bis(Bpin) (562) product. The 
Suzuki-Miyaura step was run with methyl-4-iodobenzoate. Column eluent 0-35% EtOAc 
in hexanes. 565 (151 mg, 46%) isolated as an off white amorphous solid. 
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δH (700 MHz, CDCl3) 8.91 (1H, d, J = 1.8, 5-H), 8.58 (1H, d, J = 1.8, 7-H), 8.16 (2H, m, 
3’, 5’-H), 7.71 (2H, m, 2’, 6’-H), 7.15 (1H, s, 3-H), 3.96 (3H, s, CO2CH3), 1.56 (9H, s, 
C(CH3)3); δC (176 MHz, CDCl3) 166.6 (CO2CH3), 151.9 (ArC), 143.4 (C-7), 140.4 (C-1’), 
139.9 (ArC), 139.8 (ArC), 131.1 (C-4’), 130.6 (C-3’, 5’), 127.7 (C-2’, 6’), 124.6 (C-5), 
120.5 (C-6), 115.1 (C-3), 83.2 (C(CH3)3), 52.5 (CO2CH3), 28.3 (C(CH3)3); νmax (ATR) 
1725, 1562, 1505, 1444, 1369, 1280, 1238, 1151, 1113 cm−1; Accurate Mass (ESI) found 
[M+H]+ 354.1447; C19H20N3O4 requires M, 354.1454. 
 
Borylation of 7-aza-1-(tert-butoxycarbonyl)-1H-indazole (558) 
 
General Method B was applied to 558 (354 mg, 1.62 mmol) with additional B2pin2 (82 
mg, 0.32 mmol) using Et2O as solvent. The reaction was stirred at room temperature for 
5 h giving an 88% conversion (1H NMR) to 566 and 567 in a 57:43 ratio.  
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Tandem ‘one-pot’ C-H Borylation/Oxidative Heck Couplings 
Methyl 5-[(1E)-3’-tert-butoxy-3’-oxoprop-1’-en-1’-yl]-2-nicotinate (578) and Methyl 5-
[(1Z)-3’-tert-butoxy-3’-oxoprop-1’-en-1’-yl]-2-methoxynicotinate (579) 
 
General procedure O was applied to methyl-2-methoxynicotinate (304) (122 mg, 0.73 
mmol). Borylation was carried out with Stock Solution A over 24 h to give full conversion 
to 306:307 in a 93:7 ratio. The oxidative Heck step was carried out at room temperature 
for 16 h with Na2CO3 and tert-butylacrylate. Column eluent 0-10% EtOAc in hexanes. 
578:579 (83 mg, 39%) isolated as a 5:1 mixture of isomers. 
578: Data given below 
579: δH (700 MHz, CDCl3) 8.12 (1H, d, J = 3.0, 6-H), 7.90 (1H, d, J = 3.0, 4-H), 7.59 (1H, 
d, J = 12.2, 1’-H), 5.39 (1H, d, J = 12.2, 2’-H), 4.03 (3H, s, OCH3), 3.90 (3H, s, CO2CH3), 
1.47 (9H, s, C(CH3)3); δC (176 MHz, CDCl3) 166.1 (CO2tBu), 164.6 (CO2CH3), 159.7 (C-
2), 158.6 (C-1’), 146.5 (ArC), 141.5 (C-6), 132.0 (C-4), 114.3 (ArC), 104.5 (C-2’), 80.7 
(C(CH3)3), 54.7 (OCH3), 52.7 (CO2CH3), 28.4 (C(CH3)3). 
 
Methyl 5-[(1E)-3’-tert-butoxy-3’-oxoprop-1’-en-1’-yl]-2-methoxynicotinate(578) 
 
General procedure O was applied to methyl-2-methoxynicotinate (304) (105 mg, 0.63 
mmol). Borylation was carried out with Stock Solution A over 24 h to give full conversion 
to 306:307 in a 93:7 ratio. The oxidative Heck step was carried out at 50 °C for 6 h with 
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Cs2CO3 and tert-butyl acrylate. Column eluent 0-10% EtOAc in hexanes gave 578 (140 
mg, 76%) as a colourless oil. 
δH (700 MHz, CDCl3) 8.38 (1H, d, J = 2.4, 6-H), 8.31 (1H, d, J = 2.4, 4-H), 7.52 (1H, d, J 
= 16.0, 1’-H), 6.34 (1H, d, J = 16.0, 2’-H), 4.06 (3H, s, OCH3), 3.90 (3H, s, CO2CH3), 1.52 
(9H, s, C(CH3)3); δC (176 MHz, CDCl3) 165.9 (CO2tBu), 165.0 (CO2CH3), 163.1 (C-2), 
151.0 (C-6), 139.2 (C-4), 138.8 (C-1’), 124.0 (C-5), 120.7 (C-2’), 114.3 (C-3), 80.9 
(C(CH3)3), 54.7 (OCH3), 52.6 (CO2CH3), 28.3 (C(CH3)3); νmax (ATR) 1735, 1706, 1478, 
1399, 1328, 1278, 1251, 1207, 1149, 1086, 907 cm−1; Accurate Mass (ESI) found [M+H]+ 
294.1346; C15H20NO5 requires M, 294.1341. 
 
3-(Bpin)-Anisole (206) 
 
Anisole-3-boronic acid (1 g, 6.6 mmol), pinacol (780 mg, 6.6 mmol) and MgSO4 (3.97 g, 
33 mmol) were stirred in Et2O at room temperature for 16 h under an argon atmosphere. 
The reaction mixture was filtered through a pad of celite before being dry loaded onto 
silica and purified by flash column chromatography (2% Et2O in hexanes) to give 206 
(1.09 g, 74%) as a colourless oil. 
δH (700 MHz, CDCl3) 7.41 (1H, d, J = 7.1, 4-H), 7.34 (1H, s, 2-H), 7.30 (1H, t, J = 7.1, 5-
H), 7.02 (1H, d, J = 7.1, 6-H), 3.84 (3H, s, OCH3), 1.35 (12H, s, pinCH3); δC (176 MHz, 
CDCl3) 159.2 (C-1), 129.1 (C-5), 127.3 (C-4), 118.4 (C-2), 118.0 (C-6), 84.0 (C(CH3)2), 
55.4 (OCH3), 25.0 (pinCH3); δB (128 MHz, CDCl3) 30.9 (s(br)); νmax (ATR) 1421, 1352, 
1312, 1240, 1226, 1143, 1045, 964 cm−1; Accurate Mass (ASAP) m/z found [M+H]+ 
234.1523; C13H2010BO3 requires M, 234.1542. 
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Oxidative Heck screening experiments using 206  
 
On a 1 mmol scale 206 (234 mg, 1 mmol) was reacted with tert-butyl acrylate (133) (256 
mg, 2 mmol) in DMAc (3 mL), catalysed by Pd(OAc)2 (22 mg, 0.1 mmol) in the presence 
of base (2 mmol), under oxidative conditions. The reactions were heated at 50 °C for 6 
h then dry loaded onto silica and purified by flash column chromatography (0-5% Et2O 
in hexanes). Product 582 was obtained as a colourless oil.  
 
3-[(1E)-3’-tert-Butoxy-3’-oxoprop-1’-en’1’-yl]anisole (582) 
 
δH (700 MHz, CDCl3) 7.55 (1H, d, J = 16.0, 1’-H), 7.28 (1H, t, J = 7.9, 5-H), 7.10 (1H, d, 
J = 7.9, 4-H), 7.03 (1H, s, 2-H), 6.91 (1H, dd, J = 7.9, 2.0, 6-H), 6.35 (1H, d, J = 16.0, 2’-
H), 3.83 (3H, s, OCH3), 1.54 (9H, s, C(CH3)3); δC (176 MHz, CDCl3) 166.4 (CO2tBu), 
160.0 (C-1), 143.6 (C-1’), 136.2 (C-3), 129.9 (C-5), 120.8 (C-4), 120.6 (C-2’), 116.0 (C-
6), 112.9 (C-2), 80.7 (C(CH3)3), 55.4 (OCH3), 28.4 (C(CH3)3); νmax (ATR) 1703, 1637, 
1368, 1294, 1250, 1147, 1042, 980 cm−1; Accurate Mass (ESI) found [M+H]+ 235.1341; 
C14H19O3 requires M, 235.1334. 
 
 
 
 
256 
 
Methyl 2-methoxy-5-[(1E)-2’-phenylethenyl]nicotinate (583) 
 
General procedure O was applied to methyl-2-methoxynicotinate (304) (50 mg, 0.30 
mmol). Borylation was carried out with Stock Solution A over 24 h to give full conversion 
to 306:307 in a 93:7 ratio. The oxidative Heck step was carried out at 50 °C for 6 h with 
Cs2CO3 and styrene. Column eluent 0-5% EtOAc in hexanes. 583 (56 mg, 70%) isolated 
as a colourless oil. 
δH (700 MHz, CDCl3) 8.37 (1H, d, J = 2.5, 6-H), 8.36 (1H, d, J = 2.5, 4-H), 7.50 (2H, d, J 
= 7.5, 2’’, 6’’-H), 7.37 (2H, t, J = 7.5, 3’’, 5’’-H), 7.28 (1H, t, J = 7.5, 4’’-H), 7.03 (2H, m, 
1’, 2’-H), 4.07 (3H, s, OCH3), 3.94 (3H, s, CO2CH3); δC (176 MHz, CDCl3) 165.6 
(CO2CH3), 161.8 (C-2), 149.3 (C-6), 138.1 (C-4), 136.9 (C-1’’), 129.4 (ArC), 128.9 (C-3’’, 
5’’), 128.1 (C-4’’), 126.6 (C-5), 126.6 (C-2’’, 6’’), 123.7 (ArC), 114.0 (C-3), 54.5 (OCH3), 
52.5 (CO2CH3); νmax (ATR) 1733, 1477, 1400, 1309, 1286, 1240, 1087, 1012, 960 cm−1; 
Accurate Mass (ESI) found [M+H]+ 270.1133; C16H16NO3 requires M, 270.1130. 
 
Methyl (2E)-3-(5’,6’-dichloropyridin-3’-yl)-prop-2-enoate (585) 
 
2,3-Dichloropyridine (316) (148 mg, 1 mmol) was borylated as per General Procedure A 
using a digylme Stock Solution B. The reaction was heated at 80 °C for 2 h at which point 
GC/MS confirmed full conversion to 5-(Bpin) product 317. To the reaction mixture were 
added Pd(OAc)2 (22 mg, 0.10 mmol), cesium fluoride (304 mg, 2 mmol), methyl acrylate 
(172 mg, 2 mmol). The oxidative Heck step was carried out at 50 °C for 6 h. Reaction 
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worked up as per General Method O. Flash column chromatography (column eluent 0-
10% Et2O in hexanes) gave 585 (155 mg, 67%) as a white amorphous solid. 
δH (600 MHz, CDCl3) 8.41 (1H, s, 2’-H), 7.91 (1H, s, 4’-H), 7.60 (1H, d, J = 16.1, 3-H), 
6.50 (1H, d, J = 16.1, 2-H), 3.83 (3H, s, CO2CH3); δC (151 MHz, CDCl3) 166.3 (C-1), 
150.4 (C-6’), 146.8 (C-2’), 138.4 (C-3), 136.5 (C-4’), 131.2 (C-5’), 130.7 (C-3’), 122.0 (C-
2), 52.3 (CO2CH3); νmax (ATR) 1704, 1608, 1456, 1402, 1255, 1184 cm−1; Accurate Mass 
(ESI) found [M+H]+ 231.9937; C9H8NO235Cl2 requires M, 231.9932. 
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7 Appendix 
Borylation of 2-methoxypyridine (274) (400 MHz, CDCl3) 
 
 
 
Borylation of 2-methoxypyridine (274) under boron-limiting conditions (400 MHz, CDCl3) 
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6.66.76.86.97.07.17.27.37.47.57.67.77.87.98.08.18.28.38.48.58.68.7
f1 (ppm)
1
.1
7
1
.0
0
0
.4
8
0
.5
4
0
.9
7
0
.2
0
1
.4
6
0
.1
8
287
6-H
274 + 285     
6-H
287
4-H
274
4-H 285
5-H
285
3-H
274
5-H
274 + 287 
3-H
  267 
Borylation of 2-chloropyridine (275) (400 MHz, CDCl3) 
 
 
 
Borylation of 2-chloropyridine (275) under boron-limiting conditions (400 MHz, CDCl3) 
 
 
 
  
7.17.27.37.47.57.67.77.87.98.08.18.28.38.48.58.68.78.8
f1 (ppm)
0
.8
9
1
.0
0
0
.8
2
1
.2
1
0
.9
5
1
.3
1
0
.2
5
0
.9
1
0
.7
7
0
.2
0
292
6-H
291
6-H
289
6-H
292
4-H
290
5-H
291
4-H
290
3-H
289
3-H
289
5-H
291
3-H
7.07.17.27.37.47.57.67.77.87.98.08.18.28.38.48.58.68.78.8
f1 (ppm)
1
.1
4
1
.4
8
1
.0
0
2
.0
4
0
.3
4
2
.1
0
0
.3
2
291
6-H
 275 + 289
      6-H
291
4-H
275
4-H
289
3-H
289
5-H
275 + 291
    3-H
275
5-H
  268 
Borylation of 2-(trifluoromethyl)pyridine (276) (400 MHz, CDCl3) 
 
 
 
Borylation of 2-(trifluoromethyl)pyridine (276) under boron-limiting conditions (400 MHz, 
CDCl3) 
 
 
  
7.607.657.707.757.807.857.907.958.008.058.108.158.208.258.308.358.408.458.508.558.608.658.708.758.808.858.908.959.009.05
f1 (ppm)
0
.9
0
0
.6
0
1
.3
3
1
.0
0
0
.9
2
0
.5
5
0
.8
6
295
6-H
293
6-H
294
5-H
295
4-H
293 + 294
     3-H
293
5-H
295
3-H
7.47.57.67.77.87.98.08.18.28.38.48.58.68.78.88.99.09.1
f1 (ppm)
0
.2
4
0
.6
9
0
.7
9
0
.2
5
0
.7
9
0
.4
2
1
.0
0
0
.3
9
295
6-H
276 + 293
     6-H
295
4-H
293
3-H
276
4-H
293
5-H
276 + 295
     3-H
276
5-H
  269 
Borylation of 2-fluoropyridine (277) (400 MHz, CDCl3) 
 
  
 
Borylation of 2-fluoropyridine (277) under boron-limiting conditions (400 MHz, CDCl3) 
 
 
  
6.86.97.07.17.27.37.47.57.67.77.87.98.08.18.28.38.48.58.68.78.8
f1 (ppm)
0
.2
4
0
.2
8
0
.9
2
0
.3
3
1
.0
0
0
.3
3
0
.4
1
1
.0
2
0
.1
5
0
.4
2
0
.2
2
0
.4
2
300
6-H 299
6-H
300
4-H 301
6-H
297
6-H
298
5-H
297
5-H 298
3-H
297
3-H
301
5-H
299
3-H
299 + 301
     4-H
6.86.97.07.17.27.37.47.57.67.77.87.98.08.18.28.38.48.58.68.7
f1 (ppm)
2
.5
7
0
.1
5
2
.2
5
5
.3
8
0
.3
1
4
.6
3
1
.0
0
0
.2
0
3
.0
3
5
.5
0
1
.3
8
0
.3
9
1
.6
8
0
.4
0
300
6-H
299
6-H
300
4-H
301
6-H
277 + 297
     6-H
298
5-H
277
4-H
297
5-H
297
3-H
299 + 301
     4-H
277 + 299
    3-H
277 + 301
      5-H
298
3-H
  270 
Methyl-2-methoxynicotinate (304) 
 
 
 
  
  271 
Methyl-2-fluoronicotinate (305) 
 
 
 
 
  272 
 
  
  273 
Methyl-2-chloro-5-(Bpin)nicotinate (311) 
 
 
 
 
  274 
 
  
  275 
2,3-Dichloro-5-(Bpin)-pyridine (317) 
 
 
 
 
  276 
 
  
  277 
Methyl-2-methoxy-5-(4’-methoxyphenyl)nicotinate (319) 
 
 
 
  
  278 
Methyl-2-fluoro-5-(4’-methoxyphenyl)nicotinate (320) 
 
 
 
  
  279 
Methyl-2-(trifluoromethyl)-5-(4’-methoxyphenyl)nicotinate (321) 
 
 
 
 
  280 
 
  
  281 
Borylation of methyl-2-methoxynicotinate (304) with HBpin (400 MHz, CDCl3) 
 
 
 
Borylation of methyl-2-chloronicotinate (310) with HBpin (400 MHz, CDCl3) 
 
 
  
6.86.97.07.17.27.37.47.57.67.77.87.98.08.18.28.38.48.58.68.7
f1 (ppm)
1
.0
0
0
.4
2
0
.4
2
0
.9
7
0
.9
5
0
.4
9
0
.4
9
306
6-H
306
4-H
304
6-H
304
4-H 307
4-H
307
5-H
304
5-H
7.37.47.57.67.77.87.98.08.18.28.38.48.58.68.78.88.9
f1 (ppm)
1
.0
0
0
.0
3
0
.0
4
0
.9
7
0
.1
3
0
.9
4
0
.1
3
311
6-H
310
6-H
311
4-H
310
4-H
312
4-H
312
5-H
310
5-H
  282 
Methyl-2-methoxyisonicotinate (325) 
 
 
 
  
  283 
Methyl-2-(trifluoromethyl)isonicotinate (326) 
 
 
 
 
  284 
 
  
  285 
Methyl-2-fluoroisonicotinate (327) 
 
 
 
 
  286 
 
  
  287 
Methyl-2-fluoro-6-(Bpin)isonicotinate (339) 
 
 
 
  288 
2-Chloro-4-(trifluoromethyl)-6-(3’-methoxyphenyl)pyridine (341) 
 
 
 
 
  289 
 
  
  290 
Methyl-2-methoxy-6-(3’-methoxyphenyl)isonicotinate (342) 
 
 
 
  
  291 
Methyl-2-(trifluoromethyl)-6-(4’-methoxyphenyl)isonicotinate (343) 
 
 
 
 
  292 
 
  
  293 
Methyl-2-fluoro-6-(4’-(methoxycarbonyl)phenyl)isonicotinate (344) 
 
 
 
 
  294 
 
  
  295 
Methyl-6-fluoronicotinate (346) 
 
 
 
  
  296 
Borylation of 2,5-dichloropyridine (347) (400 MHz, CDCl3) 
 
 
 
Borylation of 2,5-lutidine (350) (400 MHz, CDCl3) 
 
 
  
7.207.257.307.357.407.457.507.557.607.657.707.757.807.857.907.958.008.058.108.158.208.258.308.358.40
f1 (ppm)
2
.3
2
1
0
.6
7
1
.0
0
2
.0
5
1
3
.3
0
   347 + 348 + 349
              6-H
348
4-H 347
4-H
349
3-H
347
3-H
6.906.957.007.057.107.157.207.257.307.357.407.457.507.557.607.657.707.757.807.857.907.958.008.058.108.158.208.258.30
f1 (ppm)
1
.0
0
1
.0
0
0
.1
0
0
.9
6
350 + 352
6-H
350
4-H
350
3-H
352
3-H
  297 
Borylation of 2,5-difluoropyridine (356) (400 MHz, CDCl3) 
 
 
  
7.107.157.207.257.307.357.407.457.507.557.607.657.707.757.807.857.907.958.008.058.108.158.20
f1 (ppm)
1
.0
0
0
.0
4
0
.3
5
1
.0
3
0
.2
6
357
6-H
358
6-H
   357 + 361
        4-H
362
3-H
358
3-H
  298 
Methyl-6-fluoro-5-(Bpin)nicotinate (359) 
 
 
 
 
  299 
 
 
 
  
  300 
Methyl-6-chloro-5-(3’-methoxyphenyl)nicotinate (363) 
 
 
 
  
  301 
Methyl-6-fluoro-5-(4’-methoxyphenyl)nicotinate (364) 
 
 
 
 
  302 
 
 
  
  303 
Methyl 2-(4’-methoxyphenyl)isonicotinate (366) 
 
 
 
  
  304 
Methyl-2-(N-morpholinyl)-5-(4’’-methoxyphenyl)nicotinate (369) 
 
 
 
  305 
Methyl-2-(N-piperazinyl)-5-(4’’-methoxyphenyl)nicotinate (371) 
 
 
 
  
  306 
2,3-Dimethyl-5-(4’-methoxyphenyl)pyrazine (391) 
 
 
 
  
  307 
2,5-Dimethyl-3-(4’-methoxyphenyl)pyrazine (392) 
 
 
 
  
  308 
2-Chloro-3-methyl-6-naphthalen-1’-yl-pyrazine (393) 
 
 
 
  
  309 
2-Phenylpyrimidine (398) 
 
 
 
  
  310 
2-Phenyl-5-pyridin-3’’-yl-pyrimidine (401) 
 
 
 
  
  311 
3-Methyl-5-(Bpin)-pyridazine (410) 
 
 
 
 
  312 
 
  
  313 
3-Methyl-5-naphthalen-2’-ylpyridazine (413) 
 
 
 
  
  314 
3-Methyl-6-(3’-fluorophenyl)isoquinoline (423) and 3-Methyl-7-(3’-
fluorophenyl)isoquinoline (424) 
 
 
 
  315 
 
  
  316 
3-(3’-Methoxyphenyl)-1,8-naphthyridine (427) 
 
 
 
 
 
  317 
N-Ethoxy-pyridinium hexafluorophosphate (431) 
 
 
 
  318 
 
 
 
  
  319 
tButyl-1H-indazole-1-carboxylate (450) 
 
 
 
 
  320 
Borylation of tbutyl-1H-indazole-1-carboxylate (450) (in-situ, 400 MHz, (CD3)2CO) 
 
 
  
6.606.656.706.756.806.856.906.957.007.057.107.157.207.257.307.357.407.457.507.557.607.657.707.757.80
f1 (ppm)
1
.1
0
1
.0
7
0
.9
7
1
.0
0
451
4-H
451
7-H
451
6-H
451
5-H
  321 
1-Methyl-1H-indazole (404) 
 
 
 
  
  322 
2-Methyl-2H-indazole (453) 
 
 
 
  
  323 
1-(3’, 5’-Dimethylbenzyl)-1H-indazole (455) 
 
 
 
  
  324 
2-(3’, 5’-Dimethylbenzyl)-2H-indazole (456) 
 
 
 
  
  325 
1-{[2-(Trimethylsilyl)ethoxy]methyl}-1H-indazole (458) 
 
 
 
  
  326 
2-{[2-(Trimethylsilyl)ethoxy]methyl}-2H-indazole (459) 
 
 
 
  
  327 
1-(Methanesulfonyl)-1H-indazole (461) 
 
 
 
  
  328 
1-(Tetrahydro-2H-pyran-2’-yl)-1H-indazole (464) 
 
 
 
  
  329 
2-(Tetrahydro-2H-pyran-2’-yl)-2H-indazole (465) 
 
 
 
  
  330 
Borylation of 1-methyl-1H-indazole (404) (in-situ, 400 MHz, (CD3)2CO) 
 
 
 
Borylation of 1-(3’, 5’-dimethylbenzyl)-1H-indazole (455) (in-situ, 400 MHz, (CD3)2CO) 
 
 
  
6.406.456.506.556.606.656.706.756.806.856.906.957.007.057.107.157.207.257.307.357.407.457.507.557.60
f1 (ppm)
3
.2
7
3
.4
8
3
.0
6
1
.0
2
1
.0
0
2
.0
9
405
4-H
404
3-H
404
4-H
404 + 405
     6-H
404 + 405
     7-H
404 + 405
      5-H
6.106.156.206.256.306.356.406.456.506.556.606.656.706.756.806.856.906.957.007.057.107.157.207.257.307.357.407.457.507.557.60
f1 (ppm)
9
.2
8
3
.0
9
3
.1
9
3
.0
3
1
.1
5
1
.0
9
1
.7
8
466
4-H
455 + 466
     7-H
455 + 466
     6-H 455 + 466
     5-H
455 + 466
2', 4', 6'-H
455
3-H
455
4-H
  331 
Borylation of 1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-indazole (458) (in-situ, 400 MHz, 
(CD3)2CO) 
 
 
 
Borylation of 1-(tetrahydro-2H-pyran-2’-yl)-1H-indazole (464) (in-situ, 400 MHz, 
(CD3)2CO) 
 
 
  
6.456.506.556.606.656.706.756.806.856.906.957.007.057.107.157.207.257.307.357.407.457.507.557.60
f1 (ppm)
1
.7
5
1
.8
4
1
.5
9
0
.7
6
0
.5
9
1
.0
0
458 + 467
     5-H
458 + 467
     7-H 458 + 467
     6-H
467
4-H
458
3-H
458
4-H
6.156.206.256.306.356.406.456.506.556.606.656.706.756.806.856.906.957.007.057.107.157.207.257.307.35
f1 (ppm)
1
.2
6
1
.3
0
1
.2
9
0
.2
4
0
.1
8
1
.0
0
469
4-H
464
4-H
464
3-H
464 + 469
     7-H
464 + 469
     6-H
464 + 469
     5-H
  332 
Borylation of 2-(methyl)-2H-indazole (453) (in-situ, 400 MHz, (CD3)2CO) 
 
 
 
Borylation of 2-(3’, 5’-dimethylbenzyl)-2H-indazole (456) (in-situ, 400 MHz, (CD3)2CO) 
 
 
  
6.406.456.506.556.606.656.706.756.806.856.906.957.007.057.107.157.207.257.307.357.407.457.507.55
f1 (ppm)
1
.2
9
1
.2
6
1
.3
4
1
.1
5
470
4-H
470
7-H
470
6-H
470
5-H
6.756.806.856.906.957.007.057.107.157.207.257.307.357.407.457.507.557.607.657.707.757.807.857.907.958.008.058.10
f1 (ppm)
0
.9
9
1
.9
7
1
.0
3
1
.0
5
0
.9
8
1
.0
0
471
4-H
471
7-H 471
6-H
471
5-H
  471
2', 6'-H
471
4'-H
  333 
Borylation of 2-{[2-(trimethylsilyl)ethoxy]methyl}-2H-indazole (459) (in-situ, 400 MHz, 
(CD3)2CO) 
 
 
 
Borylation of 2-(tetrahydro-2H-pyran-2’-yl)-2H-indazole (465) (in-situ, 400 MHz, 
(CD3)2CO) 
 
 
  
6.406.456.506.556.606.656.706.756.806.856.906.957.007.057.107.157.207.257.307.357.407.457.507.55
f1 (ppm)
0
.9
9
1
.0
0
0
.9
1
0
.9
3
472
4-H
472
7-H 472
6-H
472
5-H
6.356.406.456.506.556.606.656.706.756.806.856.906.957.007.057.107.157.207.257.307.357.407.45
f1 (ppm)
1
.1
9
1
.1
5
1
.0
9
1
.0
9
473
4-H
473
7-H
473
6-H
473
5-H
  334 
1-(Methanesulfonyl)-3-(Bpin)-1H-indazole (468) 
 
 
 
 
  335 
 
  
  336 
1-Methyl-3-phenyl-1H-indazole (481) 
 
 
 
  
  337 
1-Tetrahydropyran-2’-yl-3-(4’-(trifluoromethyl)phenyl)-1H-indazole (483) 
 
 
 
 
  338 
 
  
  339 
1-Tetrahydropyran-2’-yl-3-pyridin-2’’-yl-1H-indazole (485) 
 
 
 
  
  340 
2-Methyl-3-phenyl-2H-indazole (487) 
 
 
 
  
  341 
2-{[2-(Trimethylsilyl)ethoxy]methyl}-3-[4’-(methoxycarbonyl)phenyl]-2H-indazole (488) 
 
 
 
  
  342 
2-{[2-(Trimethylsilyl)ethoxy]methyl}-3-pyridin-2’-yl-2H-indazole (489) 
 
 
 
 
  343 
2-{[2-(Trimethylsilyl)ethoxy]methyl}3-thiophen-3’-yl-2H-indazole (490) 
 
 
 
 
  344 
4-Bromo-1H-indazole (497) 
 
 
 
  
  345 
4-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}indazole (501) 
 
 
 
  
  346 
6-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}indazole (503) 
 
 
 
  
  347 
6-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}-3-[4’-(methoxycarbonyl)phenyl]-2H-
indazole (508) 
 
 
 
  348 
6-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}-3-pyridin-2’-yl-2H-indazole (509) 
 
 
 
  
  349 
4-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}-6-[4’-(methoxycarbonyl)phenyl]-2H-
indazole (511) 
 
 
 
  350 
2-{[2-(Trimethylsilyl)ethoxy]methyl}-6-[4’-(methoxycarbonyl)phenyl]-2H-indazole (514) 
 
 
 
  
  351 
2-{[2-(Trimethylsilyl)ethoxy]methyl}-4-(4’-methylphenyl)-6-[4’’-
(methoxycarbonyl)phenyl]-2H-indazole (518) 
 
 
 
  352 
2-{[2-(Trimethylsilyl)ethoxy]methyl}-3-pyridin-2’-yl-6-[4’’-(methoxycarbonyl)phenyl]-2H-
indazole (521) 
 
 
 
  
  353 
5-Bromo-2-{[2-(trimethylsilyl)ethoxy]methyl}-7-pyridin-2’-yl-2H-indazole (535) 
 
 
 
  
  354 
2-{[2-(Trimethylsilyl)ethoxy]methyl}-7-pyridin-2’-yl-5-[4’’-(trifluoromethyl)phenyl]-2H-
indazole (537) 
 
 
 
  355 
 
  
  356 
N-(4’-Methoxyphenyl)-1H-indazole (540) 
 
 
 
  
  357 
3-Pyridin-2’-yl-N-(4’’-methoxyphenyl)-1H-indazole (541)  
 
 
 
  
  358 
Pyrazolo[1,5-a]pyridine (543) 
 
 
 
  359 
3-(Bpin)-Pyrazolo[1,5-a]pyridine (544) 
 
 
 
  
  360 
 
 
  
  361 
3-(3’-Fluorophenyl)pyrazolo[1,5-a]pyridine (545) 
 
 
 
 
  362 
 
  
  363 
3-(3’-Methoxyphenyl)pyrazolo[1,2-a]pyridine (552) 
 
 
 
  
  364 
4-Aza-1H-indazole (555)  
 
 
 
  
  365 
7-Aza-1H-indazole (556)  
 
 
 
 
 
  366 
4-Aza-1-(tert-butoxycarbonyl)-1H-indazole (557)  
 
 
 
  
  367 
7-Aza-1-(tert-butoxycarbonyl)-1H-indazole (558)  
 
 
 
  
  368 
6-Aza-1-acetyl-1H-indazole (560) 
 
 
 
  
  369 
4-Aza-6-[4’-(methoxycarbonyl)phenyl]-1-(tert-butoxycarbonyl)-1H-indazole (565) 
 
 
 
  
  370 
Borylation of 7-aza-1-(tert-butoxycarbonyl)-1H-indazole (558) (400 MHz, CDCl3) 
 
 
  
7.27.37.47.57.67.77.87.98.08.18.28.38.48.58.68.78.88.9
f1 (ppm)
1
.9
0
1
.0
0
0
.2
9
0
.2
6
1
.2
2
0
.8
6
2
.5
7
558
4-H
558
3-H
567
5-H
566
4-H
567
3-H
558 + 566
      5-H
558 + 566 + 567
           6-H
  371 
Methyl 5-[(1E)-3’-tert-butoxy-3’-oxoprop-1’-en-1’-yl]-2-nicotinate (578) and Methyl 5-
[(1Z)-3’-tert-butoxy-3’-oxoprop-1’-en-1’-yl]-2-methoxynicotinate (579) 
 
 
 
  372 
Methyl 5-[(1E)-3’-tert-butoxy-3’-oxoprop-1’-en-1’-yl]-2-methoxynicotinate(578) 
 
 
 
  
  373 
3-(Bpin)-Anisole (206) 
 
 
 
  
  374 
 
  
  375 
3-[(1E)-3’-tert-Butoxy-3’-oxoprop-1’-en’1’-yl]anisole (582) 
 
 
 
  
  376 
Methyl 2-methoxy-5-[(1E)-2’-phenylethenyl]nicotinate (583) 
 
 
 
  
  377 
Methyl (2E)-3-(5’,6’-dichloropyridin-3’-yl)-prop-2-enoate (585) 
 
 
 
 
